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PURPOSE: Doppler renal resistive index (RRI) has emerged in the last decade as a 
useful prognostic indicator for transient (fluid responsive) and persistent acute 
kidney injury (AKI). The determinants of RRI are largely systemic and recent studies 
confirm that RRI measurement could also be a useful early marker for sub-clinical 
AKI and post procedural AKI risk. This study aimed to determine the feasibility of 
RRI measurement in an Emergency Department (ED) resuscitation room setting 
using a point-of-care ultrasound system.     
 
METHODS: In this prospective single centre study, RRI measurement was 
attempted in 20 non-consecutive patients (meeting the inclusion criteria) by a single 
expert sonographer. RRI measurements were evaluated against context specific 
feasibility criteria and target outcomes. 
 
RESULTS: 20 patients (11 male, 9 female) were recruited to the study. Age of 
patients ranged from 33 years to 91 years (mean 62.3 years). Adequate visualisation 
of both kidneys was achieved in 60% of patients (n=12). In patients where it was not 
possible to achieve adequate views of both kidneys (n=8), limiting technical factors 
were shortness of breath (SOB) (n=6), high BMI (n=2). At least one measurement of 
RRI was achieved in 70% of patients (n=14). However, in 9 of these patients 
(64.3%) the Doppler spectral traces achieved were substandard and did not meet 
the measurement criteria for RRI as specified in the study protocol. In 30% of 
patients (n=6) no usable spectral trace was achieved and it was not possible to 
measure RRI. SOB was noted as a technical difficulty in 60% of patients (n=12) 
including three for whom RRI measurements were achieved. In 9 patients (45%) 
SOB was recorded as the primary reason for failure to acquire a usable Doppler 
trace. All criteria for RRI measurements were met in only 3 patients (15%). 
 
CONCLUSION: 
Measurement of RRI was not feasible in patients requiring resuscitation room care 
using a current point of care ultrasound system. If RRI is to play a useful role in this 
high priority patient group, adaptation of the available technology is required to 
mitigate the problem of image blur due to patient breathing movement. 
 
 




Abbreviations, acronyms and glossary of technical terms 
AKI Acute Kidney Injury AKI encompasses a wide spectrum of renal 
injury mechanisms and is characterised by 
rapid reduction in renal function over a 
period of < 48 hours.  
AKIN Acute Kidney Injury 
Network 
AKIN is an international interdisciplinary 
network promoting clinical, research and 
educational developments around AKI. 
ATN Acute tubular 
necrosis 
Death of tubular epithelial cells that form the 
renal tubules of the kidneys. One of the most 
common causes of AKI. 
CI-AKI Contrast induced 
acute kidney injury 
Decline in kidney function occurring in a 
narrow time frame after administration of 
iodinated diagnostic imaging contrast 
material 
cPP Central pulse 
pressure 
Difference between the systolic and diastolic 




A medical treatment facility specializing in 
emergency medicine and non-scheduled 
acute care.  
EDV End diastolic 
velocity 
Quantitative Doppler measurement of the 





An estimate of the rate at which fluid is 
filtered through the kidneys. Based on serum 
creatinine level, age, sex, and race. eGFR is 
an estimated value with wide confidence 
intervals. Inaccurate in people at extremes 
of body type. 
FTE Full time equivalent Staff - full time equivalent role 
KDIGO Kidney Disease: 
Improving Global 
Outcomes 
KDIGO is an international organisation 
promoting “the care and outcomes of kidney 
disease patients worldwide through the 
development and implementation of global 
clinical practice guidelines”  (KDIGO 2014). 
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MAP Mean arterial 
pressure 
Average arterial pressure. Key determinant 
of diastolic flow and organ perfusion. 
MEW Modified Early 
Warning Score 
Scoring system published by the Royal 
College of Physicians. Used to standardise 
the assessment of acute-illness severity. 
NEW National Early 
Warning Score 
Revised scoring system published by the 
Royal College of Physicians and endorsed 
by NHS England. Used to standardise the 





A protein released by the kidneys following 
renal insult. Possible early indicator of AKI.  
NICE National Institute 
for Health and Care 
Excellence  
NICE provides national guidance and advice 




Capillary wedge pressure 
PSV Peak systolic 
velocity 
Quantitative Doppler measurement of the 




Clinician performed ultrasound at the point 
of patient care. Used as an adjunct to clinical 
examination.  
R&D Research and 
Development 
NHS Trust based research department 
RCEM Royal College of 
Emergency 
Medicine 
UK professional membership organisation 
and registered charity representing 
emergency medicine doctors 
RIFLE (Risk, Injury, 





Classification system for acute kidney injury 
stage. Pre-dates AKIN classification which is 
a modified version of RIFLE 
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An ultrasound Doppler measurement of 
blood flow in the intra-renal arteries. RRI is a 
ration of peak systolic velocity over peak 
systolic – end diastolic measurements. 
 
sCr Serum creatinine A bi-product of muscle metabolism, excreted 
by the kidneys and used as an indicator of 
renal function. Used in estimation of 
glomerular filtration rate.  
SYNTAX Scoring system 
indicating the 
severity of coronary 
artery disease 
Combines anatomic and clinical prognostic 
variables to guide surgical management of 
coronary artery disease. 
 
U&E Urea and 
electrolytes test 
A commonly performed biochemical blood 
test that measures urea and electrolytes, 
















Chapter 1 Introduction and background 
 
This chapter provides a brief introduction to the study and the background 
from which the focused research question has emerged. Context and target 
population are explained and a brief rationale for the study is presented.  
 
Acute kidney injury (AKI) is a complex disorder that is characterised by rapid 
reduction in renal function over a period of < 48 hours. The estimated annual 
costs associated with AKI exceed those of breast cancer, lung cancer and 
skin cancers combined and are expected to rise considerably in an aging 
population (NICE 2013).   
In the United Kingdom (UK) in excess of 100,000 in-hospital deaths per year 
are associated with AKI. However, with the right preventive care and 
treatment, it is estimated that up to 30% of these deaths could be prevented 
(Think Kidneys, 2018; NCEPOD, 2009).  
In acute admissions, an episode of AKI is confirmed in approximately one in 
five patients and is linked closely with poor outcome (Wang et al., 2013). Even 
where patients survive, a minority of patients remain dialysis-dependent 
(Waikar and Winkelmayer, 2006; Wald et al., 2009; Lahmer et al., 2016; 
Spatola and Andrulli, 2016). Therefore, the cost of long term community 
based care can be high. There are no curative therapies for the damage 
caused by AKI which results in irreversible reduction in renal function. 
Therefore, outcomes can only be improved by preventive care and early 
intervention to preserve renal function.  
Despite high level focus on this as a research priority, a reliable method of 
early detection and assessment of individual risk of AKI is still proving to be 
elusive (Darmon et al., 2017). The current method of AKI diagnosis is based 
on assessment of changes in serum creatinine level (sCr) which typically will 
rise 2-3 days after the initial renal insult and on reduced urine output over 
more than 6 hours (Bagshaw et al., 2010; Chang et al., 2010; Ricci et al., 
2011; Lewington and Kanagasundaram, 2011, Darmon et al., 2017). Both of 
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these markers have poor sensitivity and specificity and are limited by an 
inherent time lag between observed changes and the time of initial injury to 
the kidney.  
Oliguria may be an indicator for compromised renal function but, can be 
present due to confounding factors common in acute admissions such as 
dehydration and hypovolaemia. Rise in sCr level occurs in response to falling 
eGFR and is a late marker for reduced renal function. sCr level is also highly 
dependent on a number of patient specific variables such as age, gender, 
ethnicity and BMI. Assessment of sCr therefore requires a meaningful 
baseline value for the patient that is rarely available at the time of acute 
admission.  
Acute kidney injury is not a trivial finding. Even stage 1 AKI is essentially a 
medical emergency that requires early intervention. As definitions of AKI 
stages have been standardised and their natural progression better 
understood, the scale of the problem as a global healthcare challenge has 
emerged. In response, there has been widespread international engagement 
in the search for an alternative method of early diagnosis of AKI and 
identification of patients at risk of AKI.  
Most of the studies identified by this review focus on development of 
biomarkers capable of detecting subclinical AKI and on clinical prediction 
scoring systems to stratify patient risk (Darmon et al., 2017). Exploration of 
biomarkers in particular has gathered pace in the last decade with multiple 
studies evaluating their potential (Soto et al., 2010; Nickolas et al., 2012; 
Schinstock et al., 2012; Vanmassenhove et al., 2013; Kashani et al., 2017). 
However, these tests remain costly; they are widely unavailable and are yet to 
be validated. (These alternative approaches to early AKI diagnosis are 
discussed further in Chapter 9).  
 
Identification of a reliable and cost effective method of early detection of AKI 
could be particularly beneficial in patients admitted to the Emergency 
Department (ED). Management of sick patients in this context frequently 
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requires rapid decision making regarding use of drugs with a known 
nephrotoxic effect or referral for contrast enhanced imaging. The benefit of 
these interventions needs to be balanced against the risk of long term 
irreversible renal damage and associated poor outcome. 
 
1.1 Background 
Development of the focused research question explored by this study was 
prompted initially by discussion with clinical colleagues in critical care 
regarding the use of ultrasound and its contribution to management of 
patients with confirmed AKI. In this context, the incidence of AKI is high 
(Bagshaw, 2010; Darmon, 2011) and ultrasound is used routinely in patient 
assessment when AKI is confirmed by standard tests. 
In critical care patients, prediction of renal recovery is particularly difficult and 
has significant implications for patient management (Zhou et al., 2006; 
Bagshaw et al., 2011; Darmon et al., 2011). Early review of the literature 
focused on the potential role of ultrasound in distinguishing between transient 
reduction in renal function and persistent irreversible damage.   
Against this background, several studies were identified during Phase 2 of the 
PD Health that establish Doppler ultrasound measurement of Renal Resistive 
Index (RRI) as a potentially useful prognostic indicator for AKI (Barbani et al., 
2010; Darmon et al., 2011; Schnell and Darmon, 2012; Guinno et al., 2013; 
Viazzi et al., 2014).  
Subsequent review during Phase 3 identified a further three studies that 
explore the potential role of RRI in the early diagnosis of AKI, as well as its 
performance as a predictor of renal recovery (Bossard et al., 2011; Dewitt et 
al., 2012; Schnell et al., 2013).  
 






Table 1.1  Summary of key critical care studies  
Author, date, country 
and title 
Patient group Study type  Outcomes Key results comments 
Barbani et al (2010)  
Italy 
 
Prognostic value of 
Doppler based renal 
arterial RI in critically ill 








Measurement of RI 
within 24 hours of AKI 
diagnosis using RIFLE 
criteria. 
 
Renal recovery defined 





RRI measured at AKI onset was significantly higher in patients with 
persistence of renal failure than in patients with complete renal recovery 
(0.89 (plus or minus) 0.13 vs. 0.72 (plus or minus) 0.14, p<0.001).  
 
RRI>0.75 had a sensitivity of 81% (95% CI 67-90%), a specificity of 
70% (95% CI 53-82%) and a positive likelihood ratio of 2.75 (95% CI 
1.44-5.13) for persistent renal dysfunction at discharge 
 
n= 38  At discharge : 18 no AKI  20 persistent AKI  mortality rate was 
18.4%  
 
Small sample critical care 
patients 
 
RRI measured within 
24hours 
 
High prevalence (53%) 
High mortality (18.4%) 
Schnell D. et al (2012)  
France 
 
Renal resistive index 
better predicts the 
occurrence of  acute 
kidney injury than 
cystatin c 
n=58 critically ill 
patients with 
sepsis (n=28) or 
polytrauma (n=30) 




Measurement of RI 
and cystatin-c (in 
serum and urine) 
within 12 hours of 
admission 
RI > 0.707 on D1 was the only predictor of the development of AKI stag 
2 or 3 on D3 (p=0.0004) 
In patients with AKI stage 2 or 3 on D1, RI was the only predictor of AKI 
stage 2 or 3 on D3 (p=0.016) 
See Soto et al (2010) 
Cystatin-c as a marker of AKI 
in the ED  
 
High prevalence of AKI  69% 
Guinot P. et al (2013)  
France 
 
Doppler-based RRI can 
assess progression of 
AKI In patients 
undergoing cardiac 
surgery 





Serial measurement of 
RRI pre / post op  
RIFLE classification of 
AKI 
15 patients (18%) developed persistent AKI 
6 patients (7%) developed transient AKI 
RRI >0.73 distinguishes transient from persistent AKI with good 
predictive value 
RRI 0.72-0.75 grey zone 










Table 1.1  Summary of key critical care studies  cont. 
Darmon et al (2011)  
France 
 
Diagnostic accuracy of 
Doppler renal resistive 
index for reversibility of 
acute kidney injury in 
critically ill patients 
ICU patients with 
AKI, ventilated but 
without severe 
CRD or receiving 









Measurement of RI on 
admission and repeat 
serum creatinine. 
RI better than urinary indices for predicting persistent AKI.  
RI> 0.795 has 92% sensitivity and 85% specificity for persistent AKI.  
 
n=51    13 transient AKI (37%) 
             22 persistent (43%) 
Delays in initial 
measurement of RI in some 
patients. 
Intra/inter operator variability 
of RI measurements not 
tested. 
Right kidney only assessed. 
No prospective validation of 
cut off level.  
 
High prevalence of AKI  68% 
Barbani et al (2010)  
Italy 
 
Prognostic value of 
Doppler based renal 
arterial RI in critically ill 








Measurement of RI 
within 24 hours of AKI 
diagnosis using RIFLE 
criteria. 
 
Renal recovery defined 




RI> 0.75 has 81% sensitivity and 70% specificity and +ve likelihood 
ratio of 2.75 for persistent renal dysfunction on discharge.  
 
RRI measured at AKI onset was significantly higher in patients with 
persistence of renal failure than in patients with complete renal recovery 
(0.89 (plus or minus) 0.13 vs. 0.72 (plus or minus) 0.14, p<0.001).  
 
RRI>0.75 had a sensitivity of 81% (95% CI 67-90%), a specificity of 
70% (95% CI 53-82%) and a positive likelihood ratio of 2.75 (95% CI 
1.44-5.13) for persistent renal dysfunction at discharge 
 
n= 38  At discharge : 18 no AKI  20 persistent AKI  mortality rate was 
18.4%  
 
Small sample critical care 
patients 
 
RRI measured within 
24hours 
 
High prevalence (53%) 
High mortality (18.4%) 
Viazzi et al (2014) 
 
Ultrasound Doppler 
renal resistive index: a 
useful tool for the 
management of the 
hypertensive patient. 




Review article  
RRI value 0.60 +/- 0.01 (mean +/-SD) is usually taken as 
normal  
 
0.70 considered the upper limit of 
normal in adults by most authors*   
 
 
Old data *  










Table 1.1  Summary of key critical care studies  cont. 
 
Schnell et al (2013) 
 
Renal Perfusion 
Assessment by Renal 
Doppler During Fluid 











and after fluid 
challenge 
Renal resistive index was unchanged after fluid challenge in both non-
responders (0.72 [0.67–0.75] before and 0.71 [0.67–0.75] after fluid 
challenge; p = 0.62) and responders (0.70 [0.65–0.75] before and 0.72 
[0.68–0.74] after fluid challenge; p = 0.11). 
Systemic hemodynamic 
changes induced by fluid 
challenge do not affect RRI 
measurements in patients 
without AKI, with transient 
AKI, or with persistent AKI 
Dewitt et al (2012) 
 
Doppler resistive index 
to reflect regulation of 
renal vascular tone 
during sepsis and acute 
kidney injury 
Patients admitted 
to ICU with sepsis 





within 24 hours of 
admission.  
Median renal RIs were 0.72 (0.68-0.75) in patients without AKI and 0.76 
(0.72-0.80) in patients with AKI (P=0.001). RIs were 0.75 (0.72-0.79) in 
transient AKI and 0.77 (0.70-0.80) in persistent AKI (P=0.84). 
A poor correlation between 
renal RI and MAP, age, or 
PaO2/FiO2 ratio was found 
in septic and critically ill 
patients without AKI 
compared to patients with 
AKI. These findings suggest 
that determinants of RI are 
multiple. 
Bossard et al (2011) 
 
Early detection of 
postoperative acute 
kidney injury by Doppler 
renal resistive index in 








bypass (CPB) and 




RRI measured in the 
immediate 
postoperative period 




AKI confirmed positive 
when sCr increased 
30% above the 
preoperative baseline 
Post-operative RRI >0.74 predicted delayed AKI with high sensitivity 
and specificity (0.85 and 0.94, respectively). Multivariate analysis 
showed that AKI was associated with increased RRI and transfusion. 
RRI used in the immediate 
POP after cardiac surgery 
with CPB enabled prediction 
of delayed AKI and 





In a meta-analysis of nine related studies (including five of those listed 
above), Ninet et al (2015) investigated the performance of RRI in predicting 
the short term reversibility of AKI in critical care patients. The data analysed 
(n= 449 patients) demonstrate a pooled sensitivity of 0.83 (0.76 – 0.88) and 
pooled specificity of 0.84 (0.79 – 0.88) for persistent AKI in patients with 
elevated RRI.  
Despite methodological differences and heterogeneity in the data collected 
(RRI cut off, patient population and definition of renal recovery), in all of these 
studies RRI performs better than existing tests for AKI in identifying patients 
with persistent reduction in renal function. However, the causative links 
between AKI outcome and raised RRI were unclear. Ninet et al acknowledge 
that there are a number of uncertainties regarding the true significance of RRI 
in these patients and how this relates to renal function. This is exacerbated by 
some inconsistency between studies in interpretation of the natural 
progression of AKI from initial insult to full renal failure.  
 
1.2 How exploration of the determinants of RRI shaped the 
current research question 
To gain a better understanding of the potential role of RRI in the diagnosis 
and management of AKI, results from experimental and clinical studies were 
explored in an attempt to clarify the determinants of RRI. (The results of this 
review are summarised in chapter 3). 
It became apparent from the evidence reviewed that, the key haemodynamic 
determinants of (RRI) are systemic rather than renal. Despite the misleading 
terminology, renal resistive index is not an indicator of renal vascular 
resistance and cannot be interpreted as either a measure of renal perfusion or 
renal function. A more accurate interpretation would be that RRI is a measure 
of the pulsatility of flow in the renal vessels and is determined primarily by 
central aortic pulse pressure.  
In exploring the determinants of RRI, it becomes apparent that there is 
significant overlap between the causative mechanisms for AKI, their impact on 
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systemic and renal haemodynamics and the conditions in which RRI values 
may be raised. In essence, rise in RRI emerged as a potential indicator of the 
conditions in which AKI occurs, rather than as a direct result of renal injury.  
This led to speculation that RRI may be a useful early indicator of sub-clinical 
AKI and could potentially act as an indicator of AKI risk. No previous studies 
were identified that explore this potential predictive use of RRI.  
1.3 Rationale for the study  
If the number of in-hospital deaths associated with AKI is to be reduced, early 
intervention with these patients to preserve renal function is essential. To 
achieve this, renal protective care needs to be administered effectively. Most 
improvement strategies have therefore focused on staff training to raise 
awareness (Hulse and Davies,2015; Think Kidneys 2018). However, as the 
scale of AKI as a global health challenge continues to grow, early diagnosis 
and prediction of AKI risk are likely to be increasingly important. 
1.3.1  Rationale for the choice of patient population 
As the incidence of AKI is particularly high in acute admissions, exploration of 
RRI in patients within the emergency department (ED) was proposed. There 
are well documented operational challenges in emergency care in the UK and 
non-elective admissions (particularly during winter pressure) are associated 
with a spike in AKI associated inpatient mortality (Think Kidneys 2018). 
If subclinical AKI could be identified at the point of admission, this would allow 
early implementation of a renal protective care bundle before patient 
discharge to the ward or community. Stratification of patients to high / low risk 
groups could also inform clinical decision making in the ED, in particular 
around the use of nephrotoxic drugs and referral for contrast enhanced 
imaging.  
Patients were recruited from the resuscitation room as the incidence of AKI in 
this group is high. There is also an increased chance that patients requiring 
resuscitation room care would be admitted and that follow-up biochemistry 




1.3.2  Point-of-care ultrasound in emergency medicine 
To be of value, any new diagnostic test needs to be feasible in the context in 
which it will be used. Over the past two decades, point-of-care ultrasound 
(POCUS) in emergency medicine has emerged as an important clinical 
decision making tool (Brenchley et al., 2006; Thompson, 2008; Katz and 
Yucel, 2011; Levin et al., 2011).  
Local ED practice includes routine use of ultrasound in assessment of 
patients requiring resuscitation room care. This presented an opportunity to 
evaluate RRI measurement in the ED without significant disruption to existing 
care pathways or the need for purchase of additional equipment. 
Focused ultrasound in trauma now forms a mandatory part of training for 
specialist doctors in emergency medicine and sits within the Royal College of 
Emergency Medicine (RCEM) core curriculum. Recognition of ultrasound 
renal anatomy and identification of renal vascular landmarks should fall well 
within the capability of most UK based ED doctors. Part of the reasoning for 
evaluation of RRI in this context was the existing skill set of ED doctors. If RRI 
was confirmed as a feasible and useful indicator of AKI in this patient group, 
introduction of RRI measurement into routine practice could be achievable 
with limited additional staff training.  
Through Phase 2 review of relevant literature, no studies were identified that 
explore the use of RRI as a predictor of AKI risk, or the feasibility of RRI 
measurement in an ED context. The study objectives were formulated to 
explore these key questions. 
 
This chapter has outlined the background from which the focused research 
question emerged and a brief rationale for the study. In the next chapter, the 
definition, aetiology, diagnosis and health impact of AKI will be discussed. 
Implications for management of patients presenting to the emergency 




Chapter 2 Acute kidney injury (AKI) 
 
This chapter provides an overview of the causative mechanisms for acute 
kidney injury (AKI), predisposing risk factors for AKI and how these may relate 
to patients presenting to the emergency department (ED). The definition of 
AKI will be considered along with the limitations of current diagnostic criteria, 
the health impact of AKI and the importance of early diagnosis in patient 
outcome. 
  
2.1 What causes AKI? 
The aetiology of AKI is complex and includes pre-renal, intrinsic and post-
renal causes. (These are summarised in Table 2.1)  
In simple terms, the mechanisms for renal damage can be linked to: 
 reduction in blood supply to the kidneys (either due to low fluid volume 
or circulatory disruption) 
 concentration of substances within the kidneys that are toxic to renal 
tissues 









Figure 2.1 :  mechanisms for renal damage 
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2.1.1  Pre-renal causes of AKI 
Normal renal function is dependent on maintenance of normal blood supply to 
the kidneys. Any prolonged or significant disruption to this can result in renal 
damage. In sick patients, a fall in renal perfusion can occur as a result of 
volume depletion due to vomiting, diarrhoea, blood loss, burns or concurrent 
use of diuretics. 
Renal perfusion may also fall as a result of systemic vasodilation (triggered by 
sepsis or neurogenic shock) or by intrarenal vasoconstriction. This occurs as 
part of the complex feedback mechanisms associated with cardio-renal 
syndrome, hepato-renal syndrome and abdominal compartment syndrome.  
 
2.1.2 Intrinsic causes of AKI 
Intrinsic causes of AKI occur where there is direct damage to renal tissues. 
This may be due to: 
 exposure to medications or substances that are toxic to the kidneys  
 medications that increase risk of hypovolaemia or hypotension 
 inflammatory diseases of the kidneys 
 systemic disease that has an impact on the kidneys 
Intrinsic causes of AKI can be considered in broad categories relating to the 
renal component that is affected [glomerular, tubular, interstitial, vascular] 
(Rahman et al., 2012).    
 
In-patient episodes of intrinsic AKI are most likely to result in acute tubular 
necrosis (ATN) due to an ischemic event or exposure to a nephrotoxic agent 
(Ostermann and Joannidis, 2016). Typically, these mechanisms for intrinsic 
AKI are associated with patients who are more severely unwell. In contrast to 
pre-renal causes of AKI that typically will respond well to therapy, recovery of 
renal function in patients with ATN can be limited due to permanent tubular 
damage. These patients are monitored closely throughout their hospital stay 
and typically have poor renal outcome. 
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Tubular ischemia can also be a contributory mechanism for AKI in trauma 
patients. Muscle injury can result in luminal obstruction caused by 
rhabdomyolysis. In these patients, early diagnosis of AKI is particularly 









Figure 2.2  : Diagram of the renal nephron  
 
In patients presenting to the ED, AKI can also be triggered by  
glomerulonephritis (inflammation of the glomeruli ) resulting from acute 
infection (for example a simple throat infection) or may be present as a 
chronic response to long term illness, the underlying cause of which may be 
difficult to determine (Salifu, M. 2017, para 2).  
 
Acute interstitial nephritis is characterised by inflammation and oedema of 
the renal interstitium (and renal tubules) and is more commonly associated 
with an adverse allergic reaction to medication (Kodner et al., 2003).  
Acute interstitial nephritis is also associated with primary renal infections 
(bacterial and fungal) and with a range of systemic immunological and 
neoplastic pathologies (ibid). 
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Direct disruption of blood supply to the kidney can also trigger AKI. Vascular 
causes include renal vein thrombus, hypertension and infarction.  Underlying 
atherosclerosis may result in an embolic event causing acute arterial 
occlusion. This could be triggered by arterial catheterisation, vascular surgery 
or use of anticoagulants (Dubose TD Jr, Santos RM. 2016). 
 
2.1.3 Post-renal causes of AKI 
Post-renal causes of AKI are normally less complex with scope for full renal 
recovery if diagnosed early.  
Extra-renal obstruction mechanisms include prostatic enlargement, 
neurogenic bladder and pelvic mass.  
Intra-renal obstruction is most typically due to the presence of renal calculi. If 
associated with infection, this can lead to rapid renal cell destruction.   
 
2.1.4  Causative mechanisms for AKI in patients presenting to the 
Emergency Department  
Patients attending the ED will fall into each of these broad categories with 
further complexity in the underlying trigger for intrinsic renal failure.  
In the ED setting, determination of the underlying cause for AKI is always a 
priority as this trigger mechanism may be in itself an acute condition that 
requires rapid treatment (for example sepsis). However, in terms of patient 
recovery of renal function following an episode of AKI, current thinking 
suggests that the duration and severity of injury appear to be of more 
importance than the causative mechanism (Ninet et al., 2015). Early 
definitions of AKI distinguish between transient reduction in renal function 
(resulting from short term reduced renal perfusion) and persistent AKI that has 
resulted from permanent damage to renal structures (Ninet et al., 2015). 
However, AKI is not a ‘binary’ condition and a test +ve / -ve approach is 
unhelpful. As understanding of AKI has evolved, it has become apparent that 
AKI is a continuum (Takasu et al., 2013) of progressive renal damage that 
may be masked in patients with high functional reserve. 
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In all cases, identification of patients in the earliest possible stage of this 
process of renal cell destruction is most likely to result in good recovery of 
renal function. The Kidney Disease Improving Global Outcome Initiative 
(KDIGO) now classifies AKI as fluid responsive or non-fluid responsive, 
highlighting the importance of early detection and treatment rather than focus 
on differentiation of cause.  This represents a shift away from focus on 
differential diagnosis of cause and recognises the importance of early 
detection and assessment of risk.  This is a key driver for this study.  
 
Table 2.1  :Summary of the causes of AKI 
Pre-renal Intrinsic Post-renal 
Drop in renal perfusion 









Drop in renal perfusion 













Acute tubular necrosis (ATN) 
due to: 
 ischemic event 




 Muscle injury 
(rhabdomyolysis) 
 
Glomerulonephritis due to: 
 acute infection 
 long term illness 
 
Acute interstitial nephritis 
 allergic reaction to 
medication  
 primary renal infections 
 systemic immunological 
pathology 
 neoplastic pathology 
 
Vascular causes 
 renal vein thrombus 
 hypertension 
 infarction 
 embolic event 
 (causing acute arterial 
occlusion - triggered by 
arterial catheterisation, 










 pelvic mass 






2.2 Definition, diagnosis and classification of Acute Kidney 
Injury 
One of the challenges in review of studies relating to the diagnosis and 
epidemiology of this condition is lack of historic consensus on definitions of 
AKI. In recent years, international consensus has led to refined classification 
of AKI presence and severity (KDIGO 2012, NICE 2013). However, current 
detection methods are still based on identified changes in serum creatinine 
level (sCr) and on reduced urine output.hours (Bagshaw et al., 2010; Chang 
et al., 2010; Ricci et al., 2011; Lewington 2011).  
 
Both of these indicators are problematic in the ED where baseline sCr level 
may be unknown and rapid decision-making is required. In the absence of a 
known baseline, raised sCr is generally assumed to be attributed to possible 
AKI. This leads to low test specificity. However, patients may also present 
following recent significant renal insult but before sCr change occurs. As the 
symptoms of AKI are vague (or can be absent) in these patients, potentially 
preventable progressive renal damage may be missed.  
 
Typically, in the ED, estimated glomerular filtration rate (eGFR) (based on 
sCr, patient age, sex, and race) is used to assess AKI risk on initial patient 
presentation.  All patients admitted to the local Trust ED have a Urea and 
Electrolytes Test (U&E) on arrival. (Fig. 2.3) Follow up care includes check of 
U&E daily in those who are acutely unwell and remain at risk of AKI. 
Electronic reports are issued on a Trust wide clinical management IT platform 
for all inpatients with a rise in creatinine consistent with AKI.  An electronic 
care bundle is also available and is completed for every patient with 
























Figure 2.4: Local Trust electronic clinical management system – AKI care bundle 
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Staging to indicate severity of AKI is based on the current diagnostic criteria 
detailed in Fig. 2.5. However, there is well documented evidence that sCr is a 
poor marker of early renal dysfunction (Soto et al., 2010; KDIGO 2012). eGFR 
may remain within the normal cut off range of > 60 even where up to 50% of 
nephrons are lost (Sharma et al., 2014). This limits the value of eGFR as a 
measure of renal functional reserve. eGFR also lacks the specificity to 
distinguish between AKI, chronic renal failure and prerenal azotemia (volume 
depletion) that may be reversed through early fluid administration (Di Somma 
et al., 2010).  
Whilst consensus on AKI definition and staging is helpful, review of current 
literature confirms that the status of sCr based evaluation of patient risk has 
been largely unchanged for several decades. Current protocols remain 
susceptible to delayed diagnosis and missed decline in renal function 
(Bagshaw et al., 2013). This is a key driver in the search for alternative 
approaches to early diagnosis, prognosis and decision-making  
 The AKI staging system is based on change in serum creatinine and urine output. If 
these lead to different AKI stages, use the highest.  
 
 iCM will issue reports on all patients who sustain AKI (see below). These reports only 
take account of changes in creatinine and it is up to you to consider changes in urine 
output.  
 
Stage Serum creatinine  Urine output  
1 
 
Increase in serum creatinine of  >26mol/L from 
baseline within a 48hr period 
or 
Increase of 1.5  to 1.9 times baseline 
< 0.5 mL/kg/hour  
for > 6 hours 
2 
 
Increase in serum creatinine of 2 to 2.9 times 
baseline 
< 0.5 mL/kg/hour  
for > 12 hours 
3 
 
Increase in serum creatinine to 3 times baseline  
or  
Increase in serum creatinine to >354mol/L  
or 
Initiation of renal replacement therapy 
< 0.3 mL/kg/hour 
for > 24 hours  
or  
no urine output > 12 hours 
 Baseline creatinine is taken as the most recent stable creatinine value, extending back 
to twelve months if necessary. When no previous creatinine measurements are 
available, an estimated baseline creatinine can be back-calculated using an eGFR of 
75ml/min (this will be performed automatically in iCM). In these circumstances, a clinical 
decision has to be made as to whether a raised creatinine indicates AKI or whether the 
patient has CKD. Repeating the creatinine to look for subsequent acute change and 
taking account of the clinical picture may help. 
 
Figure 2.5: Local Trust criteria for recognising and staging AKI (2017) 
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2.3 Health impact of AKI 
AKI is recognised internationally as a major public health concern (Silver et 
al., 2017). The incidence of AKI continues to increase and is expected to 
more than double over the next decade (Bedford et al., 2014; Arias-Cabrales 
et al., 2017: Darmon et al., 2017; Medcalf et al., 2016). Although rarely the 
solitary cause of death, AKI is associated with significant mortality and has 
been associated with in excess of 40,000 avoidable deaths per annum in the 
UK alone (Kerr et al., 2014).  The financial burden of AKI on the UK National 
Health Service has been estimated at £1.02 billion (just over 1% of the total 
NHS budget.) In-hospital costs are associated with increased length of 
hospital stay, use of critical care services and increased use of complex 
interventions (Challiner et al., 2014).  
AKI is seen in 5-15% of all hospital admissions and is particularly common in 
the elderly. One in five patients with AKI will die during their hospital 
admission and mortality rates rise to above 30% in those with more severe 
AKI (stages 2 and 3).  
Incidence of AKI in patients presenting to the Emergency Department (ED) is 
unknown. In unselected UK emergency admissions it has been estimated at 
25% (Challiner et al., 2014) with approximately one third of cases confirmed 
on initial presentation.  In patients where a baseline for renal function tests 
was available at the time of admission, the incidence of AKI in these patients 
was 38%. In this study by Challiner et al (2014), as in previous studies (Zhou 
et al., 2006; Akcay, 2010; Bagshaw et al., 2011; Darmon et al., 2011), AKI 
was associated with increased hospital stay (more than double), admission to 
critical care and increased mortality (odds ratio for death : stage 1 AKI - 2.0, 
stage 3 AKI –10.1).  
A limitation of all studies exploring the incidence of AKI in acute admissions is 
the absence of a credible baseline creatinine level. Ideally this should be the 
lowest SCr recorded > 90 days prior to an acute admission (Bedford et al., 
2014). Where pre-morbid renal function is unknown, it is not possible to 
distinguish between acute and pre-existing chronic renal disease.  
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In practice, pre-hospital measurement of SCr may not be available. In a 
retrospective review of 66,829 admissions to a UK based district general 
hospital, baseline SCr was available in 87% of patients (Challiner et al., 
2014). However, the authors note that this percentage is likely to be 
significantly lower in most contexts as the Trust at which the study was 
performed has implemented routine increased frequency of testing due to 
heightened awareness of AKI risk.  
The extent to which true incidence of AKI in unplanned admissions is over or 
under estimated is unknown. However, it is estimated that, in up to two thirds 
of UK emergency patients, AKI will remain undetected until after admission 
(Challiner et al 2014). This is largely due to the limitations of creatinine based 
tests.  For these patients, potentially avoidable delay in preventive treatment 
will have implications for both cost and outcome. 
There is also some indication that the number of patients discharged with 
undiagnosed AKI may be increasing. The extent to which this may be due to 
changes in the classification and reporting of AKI is difficult to determine. 
However, following the NCEPOD report (2009), review of patients dying post 
discharge suggests that failure in AKI may be a contributory factor in around 
50% of cases (Meran et al., 2014).   
In an aging population, use of recognised nephrotoxic agents that act as 
triggers for AKI (non-steroidal anti-inflammatory and anti-hypertensive drugs 
etc.) is increasing (Akcay et al., 2010). The financial burden associated with 
short and long term treatment of AKI will rise accordingly. When extended 
hospital stays and long term community based care for these patients are 
considered, the overall costs are eye-wateringly high. Even a modest 
reduction in the number of patients with a delayed diagnosis could provide 
non trivial financial savings. The flurry of research activity around this goal is 






2.4 Risk factors for AKI 
AKI does not occur in isolation. It has been considered a marker of ill health, 
the risk of which increases as patient wellbeing deteriorates (Darmon et al., 
2017).  Patients requiring resuscitation room care are invariably unwell. 
However, there are multiple factors that may be unrelated to the patients 
presenting condition that increase individual risk of AKI.  
In patients who are pre-morbidly well (e.g. trauma patients) risk of AKI may be 
directly related to their immediate illness. (e.g. crush injury, bleeding, burns 
etc.) However, the majority of patients attending the ED will have some 
relevant risk factors that pre-date their current admission. It has been 
estimated that approximately 65% of acute kidney injury starts in the 
community (Selby et al., 2012).  
Multiple risk factors that predispose patients to an episode of AKI are well 
documented and high risk groups can be identified (Bagshaw et al., 2005; 
Challiner et al., 2014). These are summarised below. 
Table 2.2  :Summary of risk factors for AKI           
Age ≥65 years Hypovolaemia Current or recent medication with nephrotoxic 
potential - eg, NSAIDs, ACE inhibitors, 
AIIRAs, aminoglycosides, diuretics 
Chronic kidney 
disease - eGFR 
<60 
Liver disease  Use of iodinated contrast agents within the 
previous week 
Past history of AKI Diabetes Neurological impairment or disability that may 
impact on self-care and hydration 
Cardiac failure 
 
Sepsis Deteriorating early warning scores (NEWS) 
Peri-operative 
patients 
Hypertension Cerebrovascular disease 
Dementia 
 
Malignancies Chronic lung disease 
Alcohol abuse 
 
Stroke Connective tissue disease 
                             (Bagshaw et al., 2005;  Challiner et al., 2014) 
Undoubtedly, the primary risk factor for AKI is age and is associated closely 
with the long term conditions that are more common in the elderly. Poor 
outcome is noted in the frail or elderly in particular as they are more likely to 
lack the functional reserve to cope with further renal damage.  The impact of 
multiple co-morbidities (such as heart failure, diabetes and chronic renal 
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disease) may be exacerbated by dehydration due to poor self-care.  In these 
patients, there may be no single cause for AKI but rather a pattern of multiple 
risk factors including long term exposure to nephrotoxic drugs, vascular 
disease, poor cardiac output, chronic renal disease and a short term trigger 
such as fluid depletion.   
In response to the National Confidential Enquiry into Patient Outcome and 
Death report (2009), the “Think Kidneys Acute Kidney Injury (AKI) 
Programme” was established in 2013 by the UK National Patient Safety team 
(now part of NHS Improvement).  The central aim of this initiative was to 
improve the management of AKI. Building on NICE guidance (2013) one of 
the work streams within this programme focused on identification of patient 
risk factors.  Better understanding of the relationship between underlying 
contributory factors and the trigger mechanisms that result in an episode of 
AKI may improve risk prediction.  By combining detailed patient data with real 
time hospital wide electronic reporting systems, this will inform both 
preventive strategies and individual patient management decisions. These 
initiatives remain a strong focus for further research and enquiry. However, 
the Think Kidneys Report (2017) concludes that, to date there are no reliable, 
validated AKI risk scores for patients presenting in primary or secondary care. 
Therefore, for patients presenting to the ED, we remain reliant on sCr based 
tests. 
 
This chapter has outlined the triggers for AKI, why this is a major public health 
concern and the importance of early diagnosis in improving outcomes.  
In the next chapter, renal resistive index (RRI) will be considered as a semi-
quantitative indicator of renal blood flow characteristics. Results from 
theoretical models and experimental data will be considered in an attempt to 
understand the relative importance or renal and systemic haemodynamic 




Chapter 3 Doppler Renal Resistive Index 
 
This chapter provides an overview of the key haemodynamic determinants of 
renal resistive index (RRI) and aims to clarify their relative importance. With 
reference to a simplified theoretical model, evidence from experimental and 
clinical studies will be considered and early interpretation of RRI will be 
challenged. By exploring the impact of systemic and renal factors, we gain a 
better understanding of the potential value of RRI as a predictor of renal 
damage.  
 
Doppler ultrasound has been used extensively for many decades in the 
assessment of vascular disease, haemodynamics and organ perfusion.  
The Doppler Effect was first described in 1842 by the Austrian mathematician 
Christian Doppler in his landmark paper “On the coloured light of the double 
stars and certain other stars of the heavens”.  Whilst this paper described 
frequency shift in light from stars, similar effects are observed when sound 
waves are emitted from or reflected by moving structures.  This is perhaps 
most widely recognised in the shifting frequency of an emergency siren as the 
vehicle travels towards or away from the observer.  
Medical ultrasound systems utilise the shift in frequency that occurs when 
sound is reflected from a moving target (red blood cells) to determine the 
direction and velocity of blood flow in target vessels. By comparing the 
frequency profile of a reflected wave with the frequency spectrum of the 
transmitted pulse, flow within the vessel can be quantified and a range of flow 







3.1 Doppler assessment of blood flow 
3.1.1  Colour Doppler 
The Doppler signal can be displayed as either a colour-coded overlay 
superimposed on the brightness mode image (Figure 3.1a), or as a graphical 
representation of velocity proﬁle over time (Figure 3.1 b) (Venables, 2011).  
Colour coded Doppler techniques allow identification of target vessels from 
which a spectral trace can be captured by placing a sample gate within the 
position of the vessel lumen.  
 
 
3.1.2  Spectral Doppler 
Through repeated sampling along a single line of sight, a spectral trace is 
generated that corresponds to the changing profile of blood flow though the 
vessel throughout the cardiac cycle. This is achieved by transmission of 
multiple pulses along the selected line within the image frame. Analysis of the 
return signal allows extraction of Doppler shift values corresponding to 
movement of reflecting targets (red blood cells) within the sample gate. These 
signals are then displayed along a time base as brightness values 
(determined by signal amplitude) at each velocity. The resultant spectral trace 
corresponds to the flow profile across the vessel throughout the cardiac cycle. 
Typically this will be parabolic with slow moving blood close to the vessel 
walls due to frictional drag.  
 
Figure 3.1a  LS section of upper 
pole of the kidney: Colour 
Doppler box is placed over the 
renal hilum. The Doppler sample 
gate is located over the lumen of 
an interlobar artery from which a 







Figure 3.1c  Flow profile across vessel:  parabolic profile due to frictional drag at vessel walls 
 
3.1.3  Quantitative assessment of blood flow 
From the spectral trace, a range of parameters can be calculated to quantify 
flow characteristics, including peak systolic (PSV) and end diastolic (EDV) 
velocities.  
 
Figure 3.1d  Peak systolic velocity (PSV) and end diastolic velocity (EDV) measurements  







Figure 3.1 b  Colour Doppler 
is use to identify the 
interlobar vessels from which 
a spectral trace is captured. 
Peak systolic and end 
diastolic measurements are 
recorded by placing the 
measurement calliper at the 
relevant position within the 




3.2 Definition of resistive index 
Doppler Resistive Index (RI) was first proposed in the mid-1970s by French 
medical doctor / electrical engineer Léandre Pourcelot.  
RI is an expression of the percentage reduction in end diastolic flow in relation 
to maximum flow at peak systole.  
 
RI =  PSV – EDV 
               PSV 
       PSV =  peak systolic velocity 
       EDV =  end diastolic velocity 
 
3.3 Renal resistive index (RRI) 
Renal resistive index (RRI) has been used for several decades as a potential 
indicator for renal disease and progression (Darmon et al., 2011; Barbani et 
al., 2010; Scnell et al., 2012; Viazzi et al., 2013; Guinno et al., 2013). 
Emerging initially as a measure of renal function in patients with renal artery 
stenosis (Radermacher et al., 2001) RRI was assumed to be directly 
associated with altered resistance to flow within the kidney and associated 
with a range of renal pathological structural changes. Despite this, 
subsequent experimental and in vivo studies have demonstrated that RRI is 
more closely associated with systemic factors (Boddi et al., 2015; 
Cauwenberghs and Kuznetsova, 2016).  
Ironically, repeated clinical studies have demonstrated that RRI appears to 
have very little dependence on renal vascular resistance (Hashimoto and Ito, 
2011; Naesens et al., 2013; Chirinos et al,. 2014; O’Neill 2014; Kuznetsova et 
al., 2015; Lee et al., 2015). For this reason, use of RRI as a useful (direct) 
indicator for renal disease has been challenged. However, RRI has been 
shown to be affected by a number of extra-renal factors that explain the 
observed value of RRI as a strong prognostic indicator for patients with renal 





3.4 What are the theoretical determinants of RRI? 
Despite the term ‘resistive index’, this dimensionless ratio is more accurately 
an indicator of flow pulsatility. Simplified analysis (O’Neil, 2014) demonstrates 
that this model of RI is largely independent of vascular resistance.  
 
 
RI  =  PSV – EDV                             RI  =  1  -  EDV              
               PSV                                                    PSV 
 
 
Velocity (V)   =             Flow           
                          Lumen area (LA) 
 
Flow   =   difference in blood pressure  (ΔP) 




Therefore:    V   =      ΔP 
                   R x LA 
 
As    
RI  =  1  -  EDV 





Although luminal cross sectional area and pressure within the vessel will 
change during systole and diastole, renal vascular resistance is unlikely to 









Whilst this simplified model explains in part the relative independence of RRI 
from vascular resistance, this does not take into account the complexity 
associated with distal vascular compliance (capacitance) or non-uniform flow 
throughout the cardiac cycle. Once impedance of the distal vascular bed is 
considered, RI does demonstrate some dependence on resistance. (O’Neil, 
2014) 
 
3.5 What are the key haemodynamic determinants RRI? 
Whilst, experimental and in vivo studies demonstrate an inconsistent 
relationship between RRI and vascular resistance, three haemodynamic 
parameters emerge that appear to have a direct impact on RRI.   
 Ratio of diastolic to systolic blood pressure 
 Combined effect of interstitial and venous pressure 
 Ratio of lumen area in systole and diastole at the sample site 
 
O’Neil (2014) clarifies the mathematical relationship between these factors 












3.5.1  Ratio of diastolic to systolic blood pressure   (Pdiast  and   Psyst )   
The ratio of Pdiast  and Psyst is an inverse function of pulse pressure and is 








Experimental data confirm a strong correlation between RI and aortic pulse 
pressure (Hashimoto and Ito, 2011; Chirinos et al., 2014; O’Neil, 2014). 
There is also strong support from a number of clinical studies where pulse 
pressure appears to be the main determinant of RRI (Naesens et al., 2013; 
Lee et al., 2015) 
 
Pulse pressure is affected by: 
 Cardiac output 
 Fluid volume 
 Systemic arterial compliance (vascular stiffness) 
 Heart rate 
 Blood pressure 
 Renal artery disease 
 Distal vascular disease 




3.5.2  Combined effect of interstitial and venous pressure    Po  





Anything that changes interstitial or venous pressure will affect RI.  
 
The kidney is encapsulated by a thin fibrous sheath that provides a degree of 
stability and protection for the organ. In the presence of hydronephrosis, acute 
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inflammation, oedema or haematoma, the kidney volume increases. However, 
this expansion of the kidney is limited, with the renal capsule providing the 
major opposing force (Hebert et al., 1975). Intrarenal pressure therefore 
increases under these conditions.  
Similarly, venous pressure may change due to renal vein thrombosis, 
hypovolaemia or vasoplegia (due to sepsis or post-surgery). 
 
 




Vessel lumen cross sectional area (LA) changes throughout the cardiac cycle.  
The relative cross sectional area at systole and diastole is a theoretical 
determinant of RRI and is affected by  
 vascular wall stiffness 
 vessel compliance 








3.6 Determinants of RRI: Evidence from clinical and 
experimental studies 
 
Numerous clinical and experimental studies demonstrate the complexity of 
associations between RRI and systemic haemodynamic factors.  
Early investigations (primarily of patients presenting with renal artery stenosis) 
focused on renal recovery, identifying poor outcome in patients with raised 
RRI (Radermacher et al., 2001; Chirinos et al., 2014). Subsequent studies in 
critical care have generated a wealth of evidence supporting the close 
association of RRI with a number of outcome measures including renal 
recovery, need for long term renal replacement therapy and death (Ninet et 
al., 2015; Boddi et al., 2016).  
Despite the promising role of raised RRI in patient prognosis and predication 
of renal recovery, a growing body of research confirms that systemic factors 
are the key determinants of RRI and that RRI cannot be considered a useful 
direct indicator of renal disease. Interpretation of these somewhat 
contradictory findings requires a better understanding of the complex 
association between non-renal haemodynamic factors, individual patient 
characteristics, how these affect renal blood flow and their potential influence 
on risk of renal damage. The impact and relative contribution of these factors 
as determinants of RRI are explored in the following sections. 
 
3.6.1  Systemic factors - How is RRI affected by blood pressure? 
The observed relationship between RRI and the components of blood 
pressure (steady and pulsatile) are consistent with our theoretical 
understanding of RRI and also offer some insight into how these systemic 






3.6.1.1  Influence of mean arterial pressure on RRI 
General population studies (Kusnetzova et al., 2014; ) and studies of 
hypertensive patients (Calabia et al., 2014; Chirinos and Townsend 2014) 
demonstrate a consistent inverse relationship between RRI and mean 
arterial pressure (MAP) that appears to be independent of other co-variables 
(Cauwenburghs et al., 2016).  Whilst this is not a direct indicator of renal 
function, reduced MAP over time would be consistent with a pattern of poor 
renal perfusion.  
 
 
↓ MAP           ↓ diastolic pressure           ↓ EDV          ↑ RRI 
 
However, this relationship does not appear to hold in critically ill patients with 
sepsis where poor correlation between RRI and MAP is noted (Dewitt et al., 
2012; Lahmer et al., 2016). This suggests that, in these patients, other factors 
affecting renal circulation may have a more dominant role in RRI. (Whilst this 
effect is poorly understood, this does limit the use of RRI in management of 
fluid balance in these patients.) 
 
3.6.1.2  Influence of pulse pressure on RRI 
A key determinant of pulse pressure is compliance of the large arteries. In a 
normal patient, as blood is ejected from the heart, expansion of the aorta 
effectively dampens the pulse. This effect contributes to maintenance of 
continuous steady flow to the kidneys. Where compliance of the aorta is 
reduced due to vessel wall stiffening, this damping effect is absent and the 
renal microvasculature is exposed to high pulse pressure. In a review of 
studies exploring the association between aortic stiffening and microvascular 
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disease, O’Rourke et al (2005) propose that these high pressure fluctuations 
(increasing markedly with age of the patient) may result in epithelial damage 
leading to renal insufficiency.   
These findings have led to a plethora of studies that explore the relationship 
between RRI and central pulse pressure (cPP) or peripheral pulse pressure 
(pPP) (Tedesco et al., 2007; Hashimoto and Ito, 2011; Stea et al., 2013; 
Ponte et al., 2014; Kusnetzova et al., 2015). In all cases, a consistent and 
significant positive association is noted. (These are summarised in Table 3.8) 
 
↑ cPP           ↑ systolic pressure           ↑ PSV          ↑ RRI 
(cPP = Central pulse pressure) 
 
One of the key challenges of studies exploring this association is the difficulty 
of separating the contributory effects of renal and non-renal factors. This is 
further complicated by the fact that a high proportion of recent studies have 
been undertaken in critical care, where patients have multiple confounding co-
morbidities and high incidence of chronic renal disease.  
This has been resolved (at least in part) by studies of transplant kidneys 
where RRI is also noted to be strongly dependent on aortic pulse pressure of 
the recipient rather than the donor (Tublin et al., 1999; Akgul et al.,2009; 
Hashimoto and Ito, 2011; Naesens et al., 2013;  et al., 2013). 
In a landmark study in 2013, Naesens et al compared baseline RRI and RRI 
at the time of biopsy in 321 transplant recipients. Unlike studies of native 
kidneys, in transplant patients, the relative contribution of renal and systemic 
factors on RRI can be explored. This allowed close scrutiny of the relationship 
between RRI measurements and renal histology.  
In this study, the strongest independent factor for increased RRI was recipient 
age (P<0.001). However, there was also close association with increased 
pulse pressure and reduced MAP. The authors conclude that serial 
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measurements of RRI at the time of biopsy reflect characteristics of the 
recipient rather than the graft. This important study supports the conclusion 
that RRI is of limited use as a direct indicator of renal function. However, in 
the same study population, RRI was closely associated with recipient survival. 
This supports the usefulness of RRI for prognostic stratification in sick 
patients.  
 
3.6.2  Relationship between RRI and Cardiac output 
Normal renal function is dependent on a constant blood supply which is, in 
turn, dependent on cardiac output. Renal autoregulation is essential in 
maintaining stable glomerular filtration rate (GFR). The heart and kidneys also 
play a closely associated role in maintaining haemodynamic stability and 
severe dysfunction in either of these organs is unlikely to occur in isolation 
(Bock et al., 2010).  
The amount of blood available to the kidney (roughly 20% of total cardiac 
output) is dependent on total blood volume and on left ventricular output.  
Kuznetsova et al (2015) explored the relationship between RRI and left 
ventricular outflow in a general population study (n = 171). Doppler 
assessment of left ventricular outflow tract (LVOT) and transmitral peak 
velocities demonstrated significant association of RRI with central pulse 
pressure and left ventricular systolic and diastolic Doppler blood flow indexes. 
(RRI was significantly and positively associated with LVOT and E peak 
velocities (P ≤ 0.012) and VTIs (P ≤ 0.010).) 
Although the precise causal relationship is unclear (acknowledged by the 
authors), this study demonstrates that, in an unselected population, the 
Doppler spectral profile within the intrarenal arteries is influenced by cardiac 
hemodynamic factors. However, in the same study, the correlation between 
RRI and cardiac factors was not as strong as that observed with central pulse 
pressure (P < 0.0001).  
The findings of this study (of well patients) are difficult to translate to a sick or 
elderly in-hospital population where cardiac output is likely to be 
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compromised. No studies are identified that explore simultaneous longitudinal 
changes in cardiac and renal haemodynamics. However, altered cardiac 
output in a critically unwell or ED population is likely to be of more significance 
than this study suggests. This could be particularly relevant in older patients 
presenting with reduced left heart function in combination with hypovolaemia 
or vasoplegia associated with fluid loss or sepsis.  
 
3.7 Renal causes of altered RRI  
The experimental and clinical studies reviewed provide compelling evidence 
that changes in RRI are determined predominantly by systemic 
haemodynamics rather than isolated renal pathology. However, there are 
instances where a direct causal link with renal factors has been 
demonstrated.  
 
3.7.1  Interstitial pressure and vascular compliance 
RRI clearly reflects renal artery pulsatility (Cauwenberghs et al., 2016; 
Kuznetsova et al., 2015) and as such may be a useful indicator of early stage 
renal microvascular damage. From the mathematical model outlined by O’Neil 
(2014), raised interstitial pressure (iP) will also affect RRI. The impact of 
moderately increased iP may be masked by autoregulation. However, where 
iP is more markedly increased, luminal cross sectional area and end diastolic 
velocity (EDV) are likely to be affected. These predicted findings are 
confirmed by experimental study of ex-vivo hydronephrotic kidneys (Murphy 
and Tublin 2000).  
Although RRI appears to be largely independent of vascular resistance (the 
ratio of pressure to flow) (Bude et al., 1999;  Tublin et al., 1999; Chirinos et 
al., 2014) experimental evidence supports the hypothesis that changes in 
compliance of the renal vascular bed and interstitium are contributory factors 
in the raised RRI values observed where renal disease is present. Direct 
evaluation of the stiffness and elasticity of intrarenal arteries is problematic. 
However, in an elegant study of isolated perfused rabbit kidneys, Murphy et al 
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(2000) explored this effect indirectly by inducing raised interstitial pressure via 
incremental increase in ureteral pressure.  
As a surrogate measure of overall distensibility of the vascular bed, vascular 
conductance (ratio of flow to pressure) was measured (along with mean flow, 
mean pressure and RRI) under different driving arterial pressures. They 
hypothesized that the raised iP caused by obstruction of the kidney would 
restrict distension of the intrarenal arteries and arterioles.  
In this landmark study, increase in ureteral pressure was associated with: 
 consistent and reproducible increase in RRI   
 increase in RVR (overall mean renal vascular resistance) 
 significant reduction in flow 
 significant reduction in mean conductance 
(P< 0.05 for all values) 
Of particular note was the relative reduction of conductance measured at 
systole and diastole. A greater proportional reduction (and hence flow) was 
observed during diastole.  
The kidney is inherently a low resistance structure, evidenced by the positive 
flow throughout diastole seen in a normal spectral waveform.  
                                                                     
Figure 3.7:   Renal inter-lobar artery spectrum. Positive flow throughout the cardiac cycle   





In a normal kidney, iP is approximately zero. Arterioles have high cross 
sectional area and these small compliant vessels are free to expand during 
systole.  
The distensibility of a vessel is dependent on wall stiffness, the pressure 
exerted through the wall (transmural pressure) and the compliance of the 
surrounding interstitium. In this study, Murphy et al (2000) hypothesised that, 
when iP is raised, arterioles will dilate to approximately full extension during 
systole, but will collapse down to close to occlusion during diastole. End 
diastolic flow is therefore reduced.  
As RRI is a ratio of peak systolic to end diastolic flow (PSV – EDV / PSV) this 
would account for the observed increase in RRI.  
 
The relative contribution of renal vascular resistance and compliance in 
raising RRI is difficult to determine from this study. However, previous 
experimental work by the same authors confirmed that even marked increase 
in vascular resistance (through pharmacologically induced vasoconstriction) 
resulted in only minimal increase in RRI (Tublin et al., 1999; Murphy et al., 
2000). They conclude that the impact of raised iP on conductance (particularly 
at diastole) seems to be the reason why RRI rises with increased ureteral 
pressure.  
Results from these important studies suggest that, in addition to pulse 
pressure, raised interstitial pressure has an important role in increasing RRI. 
This raises the possibility that RRI could be a direct indicator of renal 
pathologies that increase interstitial pressure or reduce vessel distensibility. 
 
3.8 Patient characteristics affecting RRI 
In addition to the haemodynamic factors considered in this chapter, a number 
of patient anthropometric characteristics have also been linked with RRI.  
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General population studies (Ponte et al., 2014; Kuznetsova et al., 2015) show 
a strong positive correlation between RRI and subject age, female gender and 
body weight and a negative correlation with height.  
In addition to these independent patient characteristics, in large studies of 
hypertensive patients (Tedesco et al., 2007; Hashimoto and Ito, 2011; Stea et 
al., 2013) multi-variate analysis demonstrates a positive correlation between 
RRI, hypercholesterolemia and use of renin-angiotensin system (RAS) 
inhibitors. 
 
In general, patient age is identified in all studies as the strongest independent 





Study population ↑ RRI cut off Independent correlation 
with patient 
characteristics 




0.64 + 0.05  (female) 
0.62 + 0.05  (male) 





0.61 + 0.06  (female) 
0.59 + 0.06  (male) 






0.63 + 0.07 ↑ age, BMI 
Tedesco  
2007 


















0.65 + 0.05 ↑ age, body mass, insulin 
resistance 
↓high coffee consumption 
 
                                                                             (Adapted from Cauwenberghs p.174; 2016) 






3.9 Factors affecting AKI risk reflected by raised RRI 
 
Review of the studies referenced in this chapter identifies significant historic 
confusion regarding the determinants of RRI, which was long regarded as a 
direct reflection of renal vascular resistance (Boddi et al., 2015; Wybraniec et 
al., 2016). This view of RRI, based on early experimental data from animal 
studies, led to speculation that RRI could provide a useful non-invasive 
measure of renal perfusion and intrarenal pathology. However, as a better   
understanding of the influence of systemic haemodynamic factors has 
emerged, it is perhaps more useful to think of raised RRI as a ‘red flag’ 
marker for the conditions in which AKI risk is increased.  
The aetiology of AKI is highly complicated with multiple contributory factors 
and complex associations between pathological conditions, acute events and 
renal auto regulatory response. Individual risk of the rapid functional decline 
associated with AKI is dependent on pre-existing chronic renal damage and 
the severity of acute insult.  
In broad terms, the picture emerging from review of current literature is that 
there is significant overlap between the determinants of RRI and age related 
risk factors (such as arterial stiffening) that result in gradual functional 
decline. This pattern is consistent with evidence from critical care that 
indicates that raised RRI performs better than other independent patient 
characteristics at predicting outcome of an episode of AKI. 
 
Although the key determinants of RRI discussed in this chapter are systemic, 
there is compelling evidence that RRI can also be influenced directly by 
raised interstitial and venous pressure. This suggests that, as well as acting 
as a marker for chronic reduced functional reserve, raised RRI may also 
have potential as a marker for sub-clinical AKI in patients who are acutely 
unwell.  
The association between systemic and renal determinants of RRI and raised 




Table 3.9a Systemic determinants of RRI associated with renal functional decline 









of factor as 
determinant 
of RRI 
Potential link to 
immediate (or future) 
AKI risk 
Hypertension ↑ systolic 
pressure 
↑ PSV ↑  RRI major Microvascular trauma 
over time     →              






↑ PSV ↑  RRI major Microvascular trauma 
over time     →              







↑ PSV ↑  RRI major Microvascular trauma 
over time     →              




flow  LVOT  
↓ diastolic 
pressure 
↓ EDV ↑  RRI minor Long term hypo-
perfusion →  ischemic 









↓ EDV  ↑  RRI minor Long term hypo-
perfusion →  ischemic 





↓ EDV  ↑  RRI minor Long term hypo-
perfusion →  ischemic 
damage  →  ↓ 
functional reserve 
End diastolic velocity (EDV)   Peak systolic velocity (PSV)  
 
Table 3.9b Acute determinants of RRI associated with rapid renal functional decline 








Potential link to 








↓ EDV  
↑ ratio of 
luminal CSA 
↑  RRI Impact may be 
masked by auto-
regulation.  
Renal vein thrombosis 
Hypovolaemia 








 + hypovolaemia 
*renal vaso-
constriction 
↓ renal blood ﬂow 
↓ EDV ↑  RRI Tubular ischemia due 
to hypo-perfusion 





In this chapter, the key haemodynamic determinants of (RRI) and their 
relative importance have been explored. This provides a better 
understanding of why the factors affecting AKI risk may be reflected by 
raised RRI.  
In the following chapter, the literature search strategy used to explore the 
evidence base for use of RRI as a predictor of AKI will be outlined. Relevant 
studies will be reviewed to determine if there is evidence to support the use 



























Chapter 4 Review of current literature 
 
This chapter explores relevant literature to determine if there is evidence to 
support the use of renal resistive index (RRI) in the identification of patients at 
risk of renal injury at the point of admission to the Emergency Department 
(ED).  
 
4.1 Development of the search strategy 
This search strategy builds on previous phases of the study (PD Health Unit 5 
and Unit 8) and seeks to identify papers relevant to the research question that 
have been published in the intervening period (2016-2018).  
The primary aim of this review was to determine if there is evidence to support 
the use of renal resistive index (RRI) in the identification of patients at risk of 
renal injury at the point of admission to the Emergency Department (ED). 
The research question was framed initially in three parts in line with Royal 
College of Emergency Medicine (RCEM) guidance for review of best evidence 
(RCEM 2018).  
 Patient Characteristic 
 Intervention(s) or Defining Question 
 Relevant Outcome(s) 
 
This approach is used extensively in Best Evidence Topic (BET) reports 
(http://bestbets.org/background/bets-and-cats.php) and builds on established 
review strategies such as the Population, Intervention, Comparator and 






4.1.1  General question 
Can RRI predict AKI in patients presenting to resus? 
4.1.2  Derived three part question 
In patients admitted to the resuscitation room, is RRI superior to existing sCr 
based tests at predicting AKI risk? 
Specific objectives of the search were to identify studies that: 
 establish the current evidence base for the role of RRI in the diagnosis 
of AKI.  
 relate directly to the diagnosis and management of AKI in emergency 
department patients.  
 relate directly to the use of RRI to identify patient risk of AKI in an ED 
context. (ie Has this study already been done?) 
 
A range of subject-specific electronic data bases were used to identify 
relevant papers including EMBASE, Pubmed, Web of Science,  Scopus, 
BioMed Central, EBSCO Medical databases, Medline and the Cochrane 
library.  
Whilst coverage is similar, it has been demonstrated that using two or more 
data bases will identify a greater percentage of available citations (Wilkins T, 
Gillies R & Davies K 2005). 
4.1.3  Developed keywords 
Key search terms emerged from an initial scoping search and development of 
the focused 3 part research question. Subject specific terms were identified 
that reflect the research topic and the varied terminology used in ultrasound 
related papers.  
The term ‘acute kidney injury’ (AKI) is now recognised internationally 
(KDIGO 2017). However, in earlier phases of the study, numerous 
inconsistencies in use of terminology were identified within the literature 
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reviewed. The current search strategy was formulated using a range of key 
words and truncations that reflect these observed variations.  
English language papers reporting the use of Doppler renal resistive index 
use a variety of synonymous terms and abbreviations including renal RI, 
renal resistive index, renal Doppler, RI and RRI. 
In subsequent stages of the search these terms were used to identify studies 
of Doppler ultrasound investigation of renal blood flow parameters and the 
terms “emergency” and  “ED” were used to search for emergency 
department context specific studies.  
 
4.2 Initial search  
An initial search was performed in each database using the Boolean 
operators “AND” and “OR” to identify papers with the words “acute kidney 
injury” OR “acute renal failure” OR “acute renal injury” OR “acute kidney 
failure” in the title / abstract.  
A repeat search for renal RI, renal resistive index, renal Doppler, RI and 
RRI was undertaken using the same limits.   
Limits were activated to include Humans, Clinical Trial, Review, Meta-
analysis, All Adult: 19+ years, published in the last 5 years. No language 
restrictions were used. 
The initial search terms for AKI were then combined separately with 
emergency department OR ED (or other synonymous terms) in a 
title/abstract search. 
The Cochrane Central Register of Controlled Trials was used to search for 
AKI studies that had not been identified by combined searches within the 
other data bases. This identified 30 review articles all of which focus on the 
evaluation of drugs for the prevention and treatment of AKI and comparative 
methods of renal replacement therapy. None of the studies identified 
evaluated methods of AKI diagnosis. Further exploration of the Cochrane data 
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base for relevant trials identified only one relevant study of renal resistive 
index (Marty et al., 2015) but no additional studies.   
Review of Cochrane Renal Review Group activity (including protocols 
currently undergoing referee scrutiny) identified two protocols in progress that 
explore the use of biomarkers in the assessment of renal function. No 
protocols are identified that link directly to either the role of RRI in this patient 
group or an ED context.  
Inclusion and exclusion criteria were developed from the focused research 
question and refined through the initial scoping search.    
Inclusion criteria Exclusion criteria 
 Primary research studies 
investigating the role of RRI in the 
diagnosis of AKI 
 Primary research studies 
investigating the role of RRI in the 
prognostic stratification of 
patients with known AKI 
 Primary research studies 
investigating the role of RRI in the 
prediction of post procedural 
complications (including AKI) 
 Primary research studies 
investigating the role of 
biomarkers in the diagnosis of 
AKI 
 Primary research studies 
investigating the role of RRI in an 
ED population 
 Primary research studies 
investigating the treatment of AKI 
 Systematic  reviews of the role of 
RRI in the  diagnosis of AKI 
 Primary research studies 
investigating renal failure in 
patients post renal  transplant 
 Humans  Animals 
 Adult   Children 
 Clinical trials  
 Published in last 5 years  
 
Table: 4.1   Summary of search inclusion and exclusion criteria    
Despite the obvious advantages of electronic data bases, it is recognised that 
they are not infallible. (Aveyard H.  2010). However, in this instance, manual 
review of the reference lists for each of the papers identified above produced 
no further records of new clinical trials relevant to the search.  None of the 
studies identified related directly to an ED context. The originality of the 
proposed study is therefore confirmed.  




4.3 Review of studies  
The majority of studies identified by the above search report on the predictive 
role of RRI for clinical outcome in patients where an episode of AKI has 
already been confirmed (Bruno et al 2014, Lee et al 2015, Schnell 2015, 
Boddi et al., 2016; Lahmer et al., 2016, Di Nicolo, P., & Granata, A. 2016). 
These studies, largely from a critical care context, offer further important 
insight into the complex determinants of RRI and how these relate to the 
development of AKI. (See chapter 3) 
The primary focus of the search is on the role of RRI in prediction of AKI in a 
specific ED patient group. None of the studies identified meet both of these 
criteria.  
Five studies in total met the inclusion criteria for prediction of AKI. Four of 
these consider pre-procedural RRI as a predictor of AKI in patients following 
major surgery (Giustiniano et al., 2014; Marty et al., 2015; Marty et al., 2016; 
Hertzberg et al., 2016) and one paper evaluated RRI in prediction of contrast 
induced AKI following coronary angiography (Wybraniec et al., 2017).   
One further study identified within the Phase 2 review is included here due to 
relevance to the search question. (Guinot et al., 2013) 
No studies were identified that explore use of RRI in an ED patient population.  
 
 
4.3.1 Pre-operative assessment of AKI risk prior to surgery 
Peri-operative AKI is a known risk factor for significant surgical interventions 
and is associated with prolonged hospital stay and poor outcome (Boddi, M., 
Natucci, F., & Ciani, E. 2015, Doyle, J. F., & Forni, L. G. 2016). Five of the 
studies included in this review explore the use of RRI to predict AKI risk in 
patients presenting for major surgery. These studies include pre and post-
operative assessment of patients undergoing major orthopaedic, general and 




Giustiniano et al (2014) explored whether RRI could predict complications 
(including acute renal failure) in patients recovering from high risk surgery. In 
this prospective dual centre trial, RRI was measured in consecutive patients in 
the immediate post anaesthetic recovery period following surgery (including 
cardiac, thoracic, abdominal, brain and vascular interventions).  
Of the 205 patients enrolled, RRI > 0.70 was measured in 60 patients 
(29.3%). They note a significant correlation between raised RRI (>0.70) and 
complications at 1 week post-surgery [acute renal failure (P = 0.001),    
pneumonia (P = 0.016), septic shock (P = 0.003)]. 
RRI> 0.70 was also closely associated with longer ICU stay (P = 0.001) and 
extended period of mechanical ventilation (P = 0.004.)  
 
In a similar study, Marty et al. (2016) explored the predictive value of RRI for 
early detection of AKI in patients presenting for surgical repair of hip fractures. 
RRI was measured pre and post-operatively in a selected group of 48 patients 
with known risk factors for AKI (age, gender, hypertension, arteritis, diabetes, 
cardiac failure, use of angiotensin-converting enzyme (ACE) inhibitor and 
sCr.) 
Multi-variate analysis was used to compare the statistical significance of 
individual patient rise in pre / post-operative RRI and in absolute cut off 
values.  A significant grey zone was noted for both pre and post-operative 
prediction of AKI with (0.59 – 0.75 and 0.64 – 0.71 respectively). However, 
high value post-operative RRI ( > 0.706) performed better that all other 
preoperative measures of AKI risk.  
These findings are consistent with those of a previous study by the same 
group where pre and post-operative measurements of RRI were taken in 50 
patients presenting for hip or knee replacement (Marty et al 2015). Again, in 
this study, the most accurate cut-off value for prediction of AKI was a 
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postoperative RRI of 0.705 (sensitivity = 94%, specificity = 71%, LR+ = 3.19 and 
LR- = 0.09). 
AKI in this patient group is closely associated with increased hospital stay and 
both short and long term morbidity and mortality (Ulucay et al., 2012). The key 
trigger for surgically induced AKI is hypo-perfusion of the kidneys arising from 
hypovolaemia and hypotension (Goren, O., & Matot, I. 2015). This may be 
further exacerbated by post-operative use of nephrotoxic drugs. Where there 
is reduced functional renal reserve due to pre-existing renal disease or other 
risk factors, rapid reduction in renal function may occur in the post-operative 
period leading to poor outcome.  
However, it is interesting to note that early diagnosis of renal impairment 
(using standard tests) in these patients appears to offer little benefit (Lejus et 
al., 2012;  Marty et al., 2016). Whilst this seems counterintuitive, this may be 
due primarily to low test sensitivity and specificity of existing tests that are 
based on sCr level and urine output. Sub clinical AKI in these patients and 
delay of more aggressive preventive therapies could account for poor 
outcome rather than ineffective treatment interventions.  
The results of these studies by Marty et al (2015, 2016) suggest that raised 
RRI post-operatively may provide a useful alternative method of stratification 
of patients into a high risk group for whom early intervention could be 
beneficial. This may be particularly helpful in patients where onset of AKI is 
delayed.  
 
A further study by Hertzberg et al (2016) explores the value of pre-operative 
measurement of RRI in patients undergoing cardiac surgery. In this 
prospective cohort study, RRI was measured in 96 patients the day before 
surgery.  Multiple participant characteristics were recorded including patient 
specific data (age, gender, BMI etc), measurements of cardiac function 
(ejection fraction) and type of operative procedure. Logistic regression was 
used to analyse the association between RRI and AKI. Variables that were 
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closely associated with AKI were included in multi-variate analysis and results 
were adjusted for age, sex and eGFR. 
In the study group, 27 patients (28%) developed AKI by Acute Kidney Injury 
Network (AKIN) criteria stage 1 (or worse). The broad finding of the study was 
that patients with preoperative RRI ≥ 0.7 had a threefold increased risk of AKI.  
Positive predictive value for RRI ≥ 0.7 was 0.36 (0.24-0.5). Negative 
predictive value for RRI<0.7 (95% CI) was 0.84 (0.69 - 0.94). Sensitivity and 
specificity were 0.78 (0.58 - 0.91) and 0.46 (0.34 - 0.59) respectively.  
These results indicate a significant grey zone, and low positive predictive 
value. However, the negative predictive value of 0.84 and relatively high 
sensitivity could enable useful pre-surgical identification of a low risk group. 
When combined with additional markers of AKI risk, raised RRI could enable 
targeted protective therapy for the higher risk group.  
The study by Hertzberg et al builds closely on work undertaken by Guinot et al 
(2012) who evaluated RRI in a similar post-cardiac surgical group of patients. 
In this earlier study, (identified by the Phase 2 review) RRI was measured pre 
and post-surgery in 82 patients presenting for cardiac surgery with 
cardiopulmonary bypass. The primary aim of the study was to evaluate RRI in 
distinguishing between transient (fluid responsive) and persistent AKI in this 
group of ICU patients. Patients were not selected on the basis of known AKI 
risk factors as the authors were keen to present a more representative group.  
The demographic of this study therefore differs from others in this review.  
In this patient group there was significant heterogeneity in pre-operative RRI 
and post-operative RRI performed better. RRI  >0.73 distinguished transient 
from persistent AKI with good predictive value (95% CI 0.73- 0.75)  
 
4.3.2 Contrast induced AKI 
The final study identified by the search (Wybraniec et al 2017) analyses the 
association between pre-procedural RRI and onset of contrast induced AKI 
(CI-AKI) in patients presenting for coronary angiography. This prospective 
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observational study investigated 95 consecutive patients for whom 128 pre 
and intra-procedural variables were collected. These include multiple intra-
renal blood flow Doppler measurements acquired immediately prior to and 
repeated 1 hour after the procedure.  
The primary outcome measure was CI-AKI as defined by AKIN criteria (≥50% 
relative or ≥0.3 mg/dL absolute increase in SCr concentration) 48 hours after 
the procedure. CI-AKI was confirmed by these criteria in 9 patients (9%). 
Pre and intra-procedural data were compared in the CI-AKI and non-affected 
groups. Univariate analysis was used to identify odds ratios (OR) with 95% 
confidence intervals (CIs) for all parameters.  Patient variables achieving 
statistical significance at p<0.1 were then used in logistic regression analysis, 
from which RRI and SYNTAX* score emerged as the strongest predictors of 
CI-AKI. 
(*SYNTAX – scoring system indicating the complexity of coronary artery 
disease) 
In this analysis, patient age, presence of peripheral artery disease and 
diabetes were also associated with CI-AKI.  
 
At a threshold of RRI > 0.69 , pre-procedural RRI achieved sensitivity and 
specificity of 78% and 81% respectively, positive likelihood ratio of 4.18 (95% 
CI 2.4 – 7.3) and negative likelihood ratio of 0.27 (95% CI 0.08 – 0.9) for 
prediction of CI-AKI.  
From these combined results, the authors conclude that the greatest potential 
benefit in use of pre-procedural RRI would be found in elderly patients with 






In contrast to the other studies in this group, Wybraniec et al (2017) 
investigate multiple renal vascular parameters. These include peak systolic 
velocity (PSV), end diastolic velocity (EDV), renal resitive index (RRI) and 
renal pulsatility index (RPI) in both extra and intra renal vessels.   
 
Measurement of Renal Resistive Index                         Measurement of Renal Pulsatility Index 
 Figure 4.1 Calculation of Renal Resistive and Pulsatility Indices  
Although RRI and RPI were both significantly higher in patients developing CI-
AKI, in multivariate analysis intra-renal RRI was the only renal flow 
measurement to emerge as an independent predictor of CI-AKI onset.  
Of note in the CI-AKI group, was a tendency towards low intra-renal end 
diastolic flow (EDF). The authors speculate that this may indicate that the 
dominant mechanism for raised RRI in the high risk group is raised intra-
vascular resistance due to endothelial dysfunction. This could in part explain 
the increased likelihood of tubular injury in the presence of a highly viscous 
contrast medium.  
 
4.4 Discussion of studies exploring RRI as a predictor of AKI 
To date, only a small number of studies have explored the ability of RRI to 
predict a future AKI event. In each of the studies reviewed RRI is measured in 
a controlled (selected) group of patients prior to or following interventions with 
a known associated risk of AKI.  
In each of the above studies, baseline or post procedural RRI values were 
significantly higher in patients with confirmed AKI. Whilst the context, 
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intervention and patient groups vary, the observed association between raised 
RRI and AKI appear to be surprisingly consistent. This would support the view 
that RRI is influenced closely by the underlying risk factors for AKI and that 
RRI has potential as an independent test of AKI risk. However, multiple 
variations in the methodology, measurements and definition of outcome 
parameters are noted.  
 
With the exception of Giustiniano et al (2014), in the studies reviewed, AKI is 
defined by AKIN or RIFLE criteria.  Both systems classify AKI by serum 
creatinine (SCr) increase from a base level. Marty at al (2016) use lowest 
recorded SCr for each patient during their hospital stay. However, they 
acknowledge that this may be an inaccurate reflection of normal baseline SCr 
level for patients within their study group.  Assessment of AKI risk on initial 
patient presentation may therefore be misleading. Similarly, in an ED context, 
normal baseline level of SCr would be unknown. 
Giustiniano et al (2014), offer no information regarding classification of acute 
renal failure.  
 
A further limitation of the studies is the time limit for patient observation.  In 
five of the six studies, urine output and SCr level were monitored up to 48 
hours post procedure. This may have underestimated the rate or AKI in each 
study group. Schnell et al (2012) defined AKI at 72 hours and observed no 
additional episodes of AKI after day 3. Giustiniano (2014) monitored patients 
for a range of complications over 1 week.  However, ARF criteria and timing of 
diagnosis are not defined.  
There is wide variation in the patient populations studied by these authors. In 
all studies, exclusion criteria include known chronic renal disease and renal 
replacement therapy (RRT). Obesity, respiratory distress, tachycardia, patient 
agitation or confusion were listed as additional exclusion criteria across most 
of the studies. All of these factors may affect the feasibility and reproducibility 
of RRI measurement due to technical difficulty in achieving an adequate 
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Doppler spectral trace. This may be problematic in a non-selected ED 
population.  
In the studies reviewed, these limitations were acknowledged and mitigated in 
part by use of a single operator and close adherence to a clearly defined 
measurement protocol. By taking repeat measurements and using arithmetic 
mean values for RRI, previous studies have demonstrated fairly high reliability 
of RRI measurements (Gao J.B. 2015; Ninet at al., 2015). Whilst there 
remains some uncertainty regarding lack of intra and inter-operator 
reproducibility, there seems to be a consensus between key authors that RRI 
performs well in the assessment of short term prognosis (Schnell, D., & 
Darmon, M. 2015)  
 
4.4.1 Results of studies exploring RRI as a predictor of AKI 
Cut off values for RRI vary between studies but, are closely in agreement with 
RRI > 0.70 as an upper limit of normal.  This value is surprisingly consistent 
between studies of patient groups presenting for cardiac surgery, orthopaedic 
surgery, general surgery, sepsis and contrast enhanced angiography.  
However, there is wide variation in the confidence intervals and most authors 
note a significant grey zone around this value. The number of patients falling 
within the grey zone varies between 14% (Guinot P. et al., 2013)  and 23% 
(Marty et al., 2016). 
This is consistent with earlier studies that evaluate RRI as a predictor of 
persistent AKI (Schnell et al., 2012; Darmon et al., 2011). 
In the studies reviewed, RRI does not appear to correlate with pre procedural 
eGFR or SCr.  Wybraniec note that 17 of 95 patients presented with 
borderline eGFR 50 – 60 mL/min / 1.73m2. All of these had RRI measurement 
below the 0.7 cut off. This is consistent with Hertzberg’s findings where no 
statistical difference was seen between eGFR values in RRI < 0.7 and RFI 
≥0.7 groups.  This would support the view that raised RRI is an indicator of 




This is consistent with the findings of earlier studies from critical care settings 
where RRI is evaluated as a predictor of renal recovery and patient outcome. 
In a meta-analysis of studies exploring the predictive value of RRI for 
reversibility of renal dysfunction, Ninet et al (2015) pooled results from 9 
studies. Elevated RRI was associated with significantly increased risk of 
persistent renal damage. Pooled sensitivity and specificity were 0.83 (95% ci, 
0.77 – 0.88) and 0.84 (95% ci 0.79 – 0.88) respectively.  Again, 
methodological differences between studies and heterogeneity across patient 
characteristics, AKI definition and RRI cut off present limitations to this meta-
analysis.  However, in line with previous studies, the authors conclude that, 
whilst RRI is unsuitable as a measure of renal perfusion, RRI is a helpful 
indicator of the short term reversibility of AKI and has some potential as an 
indicator of AKI risk. 
Interestingly, in critically ill patients, there appears to be a close correlation 
between RRI and general recovery, not just irrevocable renal damage.  A 
number of studies have explored the relationship between raised RRI and 
adverse outcomes including mortality. This is consistent with the prospective 
studies identified by this review. 
Boddi et al (2016) undertook a prospective study of 125 patients admitted to 
ICU, exploring the association between RRI, persistent AKI and patient 
mortality. RRI (measured at the time of AKI diagnosis) was 0·77 (0·70-0·88) in 
survivors and 0·85 in non-survivors (0·79-0·94) (P = 0·002). In this study, 
multivariate analysis identified raised RRI >0.77 as the strongest independent 
predictor of both persistent AKI on discharge and of in-hospital death, 
regardless of diagnosis on admission.  This association remained significant 
even after correction for AKI scoring (RIFLE), need for renal replacement 
therapy and AKI aetiology.  In the ICU population, there are multiple 
confounding factors that make it difficult to attribute AKI as the precise cause 
of death in these patients. However, these findings are consistent with those 
of earlier studies and provide insight into the determinants of RRI in sick 




4.4.2 Not just about the kidney…    
The term RRI implies a direct relationship with renal vascular resistance. 
However, this is misleading. The correlation between RRI and renal 
resistance is weak and it has been recognised for some time that RRI is a 
poor indicator of renal perfusion (Ward, S. P., Taylor, M. G., & Gosling, R. G., 
1993: Bude, R. O., & Rubin, J. M. 1999; Ninet et al., 2015; , Di Nicolo, P., & 
Granata, A. 2016). This is confirmed by earlier studies of transplant patients 
where RRI reflects haemodynamic features of the host (primarily cardiac 
output and systemic vascular compliance) rather than renal perfusion 
(Naesens et al., 2013).  
The determinants of RRI are complex and include multiple renal and systemic 
vascular factors such as age, gender, fluid status, use of anti-hypertensive 
and non-steroidal anti-inflammatory drugs and pre-existing co-morbidities 
(Naesens et al., 2013; Chirinos, J. A., & Townsend, R. R. 2014; Viazzi et al., 
2014; Joslin, J., & Ostermann, M.  2012; O’Neill,  2014; Boddi et al., 2015).  
The theoretical and experimental evidence for these are explored in depth in 
Chapter 3. 
However, there is both experimental and clinical data confirming that RRI is 
markedly affected by renal interstitial and venous pressure and does therefore 
reflect altered renal microcirculation (Ward, S. P., Taylor, M. G., & Gosling, R. 
G., 1993; Boddi et al., 2015: Chirinos eta l., 2014;  O’Neill, 2014, Ninet et al., 
2015). Despite the complexity of cause, in native kidneys, numerous studies 
continue to support the role of RRI as a predictor of progressive renal 
dysfunction and increased likelihood of persistent renal damage (Sugiura et 
al, 2009; Dewitte et al., 2012; Guinot et al., 2013; Viazzi et al., 2014; Granata 
et al., 2014). 
Whilst raised RRI is not a direct indicator of altered renal function, it does 
appear to be influenced closely by the underlying risk factors and systemic 
vascular changes that lead to progressive renal damage. This is consistent 
with the findings of the studies reviewed and may support the use of RRI as a 




Whilst there is variation in patient characteristics, methodology and outcome 
measures, from the studies reviewed, RRI appears to perform consistently as 
an independent predictor of AKI. The broad confidence intervals noted 
suggest a grey zone approach may be useful with stratification of patients into 
high / low risk groups where RRI falls outside of this zone. 
No studies are identified by the review that evaluate RRI in ED patients.  
 
In this chapter, review of current literature confirms that RRI may be a useful 
independent predictor of AKI risk in patients undergoing surgical or contrast 
enhanced procedures. The extent to which this is a clinically useful approach 
to AKI prediction in an ED population is explored in the current study.   
 
In the following chapter, the study aim and objectives are defined. Study 
methodology is described and the process (and requirements) for ethical 
approval are outlined. Measurement protocols, method of data collection and 
technical factors are detailed and reproducibility of measurements is 
















Chapter 5 Methodology and methods 
 
In this chapter, the underpinning methodology for the study is considered. The 
study aim, objectives and outcome measures are defined and the study 
design is described. The process for ethical approval is outlined and the study 
method is detailed.  
 
5.0 Underpinning methodology for the study 
The current study emerged as a collaborative partnership between an expert 
sonographer and colleagues in emergency medicine. Historically, in both 
diagnostic imaging and emergency care, research has been strongly 
positivistic and quantitative in methodology and underpinning philosophy. In 
both of these professional disciplines research studies follow a typical 
‘medical model’ that focuses on quantifiable data, defined outcome measures 
and statistical analysis of findings. This largely quantitative approach, founded 
in post-positivism but, acknowledging the subjective interpretation of data, 
forms the basis for evidence based practice in emergency medicine (Adam, 
2014). 
The methodological approach and data collection methods developed are 
consistent with those used in existing studies that explore links between RRI 
and renal function. This allows comparison of test performance and test 
characteristics across patient sample groups and increases scope for future 
meta-analysis.  
The RRI measurement tool used is adapted from previous studies for use in 
the Emergency Department (Deruddre et al., 2007; Darmon et al., 2011; 
Murphy, M. E., & Tublin, M. E., 2000; Kusnetsova 2014). All technical 
amendments to the technique used for Doppler measurements have been 
tested through normal volunteer practice and are designed specifically to 




Development of criteria to assess the feasibility and clinical usefulness of RRI 
in this context was through an iterative approach. The feasibility and 
‘usefulness’ measures identified are context specific, emerging from 
combined review of existing literature, informal feedback from clinical 
colleagues and scrutiny of key national drivers for diagnosis and management 
of AKI. No previous studies were identified that test measurement of RRI in 
this patient group.  
 
5.1 Research question 
5.1.1 Aim 
The aim of this study was to evaluate whether ultrasound measurement of 
Renal Resistive Index (RRI) is a feasible and clinically useful method of early 
identification of Acute Kidney Injury in patients requiring resuscitation room 
care.    
 
5.1.2 Research objectives 
1. To determine if RRI measurement is feasible in an Emergency 
Department (ED) resuscitation room setting using a point-of-care 
ultrasound system.     
2. To determine the sensitivity, specificity, positive and negative predictive 
values of ED bedside measurement of RRI in the identification of AKI in 
patients requiring resuscitation room care.     
3. To compare the performance of RRI and conventional indicators of AKI 
risk in this context.  
4. To assess the performance of RRI as a predictor of persistent AKI in 
this patient group 
5. To identify the additional training needs of ED doctors who are 
experienced ultrasound users to enable them to perform RRI 





5.2 Study design 
Building on evidence from early landmark papers in critical care, the study 
design was developed in consultation with senior colleagues in emergency 
medicine and critical care. Expert methodological and statistical input was 
provided by Department for Health faculty at the University of Bath.      
This single centre prospective cohort study assesses the diagnostic and 
prognostic value of RRI in a selected population of adult Emergency 
Department (ED) patients admitted to the resuscitation room.  
 
As the feasibility and utility of RRI was not established in an ED context, 
inclusion of patients who lack capacity to consent or the randomisation of 
patients to alternative treatment groups on the basis of these measurements 
was not justified. However, as early intervention to prevent progressive renal 
damage remains a key national driver, exploration of RRI in this high risk 
population was supported by the Trust Research Department (who acted as 
the local sponsor for the study) and regional ethics committee.  
 
5.3 Definitions and outcome measures 
Prior to exploration of test characteristic of RRI in prediction of AKI in this 
patient group, the first objective of the study was to evaluate the feasibility of 
RRI measurement in this context.  
Context specific feasibility criteria and target outcomes were proposed as 
outlined in Table 5.3a. Ensuring minimal disruption of standard care pathways 













of the scan 
Question Target outcome 
How reliably can ED sonographer 
visualise the kidneys in this patient 
group? 
Kidneys adequately imaged in 90% 
of patients? 
In what proportion of patients 
recruited can RRI be measured?  
(3 consecutive waveforms) 
RRI measurements comply with 
study protocol in 90% of patients 
What are the limiting factors in 
achieving RRI measurement?  
Patient, context or equipment related 
factors are identified 





How long does it take to achieve 
RRI measurement? Is this 
reasonable in this context? 
90% of RRI measurements 
completed in target limit to 5 mins  
Does the scan delay standard 
patient care pathway? 
Minimal disruption / delay of standard 
care pathway. (Will vary between 
patients. Can we quantify this?) 
 
Table 5.3a Test feasibility criteria and target outcomes 
 
5.3.1 Test characteristics 
The primary outcome measure for the study was confirmed diagnosis of AKI 
(AKIN criteria) at 7-14 days (or prior to patient demise) and return to normal 
biochemistry / urine output in line with local and international guidelines [sCr 
and urinalysis at 48hrs and 7-10 days (or prior to discharge or demise)] 
(Lopes, J. A., & Jorge, S. 2013).   
 
Stage Serum creatinine  Urine output  
1 
 
Increase in serum creatinine of  >26mol/L from 
baseline within a 48hr period 
or 
Increase of 1.5  to 1.9 times baseline 
< 0.5 mL/kg/hour  
for > 6 hours 
2 
 
Increase in serum creatinine of 2 to 2.9 times baseline 
< 0.5 mL/kg/hour  
for > 12 hours 
3 
 
Increase in serum creatinine to 3 times baseline  
or  
Increase in serum creatinine to >354mol/L  
or 
Initiation of renal replacement therapy 
< 0.3 mL/kg/hour 
for > 24 hours  
or  
no urine output > 12 hours 
 
Figure 5.3b  Whilst alternative reference standards are reported (KDIGO 2012, NICE 2013), 
management of AKI within the study setting is in line with AKIN criteria. 
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For each patient, routine follow-up biochemistry results were accessed from 
the Trust clinical management data base and stored in accordance with Trust 
data protection policy.  
5.3.2 Clinical usefulness of RRI as a predictor of AKI risk 
Beyond standard definitions of test reliability and validity, the clinical 
usefulness of a diagnostic test is tricky to measure (Nelson et al 2001). In 
addition to parameters such as sensitivity, specificity and predictive values, 
the test must demonstrate context specific feasibility in the target patient 
group, provide some tangible advantage over existing tests and should be 
acceptable to patients. Ultimately, the test must facilitate patient care 
pathways that improve outcome.  
To determine the clinical usefulness of RRI in this patient group the following 
evaluation checklist was proposed: 
 
Question Check list Outcome 
Is AKI risk 
common in these 
patients? 
Is there any documented evidence 
of the prevalence of this condition in 
this patient group? 
What is the prevalence of this 
condition in local ED resus patient 
group? 
How good are 
the current 
routine tests? 
eGFR has low specificity and un-
known sensitivity in this patient 
group. 
Does RRI perform better than 
eGFR in prediction of AKI   
How good is RRI 
at predicting 
AKI? 
What are the test characteristics of 
RRI for the detection / prediction of 
AKI? 
Sensitivity, specificity. Predictive 
values for RRI 
Can we believe 
the result of the 
new test? 
Is RRI a reliable indicator of AKI risk 
in this patient group? 
Intra-operator and inter-operator 
reliability. 
 
Is this change in 
the patient’s best 
interest? 
Could use of RRI as a predictor of 
AKI improve patient outcomes? 
Is there evidence that earlier 
detection of AKI risk could reduce 
progressive renal damage in 
some patients.  
Will it change 
patient 
management? 
Only if we believe the results  Renal protective care bundle 
may be advised. Follow up 
study needed? 
What are the 
risks of NOT 
doing the test? 
High morbidity / mortality if AKI 
undiagnosed. eGFR based on sCr 
known to be a poor indicator of 
reduced renal function. 
Possible preventable renal 
damage 
What are the 
risks of doing the 
test? 
Potential delay in immediate patient 
management during the scan? 
Un-necessary withdrawal of 
nephrotoxic drugs if false +ve?  
Target - No delay in fluid 
management or other significant 
interventions.  
 




5.4 Ethical approval 
Ethical approval for the study was gained through joint application to the 
regional NHS Ethics Committee and local Trust Research Department. 
In an emergency department context, a key priority was to ensure minimal 
disruption to patient care. In patients with significant illness, any additional 
intervention may be considered burdensome. The time dependent nature of 
some medical interventions in this context was also considered. Both aspects 
are reflected in the study design.      
A key ethical challenge for the study was the necessity to balance the level of 
information needed for patients to make a fully informed decision and the 
capacity of these acutely unwell patients to read and process the information 
provided. This is explored further in Chapter 8.  
 
5.5 Setting 
The setting for this study was a 1139 bedded acute teaching hospital serving 
a population of approximately 660,000 across rural and urban areas. The 24 
hour Emergency Department receives on average approximately 400 patients 
a day.   
Patients were recruited to the study from a six bedded resuscitation room that 
receives, on average, 35* patients per day.                                            
(*Estimated from 21 day sample: Jan  2017/June 2017) 
The Trust is classified as a trauma unit. 
 
5.6 Study protocol 
All scans were performed to a strict study protocol and in compliance with the 
British Medical Ultrasound Society Safety Guidelines (Ter Haar 2017) and 
Trust infection control policy.      
The scan results were non-contributory and did not influence patient care or 
subsequent treatment in any way. The doctor responsible for the patient’s 
resuscitation room care was blinded to the RRI measurement.      
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To minimise the potential impact of the study on patient well-being, patients 
requiring time dependent interventions were excluded from the study and 
target scan time was a maximum of 5 minutes. (The full study protocol is 
summarised in Figure 5.12 below.) 
 
5.7 Sample  
20 patients admitted to the resuscitation room and meeting the inclusion 
criteria were recruited over approximately 50 non-consecutive days.  
Principal inclusion criteria 
• Adult ED patients requiring resuscitation room care   
• Capacity to consent confirmed 
 
 Principal exclusion criteria  
• Cardiac arrest   
• Lack of capacity to consent   
• Age <18    
• Known history of chronic kidney disease 
 
Level of patient illness in this context varies considerably. Patients with high 
Patient Modified Early Warning (MEW) score or high National Early Warning 
(NEW) score were excluded at the discretion of the doctor responsible for 
their care.   
 
 
5.8 Recruitment and consent  
Recruitment to the study was by individual approach by the doctor responsible 
for participant’s resuscitation room care. Following verbal explanation of the 
study, patients expressing an interest in participation were invited to read a 
short patient information sheet (Appendix  2a) and opportunity to ask further 
questions was provided.   
A more detailed version of the study information document (Appendix  2b) 
was given to recruited patients for them to read on discharge. This included 
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contact details for the research team and for the Trust Patient Advice & 
Liaison Service.  (PALS offers help, support and advice to patients, relatives 
or carers, about any issues relating to their experience of the Trust.) 
Verbal check of patient consent to proceed was undertaken by the Chief 
Investigator (an independent expert sonographer) immediately prior to the 
scan and consent was documented. 
Due to the context of the study and the time dependence of ED patient 
management, it was not feasible to allow an extended period of time for 
patients to consider participation in the study. For this reason, consent was 
approached as an on-going process with multiple opportunities for patients to 
ask questions and consider their participation or possible withdrawal. In all 
cases, the timing of initial approach and decision making was governed by the 
patient's immediate and on-going care needs.  
Resuscitation room patients are monitored constantly and their capacity to 
consent may vary over time. In all cases, routine clinical interventions took 
precedence over the research intervention. Where initial consent to participate 
was gained and the patient's clinical condition later deteriorated, the decision 
to proceed with the study intervention was discussed with the ED doctor 
responsible for their care. Where the patient was deemed to have lost 
capacity to consent, or urgent medical intervention was needed, a scan was 
not performed.  
Due to the time dependent nature of both clinical and research interventions 
in an emergency context, potential  participants who may have difficulties in 
adequately understanding written or verbal information in English were  
excluded from the study. 
 
5.9 Data collection period 
The target data collection period was restricted initially to one day per week 
for 10 months. (This was determined by expert sonographer availability and 
release from other duties.) In response to poor recruitment to the study, the 
total recruitment period was extended to 15 months. Throughput of patients in 
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the ED is variable with seasonal changes placing significant additional 
pressure on staff. The current crisis of emergency care in the NHS is well 
documented. This placed significant restrictions on research activity in the unit 




Following recruitment and consent, patients were scanned by a single 
independent expert sonographer (not the doctor responsible for patient care). 
All patients were examined in a supine or semi-sitting position. Using a 
SonoSite EDGE Portable Ultrasound system, with a C60X 60mm 5-4 MHz 
broadband curved array transducer, the right kidney was imaged and 
assessed for gross abnormality. 
Colour Doppler was used to identify the interlobar arteries. Pulsed Doppler 
was used to capture a spectral trace and RRI was measured using a 
standardised technique as described in previous studies (Deruddre et al., 
2007; Darmon et al., 2011; Murphy, M. E., & Tublin, M. E.  2000; Kusnetsova 
et al., 2014). 
Doppler gain and scale settings were adjusted to optimise the spectral trace, 
avoiding signal saturation and enabling clear identification of peak systolic 
and end diastolic velocities for accurate calliper placement.  
RRI was measured where the spectral trace from a minimum of three cardiac 
cycles could be captured. RRI measurement was repeated three times, from 
different interlobar arteries at upper mid and lower poles where feasible and 
mean RRI values were recorded. Images were captured for analysis.  
RRI was calculated as PSV – EDV / PSV  using an automatic on-screen 
measurement package (Sonosite 2016).  
 




















                                         End diastolic velocity 
 
Figure 5.10 Renal inter-lobar artery RRI measurement from spectral trace.  
 
 
The left kidney was then imaged and assessed for gross abnormality only. 
RRI measurements were not recorded from the left kidney. In the absence of 
unilateral renal obstruction (or other gross renal abnormality), previous studies 
report insignificant difference in RRI between the two kidneys (Mostbeck, G. 
H., Zontsich, T., & Turetschek, K. 2001; Deruddre et al., 2007). By restricting 
RRI measurement to the right kidney only, total scan time was kept to a 













 SonoSite  EDGE Portable Ultrasound system 
 5-4 MHz 60mm curved array transducer 
 Renal RI pre-set (Study specific to include optimised 
PRF and lowest wall filter) 
 Image depth  15cm 
 Study Participant Number entered to new patient Field.  
 Use lowest PRF without aliasing to ensure optimal 
display of waveforms 
 Reduce gain to remove noise from PW spectrum 
without loss of information 
Patient position  Supine (head raised) 
 Patient comfortable 
Image acquisition 
 
 Intercostal / subcostal image of the right kidney  
 View achieved on passive expiration where feasible 
 Colour box positioned over renal hilum 
 Fine adjustment of transducer position to identify 




 PW Doppler selected and RRI measured when a 
minimum of three reproducible waveforms are 
demonstrated.  
 Calliper placement at peak systolic and end diastolic 
for automated calculation of RRI  [(PSV-EDV) / PSV] 
 Measurement repeated 3 times  (upper, mid and lower 
pole) 
 Images demonstrating RRI measurements saved to 
system hard drive.   
 RRI measurements documented on data collection 
sheet 
Left Kidney  The left kidney should be identified 
 Any evidence of hydronephrosis or possible structural 
abnormality? 






















Diagram 5.12  Study protocol and recruitment process 
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RRI measurements were undertaken by a single expert sonographer who was 
blinded to routine biochemistry to avoid interobserver variability. 
Where a spectral trace consistent with the study protocol could not be 
achieved within the target time limit of 5 minutes (and where patient condition 
was stable), scan time was extended to a maximum of 10 minutes. Where 
patient condition was either deteriorating or not compatible with further 
attempts) the scan was abandoned and no further measurements were 
recorded.  
For each patient, age, gender, primary diagnosis on admission, NEW (or 
MEW) score, baseline eGFR, creatinine and urea were recorded. Any 
complications or technical difficulties with the scan were noted. Any incidental 
findings were recorded and reported to the doctor responsible for patient care.  
 
5.11 Data collection tool 
The data collection tool was designed to be completed at the bedside (at the 
time of the scan) and to provide a paper based record of relevant patient 
details, scan findings and any technical challenges. Patients were identified 
on the form by their ED number only. No patient names were recorded. The 
completed paper based forms were stored in a secure cabinet in the 
resuscitation room. Immediately after the scan, all data from the form were 
anonymised and recorded by the chief investigator on a non-networked 
encrypted data base with password access. (Appendix 3) 
Patient primary diagnosis on admission and MEW / NEW score were 
recorded from the patient care notes and baseline eGFR, creatinine and urea 







5.12 Confidentiality and data handling   
In line with Caldicott Principles, minimal patient identifiable data were 
recorded. All data were anonymised, stored in accordance with Trust data 
protection regulations and accessible only to the principal and chief 
investigators.      
Any person-identifiable information, such as patient hospital number , were 
stored separately to the data  collected as part of the study. These details 
were only identifiable by a ‘research study number’ and were accessed only 
by the chief investigator and the doctor supervising the study. 
 
5.13 Management of incidental findings   
Measurement of RRI requires visualisation of the kidney and adjacent organs 
on ultrasound. Where an incidental finding (such as dilatation of the kidney or 
a possible mass) was noted, the study protocol required findings to be 
documented and communicated to the doctor responsible for  the patient’s 
care and images captured for radiology review where indicated. Processes for 
management and referral of incidental findings were agreed prior to the start 
of the study to ensure a robust approach to clinical governance and record 
keeping.       
In all instances, the doctor responsible for patient care remained blinded to 
the RRI measurement. Standard care pathways were not altered.    
In this chapter, the underpinning methodology for the study has been 
considered. The study aim, objectives and outcome measures have been 
defined and the study design described along with the process for ethical 
approval and method.  
In the next chapter, results are presented and the feasibility of RRI in this 





Chapter 6 Results and analysis 
 
In this chapter, results from the study are presented and analysed. The 
feasibility of RRI in this patient group is evaluated using pre-defined criteria 
and the technical limitations of RRI measurement are discussed.  
 
6.1 Patient characteristics 
A total of 20 patients requiring resuscitation room care (11 male, 9 female) 
were recruited to the study. Age of patients ranged from 33 years to 91 years 
(mean 62.3 years).  (See Table 6.1) 
 
6.1.2 Baseline biochemistry 
Baseline sCr, urea and eGFR were recorded from the Trust clinical 
management database after measurement of RRI. The sonographer 
undertaking the scan was blinded to these results at the time of scan.  
(See Table 6.2)  
 
6.1.3 Visualisation of both kidneys 
Adequate visualisation of both kidneys was achieved in 60% of patients 
(n=12). In patients where it was not possible to achieve adequate views of 
both kidneys (n=8), limiting technical factors were shortness of breath (SOB) 
(n=6), high BMI (n=2). In one patient, the scan was abandoned due to patient 








Table 6.1  Patient characteristics and primary diagnosis on admission 
Pt 
no. 











1 74 M 3 AAA Discharged No Survived 
2 56 M 1 AF Discharged No Survived 
3 74 F 4 Upper GI bleed Admitted (Gen)  No Died 
4 72 M 1 AAA Admitted (SAU) No Survived 
5 48 F 1 Angioedema  Discharged No Survived 
6 33 F 1 Fall ? spinal injury Admitted (Gen)  No Survived 
7 63 M 0 pneumonia Admitted  ( MAU) No Survived 
8 60 M 0 Chest pain Admitted  ( MAU) No Survived 
9 65 M 0 AF Admitted  (ACC) No Survived 
10 79 M 1 ?GI bleed – SOB & 
vomiting. Ca 
pancreas 
Admitted  ( MAU) No Survived 
11 74 F 1 Spontaneous 
pneumothorax 
Admitted  ( MAU) No Died 
12 47 F 0 Abdominal pain Admitted (SAU) No Survived 
13 54 F 1 Arrhythmia + chest 
pain 
Discharged No Survived 
14 67 M 1 Chest pain – aortic 
valve rep.  
Admitted  ( MAU) No Survived 
15 53 M 2 SOB ?lung mass Admitted  ( MAU) No Survived 
16 73 F 2 COPD Admitted  ( MAU) No Died 




18 91 F 1 Atrial fibrillation and 
SOB 
Admitted  ( MAU) No Survived 
19 42 M 5 
(NEWS) 




20 63 M 3 
(NEWS) 







6.1.4 Renal resistive index  
At least one measurement of RRI was achieved in 70% of patients (n=14). 
However, in 9 of these patients (64.3%) the Doppler spectral traces achieved 
were substandard and did not meet the measurement criteria for RRI as 
specified in the study protocol. 
In 30% of patients (n=6) no usable spectral trace was achieved and it was not 
possible to measure RRI.   (Table 6.2) 
 
6.1.5 Follow-up biochemistry 
Follow-up biochemistry was recorded for 16 patients. The remaining 4 
patients were discharged following ED assessment and no further results 
were available.  
In 2 patients (10% of the study sample) AKI stage 1 was recorded (at day 2 


















             Follow up biochemistry 
Pt 
No.  




























eGFR sCr Urea Days 
post 
scan 
eGFR sCr Urea 
1 74 M 3 51 121 8.5 6 No 0.68 0.7 NM 0.69         
2 56 M 1 >60 76 5.7 10 Yes 0.54 0.57 NM 0.55         
3 74 F 4 46 101 21.9 10 Yes 0.79 NM NM 0.79 3 55 87 5.7     
4 72 M 1 >60 90 5.2 9 Yes 0.6 0.6 0.59 0.596 6 58 10
9 
4.5 15 >60 84 4.9 
5 48 F 1 >60 73 4.2 9 Yes 0.64 0.66 0.65 0.65         
6 33 F 1 >60 46 2.2 6 Yes 0.56 0.56 0.56 0.56         
7 63 M 0 >60 79 5.6 10 Yes NM NM NM NM         
8 60 M 0 >60 64 4.4 9 yes 0.54 0.64 0.62 0.6 31 >60 68 3.9     
9 65 M 0 >60 96 9.5 8 yes 0.54 0.54 0.54 0.54         
10 79 M 1 >60 74 15 14 yes 0.59 0.52 NM 0.55 7 >60 58 11 14 >60 59 6.1 
11 74 F 1 >60 46 3.6 7 No NM NM NM NM         
12 47 F 0 >60 80 5.7 5 yes 0.57 0.56 0.56 0.563         
13 54 F 1 >60 71 5.5 8 yes 0.5 0.51 NM 0.505         
14 67 M 1 >60 65 4.8 5 No NM NM NM NM 6 >60 60 5.3     
15 53 M 2 >60 57 4 4 No NM 0.62 NM 0.62 7 >60 66 2.4 14 >60 61 2.8 
16 73 F 2 >60 51 2.4 4 No NM NM NM NM 12 >60 59 4.6     
17 59 F 1 >60 54 2.5 6 No 0.75 0.74 0.74 0.74 5 >60 67 2.9     
18 91 F 1 54 85 8 12 No NM NM NM NM 2 49 92 6.8     
19 42 M 5 
(NEWS) 
39 167 8.4 8 No NM NM NM NM 2 60 10
8 
6 7 >60 83 3.5 
20 63 M 3 
(NEWS) 
>60 90 6.4 7 Yes 0.64 0.64 0.63 0.636         




    Mean 
7.8  
             
Table 6.2   Results
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6.2 Performance of the scan 
6.2.1 Scan time 
Recorded scan time for all patients ranged from 4 – 14 minutes. In patients 
where at least one measurement of RRI was achieved, scan time ranged from 
5 – 10 minutes. Mean scan time was 7.7 minutes (+ 2.3) 
One scan was abandoned after 4 minutes due to patient distress. 
 
6.2.2 Technical limitations of the scan 
Where technical difficulty was experienced, the reason for failure to acquire 
high quality Doppler spectra was documented at the time of scan. RRI 
measurements were further evaluated retrospectively through review of stored 
images. (Table 6.3) 
In 5 of the 6 patients where no usable RRI measurement was achieved, 
patient shortness of breath (SOB) was noted as a key technical factor. The 
remaining patient where no measurement was obtained was noted to be 
morbidly obese.  
Shortness of breath (SOB) was also noted as a key technical factor in 4 
patients where suboptimal Doppler traces only were achieved. In the 
remaining 2 patients with suboptimal Doppler, the scan was abandoned as 
the 10 minute target time limit had been exceeded.  
In total, shortness of breath was noted as a technical difficulty in 60% of 
patients (n=12) including three for whom RRI measurements were achieved.  
In 9 patients (45%) SOB was recorded as the primary reason for failure to 







Table 6.3  Technical limitations of the scan 
Pt no. Age M / F MEW 
score 
Technical difficulty? Measurement 
of RRI 
achieved 
1.  74 M 3 High BMI  SOB Limited 
2.  56 M 1 Time limit  Limited 
3.  74 F 4 SOB -  Difficult to track 
vessels 
Limited 
4.  72 M 1 None recorded Yes 
5.  48 F 1 SOB Yes 
6.  33 F 1 None recorded Yes 
7.  63 M 0 High BMI SOB -  Six attempts 




8.  60 M 0 None recorded Yes 
9.  65 M 0 None recorded Yes 
10.  79 M 1 Limited views left kidney Limited 
11.  74 F 1 Severe SOB – Patient in pain. 
No usable views 
No 
measurement 
12.  47 F 0 Limited views left kidney.  Yes 
13.  54 F 1 SOB Limited 
14.  67 M 1 SOB - no usable trace  No 
measurement 
15.  53 M 2 SOB patient distressed. Very 
limited views. Scan 
abandoned  
Limited 




17.  59 F 1 SOB Lt kidney difficult to 
image 
Limited 
18.  91 F 1 SOB rapid shallow breathing 
– no usable traces 
No 
measurement 
19.  42 M 5 
(NEWS) 
Morbidly obese. No intrarenal 
flow seen on colour Doppler. 
No 
measurement 
20.  63 M 3 
(NEWS) 

















































         X  
Doppler gain 
optimised 





























































peak systole  





  X   NA       
Measurement 
repeated 3 
times  (upper, 
mid and lower 
pole) 
X X X X  X X  X X   
Measurements 
meet criteria 
N N N N Y N N N Y N N N N Y N N N 
*Participants 6,7 and 9  - Images stored to the ultrasound system hard drive were lost before backup due to an equipment fault. 
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6.3 Evaluation of RRI measurements  
RRI measurements were evaluated against the study criteria by review of 
stored images. For three participants, images were lost prior to backup due to 
an equipment malfunction.  
The remaining 17 participant image sets were graded using pre-determined 
measurement criteria. (Table 6.4) 
 
From the image sets reviewed, the stored spectral traces met all criteria for 
RRI measurement in only 3 patients (15%). In a further 2 patients, 
measurement criteria were met for at least one interlobar vessel but, were not 
repeatable for three vessels (upper, mid, lower pole) as specified in the 
measurement protocol.  
Individual RRI evaluation criteria were met in at least one measurement in a 
total of 5 patients (25%).  
 
6.4 Analysis of RRI measurements 
Insufficient data were collected to allow meaningful statistical analysis of the 
relationship between RRI and patient biochemical markers on arrival. For the 
small number of patients where at least one measurement of RRI meets the 
defined measurement criteria (n=5), there is no obvious correlation between 
RRI and sCr on presentation or between mean RRI and urea. This is 
consistent with previous studies (Giustiniano et al., 2014; Marty et al., 2015; 
Marty et al., 2016; Hertzberg et al., 2016).  
Results from pre-operative studies (discussed in Chapter 4) suggest a cut off 
value of RRI ≥ 0.7 as a predictor of increased AKI risk (Giustiniano et al., 
2014: Marty et al., 2016: Hertzberg et al., 2016).  
In the current study, RRI measurements from only two patients exceed this 
RRI ≥ 0.7 cut off.  
In one patient, a single measurement of RRI = 0.79 was recorded. However, 
on review of the stored image, the spectral trace from which RRI is calculated 
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failed to meet the study measurement criteria. In particular, peak systolic 
velocity (PSV) is over estimated due to poor signal quality and incorrect 
calliper placement. The recorded RRI of 0.79 will therefore be overestimated. 
Follow-up biochemistry at day 3 did not confirm AKI by AKIN criteria. 
However, this patient presented with reduced baseline eGFR of 46 
ml/min/1.73m2 that may indicate underlying chronic renal disease. 
In one further patient, three high quality measurements of RRI were imaged 
and a mean RRI = 0.74 recorded. AKI stage 1 was confirmed at day 4.  
It is interesting to note that this is one of only two patients within the study 
sample with confirmed AKI (stage 1) shortly after admission. One additional 
patient with confirmed AKI at day 2 was morbidly obese and no RRI 
measurement was achieved.  
 
No further statistical analysis was attempted for this small data set. Test 
characteristics for RRI as a predictor of AKI could not be determined and this 













6.5 Feasibility of RRI measurement in this context 
Performance of RRI measurement was evaluated against the performance 






of the scan 
Question Target outcome Outcome Target 
criteria met 
How reliably can ED 
sonographer visualise 
the kidneys in this 
patient group? 
Kidneys adequately 
imaged in 90% of 
patients? 
60% (n=12) No 
In what proportion of 
patients recruited can 




comply with study 
protocol in 90% of 
patients 
15% (n=3) meet 
ALL measurement 
evaluation criteria.  
 
25% (n=5) meet 
criteria for at least 
one measurement 
No 
What are the limiting 
factors in achieving 
RRI measurement?  
Patient, context or 
equipment related 
factors are identified 
SOB  











Can these be 
mitigated? 
Are there any 
technical / other 
solutions? 




Time for scan 
How long does it take 
to achieve RRI 
measurement? Is this 
reasonable in this 
context? 
90% of RRI 
measurements 
completed in target 
limit to 5 mins  
Mean scan time  7.7 
mins 
No 
Does the scan delay 
standard patient care 
pathway? 
Minimal disruption / 
delay of standard care 
pathway. (Will vary 
between patients. Can 





Table 6.5    Feasibility criteria 
 
In this context, reliable measurement of RRI (to the agreed protocol) was not 
feasible in 85% of patients. In 20% of patients (n=5), no Doppler spectral trace 
was obtained despite multiple attempts. The primary limiting factor was 
patient inability to hold their breath throughout capture of Doppler readings. 
This is discussed further in chapter 7.  
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Chapter 7 Discussion of findings 
 
In this chapter, the technical factors limiting feasibility of RRI measurement in 
this patient group are discussed and potential technical solutions are 
explored.  
The aim of this study was to determine whether ultrasound measurement of 
Renal Resistive Index (RRI) is a feasible and clinically useful method of early 
identification of Acute Kidney Injury in this patient group. 
When the study was proposed, no previous studies had been identified that 
explore either measurement of RRI in an ED point of care setting or the 
potential use of RRI as a predictor of AKI. To our knowledge, at the time of 
writing, this remains the only study to explore the potential use of RRI in this 
context.  
 
7.1 Feasibility of RRI measurement in the resuscitation room 
The first objective of the study was to determine if RRI measurement is 
feasible in an ED resuscitation room setting using a point-of-care ultrasound 
system.   
Multiple studies in critical care demonstrate that, with minimal additional 
training, ultrasound skilled intensivists are able to perform RRI measurements 
in high dependency patients (Barbani et al., 2010; Darmon et al., 2011; 
Schnell et al., 2012; Viazzi et al., 2013; Guinno et al., 2013; Schnell et al., 
2013).  
However, in patients requiring ED resuscitation room care, performance of 
RRI measurement was technically challenging. In this study, where RRI 
measurements were achieved, only 15% (n=3) met the full feasibility 
performance criteria outlined in Chapter 5.  
The key technical challenge was patient inability to hold their breath during 
capture of the spectral trace from which RRI is calculated.  
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7.2 RRI measurement technique 
The operator dependence of Doppler RRI measurement is well recognised 
(Gottlieb et al., 1997; Deruddre et al., 2006; Ninet et al., 2015; Darmon et al., 
2011). However, with careful measurement technique, excellent levels of 
interobserver and intraoperator reliability can be achieved (Knapp et al., 1995;  
Darmon et al., 2011; Lee et al., 2015).  
From the critical care studies reviewed, reported intraoperator errors for RRI 
range between 2.1% (+2.6) to 3.29% (+ 2.18). The measurement protocol 
used for this study was adapted from the validated approach proposed by 
these early authors.  (see Figure 5.11) 
 
Following localisation of the intrarenal vessels on colour Doppler, the Doppler 
sample gate is placed within the lumen of the vessel. This is achieved by 
selecting the pulsed wave (PW) spectral Doppler mode and using the track 
pad on the machine control panel to align the PW sample line with the 
selected vessel. The sample gate is then moved to the lumen of the vessel at 









Figure 7.2 :  Spectral Doppler sample gate is placed over the lumen of the target vessel. 
Transducer is positioned to align the sample beam and vessel to eliminate need for angle 
correction.    
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Doppler estimates of blood flow velocity are affected by the angle 
dependence of the Doppler shift.  
 
Δf = 2fo Vcosθ / C        Where    Δf  =   Doppler shift 
     fo    =  transmitted frequency 
     V  =  velocity of flow 
     C  =  speed of sound 
     θ   =  beam to vessel angle 
 
Error resulting from poor beam to vessel angle can be reduced by use of an 
angle correction function or by aligning the Doppler sample beam along the 
lumen of the vessel to ensure an angle of 0o. (See Figure 7.2) 
 
As a ratio (PSV – EDV / PSV), resistive index (RI) is largely independent of 
angle of insonation. However, measurement reliability can be improved by 
careful transducer positioning and alignment of the sample beam and vessel 
to eliminate the need for angle correction.   
 
PW mode is then selected, Doppler gain and velocity scale settings are 
optimised and a spectral trace captured.   
This process must be completed whilst keeping the target vessel within the 
field of view. The vessel must then remain stationary relative to the Doppler 

















Figure 7.2c  RRI measured from the spectral trace captured over a minimum of three 
cardiac cycles  
This sequence of image optimisation and capture of a spectral trace requires 
a high degree of operator dexterity and patient cooperation. The kidney is a 
mobile structure that moves in response to changing diaphragm position as 
the patient breathes. Once the target intrarenal vessel is identified, the patient 
must be able to hold their breath as the Doppler sample gate is placed and 
the spectral trace captured. Breathing movement during this period typically 
will result in complete loss of the Doppler signal. For a patient with even a 
moderate degree of breathing difficulty, this may be problematic.  
Typically, the process of initial Doppler image acquisition, optimisation of 
settings and capture of the trace will take place over several breath holds. 
Throughout this period, any other movement of the patient will result in loss of 
alignment between the ultrasound sample beam and the target vessel.       
During capture of the spectral trace, magnification of the real time image of 
the kidney is reduced and a small static image is displayed on the screen 
above the Doppler waveform (Figure 7.2d). Fine adjustment of the scan 
position to ensure correct placement of the sample gate is maintained is 
difficult during this spectral capture phase. Successful capture of a high 
quality spectrum is therefore dependent on successful patient breath hold and 
elimination of patient or transducer movement.   
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Figure 7.2d  Doppler sample gate moves in and out of the vessel lumen with 
movement of the kidney during breathing motion. This results in loss of the Doppler 
signal and gaps within the spectra trace (bold arrows).   
 
7.2.1  Adaptation of scan technique  
Prior to commencement of the scan, the importance of breath hold was 
explained to the patient. Normal scan technique when imaging the kidney 
normally requires the patient to hold their breath on inspiration. This pushes 
the kidney lower into the abdomen improving visualisation from a subcostal or 
intercostal approach. However, breath hold on inspiration can be tiring for the 
patient. For the purpose of this study, an adapted scan technique was used to 
minimise patient fatigue and improve patient cooperation.  
To identify the intrarenal vessels and capture a spectral Doppler trace, it is not 
necessary to visualise the kidney in its entirety. Imaging on passive 
expiration will normally enable good visualisation of the kidney and requires 
less patient effort to maintain breath hold. This technique (breathe in – 
breathe out – stop breathing) was demonstrated to the patient by the 
operator and each patient was invited to practise the technique (as a check of 






































Figure 7.2e  Scan sequence for Doppler RRI measurement.  
Typically, the process of Doppler image acquisition, optimisation of settings and 





7.3 Measurement of RRI in patients requiring resuscitation room 
care 
Review of the images acquired from the ED patient sample demonstrates 
incomplete spectral traces (fewer than 3 complete waveforms captured) in 
85% of measurements (n=17).  
In 30% of patients (n=6) no usable spectral trace was achieved and it was not 
possible to measure RRI. Patient shortness of breath (SOB) was noted as a 
limiting factor in all cases.   
 
Whilst RRI measurement requires operator dexterity and a good 
understanding of equipment controls, in a cooperative patient, this 
measurement is achievable and used extensively in routine general 
ultrasound practice. In critical care patients, breathing movement is avoided 
by pausing mechanical ventilation as the spectral trace is captured. This 
eliminates movement of the kidney and avoids need for patient cooperation. 
This would explain the lack of technical difficulties reported (other than high 
BMI) and the limited additional operator training required in early studies in a 
critical care context (Darmon et al., 2011; Barbani et al., 2010; Schnell et al., 
2012; Viazzi et al., 2013; Guinno et al., 2013; Schnell et al., 2013). 
 
More recent studies (exploring the predictive value of RRI for AKI) focus on 
patients who are undergoing planed surgical intervention (Giustiniano et al., 
2014; Marty et al 2015; Marty et al., 2016; Hertzberg et al., 2016).               
Pre-surgical measurement of RRI was performed during pre-operative 
assessment, with follow-up measurement during the immediate post-surgical 
period. Consistent with the current study findings, respiratory distress is noted 
as an exclusion factor in recruitment to these perioperative studies. Post-
operative measurements were taken either while mechanical ventilation was 
paused or during the recovery period. Again, patients who were unable to 
cooperate (due to SOB or confusion) were excluded from follow-up.  
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These studies demonstrate that, in patients who are either ventilated or pre-
morbidly well, RRI is consistently achieved. However, whilst not explicitly 
stated by any of these authors, RRI was not measurable in patients who lack 
capacity to cooperate by breath hold during capture of the Doppler spectral 
trace. This is confirmed by the current ED study where SOB was identified as 
the most likely cause of measurement failure. 
 
7.4 Operator training 
To be clinically useful in an ED context, there must be sufficient operators 
trained in the technique of measuring RRI. Bedside ultrasound is performed 
routinely by UK Emergency Medicine doctors for a range of trauma and acute 
clinical indications. Ultrasound competencies have formed part of the formal 
credentialing for ED specialist trainees since 2013 (RCEM 2018). Therefore, it 
was anticipated that ED staff that have completed RCEM competencies would 
require minimal additional training for measurement of RRI in a cooperative 
patient.   
In the critical care studies reviewed, discussion of operator training and 
background is limited. In a letter to the Journal of Critical Care, Schnell et al 
(2015) acknowledge that level of prior ultrasound experience required to       
“… allow adequate RRI measurement is unclear”. However, for intensivists 
with experience of focused echo in life support, they propose that a half day, 
Radiology led, training event (1 hour didactic, 2-3 hours hands on practice) 
was sufficient.  
This level of training would be consistent with that required for other point of 
care ultrasound techniques used extensively in emergency medicine. 
However, it is of note that Schnell et al are referring to measurement of RRI in 
patients where ventilation can be paused.  
 
In their earlier study, Schnell et al (2014) compared RRI measurement from 
junior operators with half-day training and senior operators (intensivists with 5 
years + experienced of renal Doppler). They report reasonably good 
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agreement between senior and junior staff (interclass correlation coefficient 
89%; 95% confidence interval 82% - 93%) with negligible systematic bias 
(p=0.001). They note also that the 95% limit of agreement for this study was 
consistent with previous studies using only experienced operators. Inter-
operator reproducibility was acknowledged as a limiting factor by these 
authors but, they conclude that RRI still performs well as a predictor of overall 
patient outcome in a critical care context.  
Within the limitations of the current study, the training required by ED doctors 
to undertake renal Doppler measurements was not explored due to the 
technical difficulties outlined above. However, it is worth considering if RRI 
measurement in this patient group could be improved by additional operator 
training. 
In the current study, RRI measurement was performed by a single expert 
sonographer with extensive experience of renal ultrasound and Doppler 
measurement technique. Despite this level of operator expertise, adequate 
RRI measurement was not achieved in 85% of patients (n=17). Even high 
intensity targeted training for ED point of care ultrasound users is therefore 
unlikely to provide the skills required to deliver reliable measurement of RRI in 
these patients.   
 
7.5 Could the feasibility of RRI measurement be improved by use 
of a higher specification ultrasound system? 
The ultrasound equipment used is a laptop based system designed explicitly 
for the point of care market. As such, some of the system software packages 
and user operator controls are somewhat simplified compared to the high end 
systems used in central imaging departments. However, key Doppler operator 
controls are standard between most commercially available systems. The 
sequence of control adjustments that needs to be made to capture a spectral 
trace (as detailed in Figure 7.2e) is common to both high specification and 
point of care systems.  
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The improved spatial and contrast resolution offered by a high end ultrasound 
system may enable better visualisation of the kidney and easier identification 
of intrarenal vessels. However, this would not resolve the issue of patient 
breathing movement. 
 
7.6 Possible technical solutions 
7.6.1 Pulsatile flow detection 
Pulsatile Flow Detection (PFD) is a manufacturer specific equipment function 
launched in 2000 by GE Medical and is specific to the GE Logiq 700 Expert 
ultrasound system (GE 2000) 
PFD provides real-time analysis of blood flow dynamics to identify vessels in 
which pulsatile flow is detected. The Doppler signal is analysed to identify flow 
characteristics such as high temporal variance (rapid velocity change) 
consistent with pulsatile arterial flow. 
In a standard colour Doppler system, mean Doppler frequency is displayed by 
colour hue within the region of interest (as defined by the colour box) with 
directional information colour coded as red and blue. 
 
 
Figure 7.6a  Conventional colour Doppler. Flow towards the transducer is coded as 





In this conventional colour Doppler system (Figure 7.6a), blood flow 
characteristics can be visualised using fast Fourier transform (FFT) analysis. 
However, in patients with limited ability to hold their breath, visual perception 
of pulsatile flow is limited by relative movement of the colour sample box and 
target vessels. The Pulsatile Flow Detection (PFD) facility tracks flow 
characteristics and highlights areas demonstrating characteristics of pulsatile 
flow as a separate colour map superimposed over the standard colour box.   
 
 
Figure 7.6b  Pulsatile Flow Detection map (green) superimposed over a 
conventional colour Doppler map of renal blood flow.  (From Kim SH et al., 2002) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713986/  
 
Early clinical studies of this technique include an evaluation of PFD in 
measurement of renal resistive index (Kim SH et al., 2002). Using 
conventional CFM and PFD guided techniques; Kim compared time to acquire 
RRI measurement and quality of the spectral trace in 56 native kidneys. In this 
study of healthy volunteers, they conclude that, the time to acquire RRI can 
be reduced with PFD guidance with no change in the quality of spectral trace.  
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However, this is a time reduction (mean of 30 seconds) for the overall scan. 
Essentially, the benefit offered by this technique is easier differentiation 
between arterial and venous flow. This could allow more rapid identification of 
target intrarenal arteries, particularly for an inexperienced operator. However, 
the duration of patient breath hold required during capture of the spectral 
trace is not affected. Overall scan time may be reduced but, there would be 
no obvious benefit of this technique in a breathless patient.   
 
 
Figure 7.6c  Pulsatile Flow Detection map (green) used to locate an intrarenal vessel 
from which a conventional measurement of RRI is captured.  (From Kim SH et al., 
2002) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713986/  
 
No further references to PFD techniques were identified through targeted 






7.6.2 Two-dimensional flow index mapping (2D-FIM) 
Only one study was identified that offers a potentially credible alternative to 
the standard approach to capture and manual measurement of RRI.  
Building on an earlier feasibility study by Sikdar et al (2007), Zhang et al 
(2010) propose a two-dimensional flow index mapping function for rapid 
quantitative imaging of flow indices. This method provides automated 
estimates of RI directly from the power Doppler signal. 
Using a thresholding technique and a clutter filter to remove signals from 
static tissues, vessel wall movement and low velocity venous flow, the power 
of the filtered Doppler signal   (Pfilt), is extracted as a function of the 
Doppler shift at each image location. 
 
By synchronising signal capture with an ECG trace, values for Pfilt  are 
captured at peak systolic and end diastolic image frames.  
They demonstrate that, as Pfilt is linearly related to estimated Doppler shift 
(Δf). Therefore Pfilt at peak systole and end diastole can be used as surrogate 
measures from which resistive index (RI) can be calculated. 
 
 
RI  =   PSV – EDS    ≈       Pfilt
systole  -   Pfilt
diastole 
               PSV                                  Pfilt





PSV   =   peak systolic velpcity 
EDV  =   end diastolic velocity 
Pfilt
systole
   =   power of the filtered Doppler signal at systole 
Pfilt
diastole  





In an original feasibility study by Sitkar et al (2007), RRI values acquired by 
standard measurement technique and by 2D-FIM were compared in 9 
transplanted kidneys and 4 normal volunteers (upper, mid and lower pole 
interlobar arteries). 2D-FIM acquired indices showed a high level of 
correlation (r=0.8, P<0.0004) with those generated by manual capture and 
measurement of a PW spectral trace.  
A follow-up study by the same group (Zhang et al., 2010) confirmed these 
findings in a further 8 normal volunteers and 8 transplant kidney. Again, a high 
level of correlation (r=0.84) was found between 2D-FIM and standard 
acquired RRI values.  
 
Unlike the standard measurement of RRI from a single target vessel, 2D-FIM 
provides a two dimensional map of resistive index within the selected region 
of interest. From this, post-acquisition quantitative values for RRI in specific 
vessels can be calculated.  
Using 2D-FIM, mean time to acquire RRI values was 10 seconds. Total scan 
time was 5 minutes including location of the kidney and orientation of the 
required section. This capture time for mapping of simultaneous RRI 
calculation across multiple vessels is impressive. However, the authors note 
that motion blur may still be problematic.  
 
In the original feasibility study (Sikdar et al., 2007) a static clutter filter was 
used to reduce noise but, no motion correction was applied to the captured 
2D data set.  An inherent feature of power Doppler is the need for low pulse 
repetition frequency (PRF) and hence an associated low temporal resolution 
(9-13 frames per second in this study).  
Although no statistical difference was seen between 2D-FIM and manually 
acquired RRI measurements, Zhang et al (2010) acknowledge that low PRF 
could in theory lead to an underestimate of RRI as there is the risk that peak 
systole (the time of maximum flow velocity) could be missed.  
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Of more significance to the current study is the impact of image blur due to 
poor temporal resolution. This is not addressed in the studies by Sikdar and 
Zhang but, it is of note that, in these studies, 2D-FIM was evaluated in normal 
healthy volunteers and in transplant kidneys. In both groups, inability to 
maintained breath hold was not an issue. However, it may not be possible to 
replicate these findings in an ED population. 
 
The system described combines 2D-FIM processing with a conventional 
image formation technique that is limited by a standard pulse transmission / 
reception sequence. In newer systems, full field transmission techniques offer 
increased PRF and rapid image capture from a single pulse transmission. 
This could reduce motion blur as temporal resolution would be improved.  
Further improvement could be achieved by limiting the power Doppler sample 
box size to encompass a single target vessel. This would allow increased 
PRF by reducing the area over which multiple power Doppler sample gates 
are employed.  
 
7.7 Measurement of resistive index in an alternative vascular 
bed 
As the potential technical solutions explored fail to resolve the challenge of 
breath hold in sick patients, it may also be worth exploring the potential value 
of resistive index measurement in an alternative vascular bed (i.e. not the 
renal vessels). 
From the experimental and clinical evidence reviewed, it is clear that the 
determinants of RRI are systemic rather than renal and that a strong 
correlation exists between RRI and factors such as aortic pulse pressure. 
Logically, other abdominal vascular beds that are also affected by cardiac 
output and systemic arterial compliance may offer an alternative to 
measurement of RI in the kidney.  
Building on early experimental evidence from animal studies (Norris and 
Barnes, 1984; Seiler et al., 2012), a number of authors speculate that RRI 
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should correlate with resistive index measured in the spleen (SRI) and that 
the clinical significance of raised SRI would be similarly indicative of systemic 
risk factors for renal disease (Seiler et al., 2012; Grün et al., 2012; O'Neill, 
2014; Grupp et al., 2017). The research questions addressed by these 
authors differ in focus from the current study but, they provide useful evidence 
of close correlation between determinants of haemodynamics in these related 
abdominal vascular beds.   
 
In a study of stable transplant recipients (n=87) Seiler et al (2012) measured 
RRI, SRI and carotid artery intima-media thickness (IMT). Interestingly, this is 
one of only three studies identified that examine RRI prospectively in stable 
transplant recipients and the first study to consider SRI as a potential 
surrogate measure to predict patient and allograft outcome.  
In this study, IMT and RRI were measured using standard techniques. SRI 
measurement was repeated three times in the segmental branches of the 
splenic artery at their entry to the splenic parenchyma and SRI values 
averaged. 
Seiler et al claim a strong association with IMT (as an established marker for 
systemic vascular disease) and with patient mortality for both RRI and SRI. 
However, their results indicate a fairly weak correlation between these factors. 
[RRI: r=0.203 (P=0.006); SRI: r =0.315 (P<0.001)].   
Interestingly, they note that, as a predictor of overall patient outcome, SRI 
performs slightly better than RRI in this study. However, raised RRI and 
raised SRI both failed to predict clinically significant decrease in eGFR or 
need for dialysis and neither ratio performed better than recipient age as an 
independent risk factor for allograft outcome. The findings of this study appear 
to be somewhat over stated. However, they are consistent with evidence from 
other studies of transplant kidneys that confirm the relationship between 




Grün et al (2012) explored the difference between RRI and SRI as a potential 
marker for renal parenchymal damage in native kidneys. In this larger 
prospective study, the difference of resistive indexes (RIs) in the spleen and 
kidney (DI-RISK) was compared in unmatched cohorts of healthy volunteers 
(n=152) and in patients with known chronic renal disease (n=290).  
In this study, a slightly stronger correlation between RRI and SRI was 
confirmed (r = 0.54, P= 0 .001) and both demonstrated a weak association 
with patient age (RRI: r = 0.18, P = 0.027; SRI: r = 0.33, P = 0 .001) and with 
common carotid artery IMT (RRI: r = 0.19, P =0 .022; SRI: r = 0.23, P = 
0.005). 
 
Both studies demonstrate that RRI and SRI are similarly influenced by 
systemic cardiovascular factors that are known markers for renal disease. 
However, consistent with previous studies, neither predicts specific renal 
outcomes.  
 
A more recent study by Grupp et al (2018) explores the difference between 
RRI and SRI as a potential marker for renal artery stenosis (RAS).  Both 
indices were measured in hypertensive patients with no evidence of renal 
artery stenosis (n=181) and in patients with suspected stenosis who were 
followed up by angiogram (n=24).  
In the cohort where RAS was not suspected, they note an age related steady 
rise in absolute values for both RRI and SRI (from age of 30) with values for 
SRI consistently slightly lower across all ages with a median difference of 
0.055. In patients with confirmed RAS on angiogram, the difference between 
RRI and SRI was significantly lower [(median - 0.05) P=  0.002].  
 
For SRI to offer a viable surrogate measure for RRI there must be a 
predictable and constant relationship between these respective flow indices. 
Of note from the study by Grupp et al was the consistent relationship 
109 
 
demonstrated between RRI and SRI across age groups. The slope of age 
dependency was absolutely parallel for RRI and SRI with both indices 
independent of gender and kidney location (left v right).  
The primary question addressed by this study was diagnosis of RAS. 
However, confirmation of the constant relationship between splenic and renal 
flow indices does confirm the dependence of both on systemic factors (where 
RAS is absent) and suggests that use of SRI may be a viable alternative to 
RRI measurement.   
No studies were identified that explore alternative vascular beds other than 
the spleen.  
 
Measurement of splenic resistive index 
In the context of the current study in an ED population, the technique used to 
measure SRI and its feasibility is worth considering. Ultrasound identification 
of the spleen in patients requiring resuscitation room care is within the normal 
skill set of ED point of care ultrasound users. The spleno-renal space is 
examined routinely as part of the focused assessment with sonography in 
trauma (FAST) protocol to identify intra-abdominal bleeding in blunt trauma 
and forms part of standard trainee credentialing. However, visualisation of the 
splenic perihilar arteries can be challenging. In a supine patient, this region is 
frequently obscured by overlying bowel gas in the stomach and an adapted 
technique (requiring patient movement and cooperation) may be required to 
visualise the splenic hilum. Visualisation also varies considerably with patient 
body habitus and is challenging in patients with high BMI.  
In the studies reviewed, patients and normal volunteers were fasted to reduce 
gastric contents and overlying bowel gas. Patients were examined in both 
supine and decubitus positions and all subjects were ambulatory. All of these 
technique adaptations may be problematic in patients requiring resuscitation 
room care. Splenic perihilar arteries are slightly larger than renal interlobar 
arteries and are arguably easier to identify and localise if the spleen is 
visualised. However, both renal and splenic arteries are subject to movement 
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with the diaphragm as the patient breathes. Whilst this was not explored 
within the remit of the current study, SRI measurement may be worth further 
exploration in an ED patient sample. However, patient inability to achieve 
adequate breath hold is not necessarily addressed by use of SRI as a 
surrogate for RRI.  
 
Conclusion 
Pulsatile Flow Detection (PFD) may offer some benefit in speeding up 
localisation of intrarenal vessels, particularly for inexperienced operators. 
However, this technique offers no benefit in sick patients where a high quality 
spectral trace cannot be achieved.  
 
2D-FIM does not offer a complete solution to the challenge of RRI 
measurement where SOB is a limiting factor. However, adaptation of this 
technique for targeted single vessel sampling could be worth exploring as a 
method of rapid acquisition of RRI estimate in patients who have difficulty with 
breath hold. 
 
There is some evidence supporting the use of SRI as a surrogate measure for 
RRI and this may be worth further exploration in relation to prediction of AKI.  
However, technique adaptation required for SRI measurement may be limited 
in patients requiring resuscitation room care and both measurements are 
affected by patient ability to hold their breath.  
A technical solution is likely to be a more promising approach if adoption of 
RRI or SRI as a predictor of AKI is to be considered. Even where patients are 
pre-morbidly well, these measurements require a degree of operator skill and 




In this chapter the technical limitations of RRI measurement in this context are 
discussed along with potential technology focused solutions.  
Currently available commercial systems do not have the functionality to allow 
reliable and rapid RRI measurement in a breathless patient. However, in 
newer (post 2010) systems with high temporal resolution, use of an adapted 
version of the power Doppler signal processing technique 2D-FIM for targeted 
RRI measurements may be worth exploring. 
Use of flow indices in alternative vascular beds offers some promise, 
particularly where unilateral renal disease is suspected. However, use of SRI 
as a surrogate measure is unlikely to resolve the challenge of breath hold in 
an ED population.  
 
The study findings need to be interpreted in the context of the challenges 
presented by research in an emergency department setting with an acutely 














Chapter 8 Ethical considerations and patient consent 
 
Patients requiring resuscitation room care are acutely unwell and are, by 
definition, a vulnerable population. Informed consent for research participation 
in this context is both controversial and ethically unclear (Schmidt et al 2004). 
In this chapter, the ethical issues relevant to research in emergency medicine 
are explored and their impact on the current study is discussed.  
Research in an emergency or acute care context is difficult (Hirshon et al., 
2013; Kraus et al., 2012; Levine et al., 2017; Sahan et al., 2016; Tucker et al., 
2014). Conflicting ethical priorities may stifle research and lead to practices 
for which the evidence base is uncertain. There are also multiple additional 
factors that may disrupt standard approaches to research, not least of which 
is the current unrelenting pressure on front line clinical services.  
As formal research governance procedures have emerged, along with 
considerable legislative confusion, there is growing concern that many acute 
conditions, urgent treatments and interventions are under-researched. The 
pressing need for high quality research in emergency medicine needs to be 
balanced alongside the decision to involve vulnerable individuals in research 
activity. Central to this is the question of patient capacity to consent and how 
this can be interpreted in the context of an acute presentation.  
 
8.1 Review of ethics literature relevant to research in an 
 Emergency Department context 
A focused literature review was undertaken to gain a better understanding of 
current legislation and best evidence for management of ethical issues and 
consent in an emergency context. In addition to the legislative documents 
outlined, the papers identified are focused largely around patient attitudes to 
consent, barriers to patient enrolment, deferred consent, surrogate decision 
makers, proxy consent and non-voluntary enrolment. The broad findings from 
this review are detailed below with discussion of how they have influenced 
ethical review and approach to consent for the current study.  
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8.2 Legislative framework 
The current UK position regarding patient consent for emergency research 
has emerged against a backdrop of complex and at times contradictory 
European Union (EU) and non-EU international legislation (Kompanje et al., 
2014; Mentzelopoulos et al., 2015) 
Directive 2001/20/EC in particular was criticised widely for effectively halting 
research in an emergency setting by requiring consent prior to enrolment for 
all research participants. Before revision of 2001/20/EC in 2014, some 
member countries (including the UK) introduced the option of deferred 
consent and this was adopted as part of Good Clinical Practice (GCP) 
standards (NHS Health Research Authority 2017). https://www.hra.nhs.uk/planning-
and-improving-research/policies-standards-legislation/good-clinical-practice/  
In response to widespread challenge, EU legislation 2001/20/EC was 
amended to include the option of deferred consent (EU Regulation 536/2014).  
 
8.2.1 How is consent defined in legislative guidance? 
The European Commission Clinical trials - Directive 2001/20/EC defines 
informed consent as  
“…the decision, which must be written, dated and signed, to take part in a clinical 
trial, taken freely after being duly informed of its nature, significance, 
implications and risks and appropriately documented, by any person capable 
of giving consent or, where the person is not capable of giving consent, by his 
or her legal representative; if the person concerned is unable to write, oral 
consent in the presence of at least one witness may be given in exceptional 
cases, as provided for in national legislation."  (https://ec.europa.eu/health/human-
use/clinical-trials/directive_en)  
The 2001 European Clinical Trials Directive (2001/20/EC) forms the basis of 
national law in the member countries including the UK.  In the document Good 
Medical Practice (2013) the UK General Medical Council provide guidance on 
good practice in health research. Subsection 33-35 details consent 




Guidance here is based on recognition within the Mental Capacity Act 2005 
that urgent research in emergency medicine may require retrospective 
consent. Where this is necessary, agreement from a doctor not involved in the 
research is required and consent must be gained retrospectively where this is  
feasible.   
UK guidance on legislation relevant to research in the ED is published by the 
Health Research Authority via the NRES website. Based on scrutiny by the 
National Institute of Health Research (NIHR) Injuries and Emergencies 
National Specialist Group, the guidance provided seeks to translate the 
complex EU legislation into practical ‘real world’ recommendations.  
A clear distinction is made by NIHR between trials involving drug products - 
Clinical Trials of Investigational Medicinal Products (CTIMPs) and trials of 
“other intrusive emergency research”.   
In adults who are unable to consent, English (and Welsh) law allows them to 
be recruited to emergency studies (other than CTIMPs) without prior advice 
from a consultee if:  
 treatment needs to be given urgently 
 it is also necessary to take urgent action to administer a drug for the 
purposes of the trial 
 it is not reasonably practicable to seek advice from a consultee 
 the procedure is approved by a NHS Research Ethics Committee 
 a consultee is consulted as soon as possible to seek advice on the 








8.2.2 Non-European guidance on consent for emergency research 
Many of the studies reviewed refer to emergency research carried out in the 
United States of America where legislation governing consent is provided by 
the Food and Drug Administration (FDA).  
For the purpose of research in emergency medicine in the US, a series of 
fairly narrowly defined exemptions from the principle of offering an "informed 
and free decision" are adopted, as outlined in the FDA document Exception 
from Informed Consent Requirements for Emergency Research (FDA 2013).  
Within the scope of these non-binding recommendations, ethics panels may 
decide that, where research is justified and prospective consent cannot be 
gained from the patient (or their authorized legal representative), this can be 
waived.   
This complex, detailed document was produced by the FDA in response to 
growing concern that, due to patient lack of capacity to consent, much of the 
standard therapies and interventions used in emergency medicine had not 
been adequately evaluated through robust clinical trials.  
 
By offering some scope for exception from informed consent, the FDA was 
seeking to promote research activity that would: 
 evaluate potentially lifesaving therapies 
 explore the effectiveness and safety of existing therapies 
 improve interventions for conditions that currently have poor outcomes 
 
To meet the FDA requirements for prospective informed consent to be 
waived, studies must also meet a series of defined criteria (21 CFR 50.24         





In broad terms these stipulate that: 
 subjects must be in a life threatening situation, intervention is required 
and available treatments are unproven 
 subjects must be unable to consent as a result of their medical 
condition 
 contact with a legally authorized representative is not feasible 
 prospective recruitment of participants is not possible 
 participants may benefit directly from intervention 
 evidence from experimental studies supports the potential for this 
intervention in this patient group 
 risks associated with the study investigation are reasonable in the 
context of this condition 
 
The FDA stipulates additional responsibilities for research parties that offer 
explicit protection to participants when informed consent is not gained prior to 
study intervention.   
These include: 
 consultation with representatives of the community(ies) in which the 
research will take place and from which the subjects will be drawn 
 public disclosure of information before the start of the study and 
following its completion 
 a commitment by the investigator to try to locate the subject’s legally 
authorized representative or contact a family member to determine 
whether the family member objects to the subject's participation 
 study oversight by an independent data monitoring committee. 






8.3 Gaining consent in sick patients 
The central ethical challenge in research in an emergency context is patient 
inability to provide informed consent and time constraints that make contact 
with a legal representative non-feasible (Sahan et al., 2016).   
Capacity to consent is measured by individual ability to 
 understand the information relevant to the decision  
 retain the information  
 use or weigh the information  
 communicate his or her decision (by any means) 
(Mental Capacity Act 2005) 
In patients attending the ED and requiring resuscitation room care, capacity in 
all four of these broad areas may be compromised and difficult to assess. 
Arguably, normal mental status is highly unlikely in this context. Therefore, it 
is questionable whether fully informed consent is ever achievable in this 
patient group. This raises the difficult question of how consent in emergency 
care patients should be approached.   
 
8.4 What are the alternatives to prospective patient consent? 
8.4.1 Use of a Legal Authorised Representative  
Where an individual is incapacitated and unable to provide consent, the 
Mental Capacity Act defines conditions in which advice may be sought from a 
Legal Authorised Representative (LAR) acting on behalf of the patient. In the 
studies reviewed, it is evident that use of a proxy or surrogate decision maker 
is common practice (Bryant et al., 2012; Mentzelopoulos et al., 2015). 
However, it is recognised that in an emergency setting, it may not always be 
feasible to contact a LAR or next of kin. 
There are also uncertainties regarding the extent to which relatives are able to 
accurately predict patient preferences. Bryant (2012) investigated preference 
discrepancies between surrogate decision makers (n=200) and suspected 
stroke patients (n=200) presenting to an acute stroke assessment unit. In this 
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study, high levels of agreement were observed in prediction of preferences 
regarding standardised interventions (80.2% accuracy). However, agreement 
regarding preference for research participation was much lower (49% - 74% 
accuracy depending on the type of clinical trial).  
In a follow up study of out of hospital cardiac arrest patients, Kamarainen et al 
(2012) explored the opinions of patients and their spouses (surrogated 
decision makers) on the policy of surrogate consent for research participation. 
High levels of agreement were noted between patients and relatives. 
However, as an interesting foot note to this study, the clinicians consenting 
patients to research participation were sceptical about the ability of surrogates 
to provide valid consent. All of the spouses surveyed reported a high level of 
confidence in their ability to decide on study participation on their partner’s 
behalf. However, it could reasonable be argued that, in the context of pre-
hospital cardiac arrest, the patient’s spouse is also likely to be incapacitated 
to some extent. This could account for the lack of confidence in surrogate 
consent expressed by the recruiting doctors.  
A study by Dutton et al (2008) explored capacity to consent in a cohort of 
2011 consecutive patients presenting to a large trauma centre at the 
University of Maryland. Potential to consent to a hypothetical research study 
was assessed at 1 hour post admission in all patients and whether consent 
could be gained by proxy (LAR) within 3 hours.  Complete data were captured 
for 1734 patients.  Of these 982 (57%) were judged to have capacity to 
consent. Of the remaining 752 patients, LAR consent was not available for 
348 (20% of total).  
Of particular relevance to the current study of RRI is Dutton’s retrospective 
review of patients who were assessed as able to provide consent on initial 
presentation. In two thirds of these patients, findings “strongly suggestive of 
(mental) impairment” were noted.  Although the patients assessed by Dutton 
et al were severe trauma patients, this study does call into question the 
perceived capacity to consent in patients requiring high level care and the 
limited feasibility of LAR consent.   
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For the current study of RRI, consent by surrogate was rejected. Next of kin 
are not always available and patients lacking capacity to consent would be 
unlikely to cooperate with the scan. 
 
8.4.2 Deferred consent  
Revision of 2001/20/EC in 2014 to permit deferred consent recognised that 
research in emergency medicine may require retrospective consent. Where 
this is necessary, agreement from a doctor not involved in the research is 
required and consent must still be gained retrospectively where this is 
feasible. This approach requires researchers to build into a research proposal 
a strategy for contacting participants after the research intervention has taken 
place. This has clear resources implications.  
Offerman et al (2013) explore the use of follow up telephone contact to gain 
delayed consent for patients enrolled to a prospective multi-centre study of 
outcomes in anticoagulated patients with blunt head trauma (n=506). In this 
example of deferred consent, patients were not informed of the study during 
their initial hospital visit. The patient (or their legal representative) was 
contacted by telephone a minimum of 14 days after ED discharge. Five 
patients were lost to follow up but, in 500 of the remaining 501 patients 
consent was confirmed. They conclude that this approach was both effective 
and well received by subjects and their representatives.  
The study by Offerman et al is purely observational. Outcome data were 
collected (along with patient contact details). However, there was no direct 
patient contact or need for consent to an immediate intervention. Although 
RRI measurement is non-contributory in the current study, ultrasound is still 
an intervention for which patients would normally be asked to consent and it 
requires patient cooperation at the time of scan. Consensus was reached that 





8.4.3  Consent waiver 
Where research interventions involve rapid decision making (for example in 
trauma, stroke or cardiac arrest), the current regulatory framework provides 
scope for consent to be waived (GMC 2018). However, this approach still 
requires subjective judgement of patient mental state and their lack of 
capacity to consent. Each individual must be assumed to have capacity 
unless there is clear evidence that this is lacking. 
The broad pattern emerging from review of the literature suggests that 
consent waivers are most likely to be applied for purely observational studies 
of time critical interventions (Wright et al., 2008; Fox et al., 2013) or where 
there is low chance of patient survival.  The argument for consent waiver 
where there is no change to patient management is relatively easy to resolve. 
However, non-voluntary enrolment of critically ill patients does raise the 
question of whether this is ever morally justifiable.  
Tigard (2016) presents an interesting philosophical discussion that essentially 
turns this question around to examine the moral implications of stifling 
research into interventions that could improve patient outcome. Tigard argues 
that there is a strong moral case for pursuing innovation in emergency 
medicine but, only where this occurs as a “by-product of pursuing therapeutic 
success”. This condition for consent waiver (described by Tigard as a “double-
effect” principle) is consistent with the American Food and Drug 
Administration (FDA) requirement that, for prospective informed consent to be 
waived, “..subjects must be in a life threatening situation, intervention is 
required and available treatments are unproven…. and participants may 
benefit directly from intervention”. 
For example, UK studies meeting this “double-effect” principle include early 
studies of focused ultrasound assessment of blunt abdominal trauma where 






8.4.4  Community consultation 
A small number of studies were identified by the review that explore the 
efficacy of community consultation and the attitudes of clinical staff to tests of 
community perception (Biros, Sargent & Miller, 2009; Dickert et al., 2014). 
Whilst public consultation is not required for approval of consent waivers, 
research ethics panels are expected to consider questions and potential 
concerns from the public.  
In a survey exploring public attitudes to emergency medicine research (Biros 
et al., 2009), 1901 participants were asked their views on different 
approaches to consent. Whilst 88% of respondents supported research in an 
ED context, this fell to 35% for studies where consent was waived. This 
increased to 51% when applied to the respondent in person and their attitude 
to personal research involvement.   A limitation of this study is that level of 
patient illness and urgency of care decisions were not defined. The authors 
acknowledge that responses may have been different if time critical scenarios 
(for example trauma) had been specified.  
Biros et al also report a high number of ‘no opinion’ responses on returned 
questionnaires and note that these are disproportionately associated with 
respondents on low income or with low educational achievement. This could 
indicate lack of understanding of the questions. They suggest that two way 
conversation within a community group may be of benefit. However, this 
needs to be balanced against the risk of observed opinions being swayed by 
lone dissenting voices.  
Concerns regarding public understanding of consent waivers in an ED context 
are echoed by Dickert et al 2013. They undertook a retrospective survey of 
patient (n=24) and next of kin (n=37) experience of research participation for 
which prospective consent was not obtained. 95 % of respondents supported 
research in an ED context and 73% were in favour of consent waiver. 
However, 62% of interviewees did not appear to understand several key 
questions despite opportunities for questions and probing of their answers.  
These findings bring into question the validity of consent by public opinion and 
are consistent with discrepancies in opinions amongst healthcare 
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professionals and patient participants.  Ripley et al (2012) explored attitudes, 
beliefs and experiences of emergency care providers who were involved 
directly in studies requiring consent waiver. Findings confirmed support for 
research activity in all respondents. However, discussion of consent waiver 
identified complex and divergent opinions with a predominant feeling that 
individual patient right to decide outweighs decisions based on community 
consultation.  
 
8.5 Could prospective consent have been waived for the current 
study? 
In the context of this observation study, it is difficult to argue that ultrasound 
measurement of RRI (unproven and non-contributory) meets the criteria for 
prospective consent to be waived. The proposed intervention is not time 
critical (as for example a FAST scan for blunt trauma) and offers no 
immediate benefit to the patient. Therefore, despite concerns regarding 
patient capacity, formal consent was required prior to scan.  
In discussion with the Trust Research and Development (R&D) advisor and 
with reference to the Regional Research Ethics Committee (REC), the study 
protocol was designed to reflect the challenges of consent in this context.  
Central to this was the need to approach consent as an ongoing process 
rather than a ‘one off’ decision. Even in patients who respond positively to 
initial recruitment, capacity to consent is likely to change over time and may 
be altered by pain and use of analgesia or sedatives (Sahan et al., 2016).  In 
evaluation of patient capacity in the resuscitation room, patient general level 
of illness, the likelihood of rapid deterioration and the need for urgent time 
dependent interventions must also be considered. For this reason, the initial 
approach to patients was by the doctor responsible for their care. This is 






8.6 Consent not coercion 
A number of the studies reviewed highlight the additional risk of coercion and 
question how voluntary ‘voluntary consent’ is in practice (Schmidt et al., 2004; 
Halila, R. 2007; Baren et al., 2010). By using a doctor who is not involved in 
the research study to make the first approach to patients, it can be argued 
that risk of coercion is reduced. Their primary concern is with management of 
the patient’s urgent and ongoing care needs rather than research 
participation.  
This approach is consistent with the basic principles outlined in the World 
Medical Association Declaration of Helsinki (1996) as outlined in the Good 
Clinical Practice document ( 2017). This advises that, when obtaining 
informed consent, if there is any risk of duress, consent should be “obtained 
by a physician who is not engaged in the investigation”.  
 
8.7 Consent as an ongoing process 
The initial approach to patients was by a brief verbal explanation of the study 
given by the recruiting doctor. This was followed by introduction of the patient 
to the primary investigator (an expert sonographer) who provided a one page 
study information sheet for the patient (and any attending relatives) to read. 
The study proposal and implications of participation were then discussed and 
opportunity for questions provided.  
In an interesting study exploring the behaviours of ED research participants, 
Baren et al (2010) observed a large cohort of 1609 during the consenting 
process. They noted whether participants read the study and consenting 
information provided, how long they spent reading it and whether questions 
were asked. The authors note minimal engagement with information provided 
during consenting from approximately half of the study participants. 53% read 
the information provided but, only 13% spent more than 2 minutes considering 
a 2 page document. Only 20% of patients asked any questions to clarify the 
research or consenting process.  47% did not read the information provided 
prior to consenting.  
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It is difficult to generalise from this study but, these findings suggest that a 
significant proportion of ED patients may pay limited attention to written 
information provided as part of the consenting process. It is therefore 
important that check of understanding is included in the protocol with 
opportunity for question and verbal review of the implications of study 
participation.   
For the current study, once the patient had indicated their initial willingness to 
participate, the PI and recruiting doctor signed the study consent form to 
confirm their agreement that the patient demonstrated capacity to consent. 
This provided an opportunity to check for any concerns regarding capacity at 
an early stage of the recruitment process.  
The patient was then presented with the paper based consent form (Appendix 
5) and consent checks were read aloud by the PI. Understanding was 
checked and the patient was asked to initial each section and add their 
signature to the form. Right to withdraw at any time was emphasised 
throughout this process.  
 
Patients in an emergency context are likely to be distracted, with shortened 
attention span. In discussion with Trust R&D and following feedback from the 
REC, study information sheets were provided in short and long versions 
(Appendix 2a /  2b)  
The initial information sheet given to patients was restricted to one page with 
large text and bullet point information only.  This was supplemented by a 
verbal description by the PI of what participation would entail and opportunity 
for withdrawal at any time was explained. A detailed version of the information 
form was provided for patients to take away with them and for any attending 
relatives to read.  
Throughout the scan, patients were offered further opportunity to ask 
questions. Through this, the PI was able to provide additional information 




In this chapter, the ethical issues relevant to research in emergency medicine 
have been explored and their impact on the current study discussed.  
In the next chapter, the limitations of the study are considered and 






















Chapter 9 Further discussion 
 
In this concluding chapter, limitations of the study are considered, conclusions 
are presented and recommendations are made for further study. 
 
The aim of this study was to evaluate whether ultrasound measurement of 
Renal Resistive Index is a feasible and clinically useful method of early 
identification of AKI in patients requiring resuscitation room care. The 
rationale for the study emerged initially from review of a wealth of supportive 
evidence from critical care studies reporting the prognostic value of RRI in 
patients with confirmed AKI and from discussion with clinical colleagues about 
the challenge of AKI diagnosis in the ED. In the intervening period from initial 
proposal of the study, further compelling evidence from critical care studies 
has emerged supporting the role of RRI as a useful prognostic indicator for 
sick patients with known AKI. 
In gaining a better understanding of the haemodynamic determinants, it 
became apparent that RRI is largely a reflection of systemic factors rather 
than a direct indicator of renal perfusion or renal function. This led to 
speculation that RRI may be a useful early indicator of sub-clinical AKI and 
could potentially act as an indicator of AKI risk. Further in-depth review of the 
literature (at the time of study proposal) identified no previous studies that 
explore the potential use of RRI as a predictor of AKI.  
 
As a population, patients admitted to the ED and requiring resuscitation room 
care are at increased risk of AKI. However, individual patient risk varies 
(Thomas et al., 2015; Hodgson et al., 2017). Despite extensive evaluation of 
renal bio-markers and the introduction of real time electronic reporting 
systems, initial diagnosis of AKI in ED patients remains dependent on 
standard tests of sCr and urine output, where lack of baseline measurements, 
and a recognised lag between change and initial renal insult may delay 
diagnosis and treatment.  
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A high proportion of resuscitation room patients are admitted to hospital and 
their renal function will be monitored carefully throughout their hospital stay. 
However, earlier detection of sub-clinical AKI at the point of admission would 
allow implementation of a renal protective care bundle prior to discharge to 
the ward or for community based care (Kolhe et al., 2015; Bagshaw, 2015; 
Kolhe et al., 2016). Although at present unproven, given the dismal outcome 
for patients in whom AKI has resulted in permanent renal damage, these 
benefits could be considerable.  
Identification of a simple test that can accurately predict individual patient risk 
of AKI would be of significant benefit in the ED. Existing tests of AKI are 
based on changes in biochemistry and urine output that signal that damage to 
the kidneys has already occurred. However, these tests tell us little about 
patient renal functional reserve or risk of a future episode of AKI. At present, 
clinical decision making around use of known nephrotoxic drugs or contrast 
enhanced imaging investigation is supported by risk assessment algorithms 
(based on multiple risk factors such as patient age, gender BMI and ethnicity). 
The local Trust clinical management system combines detailed patient data 
with real time hospital wide electronic reporting systems. However, to date 
there are no reliable, validated AKI risk scores for patients presenting in 
primary or secondary care (Think Kidneys Report 2017). Identifying a simple, 
reliable test that can accurately estimate individual patient risk of AKI is 
therefore a research priority.   
 
9.1 Have the study research questions been answered? 
The first research objective of this study was to determine the feasibility of 
RRI measurement in the ED. Essentially, the study findings indicate that, 
using a standard point of care ultrasound system, RRI cannot be reliably 
achieved in patients requiring resuscitation room care. Training requirements 
for ED doctors to perform RRI measurement were not explored as the test, in 




The remaining study objectives (as outlined in Chapter 5) were focused on 
evaluation of test characteristics for RRI (in the diagnosis of AKI and 
prediction of AKI risk), and on the potential training requirements of ED 
doctors to perform these measurements.   
Due to the small sample size and lack of reliable measurements achieved, it 
has not been possible to characterise RRI as an indicator of AKI in these 
patients.  
 
9.2 Limitations of the study 
Research in emergency medicine is beset with challenges and there are well 
documented issues including slow participant recruitment, small sample size 
and premature discontinuation of trials (Schandelmaier et al., 2016; Thomsen, 
2015). This study is no exception and has highlighted the difficulty of patient 
recruitment in this context and the impact of high workload on recruitment 
strategies. 
 
9.2.1  Sample size 
The final sample size is too small to allow meaningful analysis of the test 
characteristics of RRI as an indicator of AKI. Research objectives 2-4 that 
explore the performance of RRI in diagnosing and predicting AKI cannot be 
answered by this study. 
The importance of a priori calculation of study sample size and anticipated 
study power is well documented (Suresh et al., 2012; Peeling et al., 2010; 
Bacchetti et al., 2010 ;Fozgate et al., 2009). However, during development of 
the initial proposal for this feasibility study, a formal power calculation was 
rejected due to the extent of unknown factors. This is consistent with National 
Institute for Health Research guidance (NETS-CC Annex A 2018) for studies 
that test the feasibility of an intervention not previously validated in the study 
population.  
In general, when assessing diagnostic test characteristics, the larger the 
sample size, the narrower confidence intervals are likely to be. However, in an 
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Emergency Department setting, where patients are un-well and disruption to 
care pathways needs to be minimised, a large sample size may be ethically 
unjustified.  
One of the key challenges was estimating how well RRI was likely to perform 
in the study population. Sensitivity and specificity were unknown, as was 
prevalence of the condition in the study population. A priori power calculation 
would therefore be based on ‘best guesses’.    
A pragmatic approach was taken with a defined target recruitment period (10 
months) and planned review of patient recruitment at key stages.   
The small final sample size (n=20) reflects the stringent exclusion criteria 
(particularly around patient capacity to consent), difficulty of recruitment in the 
ED and the limited feasibility of RRI measurement in this patient group.  
 
9.2.2  Barriers to recruitment in emergency medicine 
Barriers to recruitment in emergency medicine are well documented (Johnson 
et al., 2016; Schandelmaier et al., 2016). Practical challenges such as staff 
time, staff training and availability of local resources may be exacerbated by 
high work pressure, need for urgent clinical intervention and critical over-
crowding in the ED.  
For the purpose of this study, impact on clinical services was minimised by 
restricting data collection to a single (supernumerary) expert sonographer who 
was seconded to the department for approximately one day per week for 10 
months. However, input was still required by each doctor responsible for 
patient care during initial recruitment and consenting. It was therefore 
important that clinical staff understood the protocol including exclusion / 
inclusion criteria and were supportive of the broad study aim. 
 
9.2.3  Staff engagement 
Before recruitment began, the study was promoted by the PI and by the ED 
research lead via staff newsletters, closed ED group social media and PI 
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attendance at regular team briefings. Ongoing individual briefings were time 
consuming but essential to maintain staff engagement.   
Overall, the study proposal was well received and most staff expressed 
enthusiasm for the broad study aim. However, pressure on clinical staff 
resulted in their cautious approach to recruitment, particularly in the early 
stages, rather than general lack of engagement or unwillingness to 
participate.  
Ripley et al (2012) comment on the conflict between the role as clinician and 
the role as researcher in emergency medicine doctors and note that this can 
impact on participant recruitment. In all cases, patient care was prioritised 
and, in busy periods in particular, this resulted in very slow recruitment. 
During periods of atypical high pressure within the department, recruitment 
was paused completely.  
In an evaluation of research capacity among ED clinicians, Lawlor et al (2014) 
identified insufficient time (71.2%), lack of support [training or supervision] 
(61.8%), lack of interest in a topic (42.0%), and inadequate resources (23.6%) 
as the four barriers most likely to influence research involvement.  Staff 
support for the current study was encouraged by promoting the importance of 
the topic and by minimising impact in the remaining areas. This was vital for a 
study that was non-portfolio (not supported financially by the Trust) and 
undertaken by an honorary visiting researcher. However, resource related 
barriers could not be fully addressed and, in the current climate of high 
workload in the ED, these were undoubtedly a significant limitation, affecting 
recruitment in particular. 
 
9.2.4  Patient population 
A further uncontrollable factor affecting recruitment was the population 
demographics for patients admitted to the resuscitation room, with a high 
proportion unable to demonstrate capacity to consent. Factors such as patient 
general confusion and agitation, combined with other exclusion criteria 
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(history of known renal disease, cardiac cause for admission, non-English 
speaking) reduced the potential pool of participants considerably.  
The combined limiting effects of patient demographics and ED staff 
time/availability to check capacity to consent resulted in very low recruitment 
over the initial 10 month target period. This included a period of approximately 
3 months where recruitment was paused due to atypical pressure on the 
department. The recruitment period was then extended for a further 4 months 
before data collection was halted.  
 
9.2.5  Stop criteria 
One of the ethical challenges of research in emergency medicine is the widely 
reported issue of premature study discontinuation.  
In a retrospective review of 894 clinical trials, Schandelmaier et al (2016) 
compared discontinuation in studies carried out in acute and non-acute 
settings. They report a four-fold higher risk of early discontinuation in studies 
in an acute setting with slow recruitment highlighted as the most common 
cause. This raises the question of how this effect can be mitigated in study 
design for research in the ED. For a small scale study that is non-portfolio 
(and hence cannot expand paid staff involvement), an extended recruitment 
period was the only feasible pragmatic response.  
One of the weaknesses of the current study is that recruitment ‘stop criteria’ 
were not defined at the time of study proposal. Tyson et al (2016) note that 
“stopping guidelines are often vague or unspecified” in the design of clinical 
trials and that this is a long standing challenge that is often not addressed 
during ethical review.  
In a large scale review of published randomised controlled trials, Stegert et al 
(2016) found that approximately two-thirds of protocols did not include clear 
stopping rules. Tyson (2016) focuses on the importance of planned expert 
statistical interim review of data with analysis of conditional power and 
predictive probabilities. However, for the current study, where a priori power 
calculation had been rejected and the feasibility of the intervention was 
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unproven, this was of limited value.  It is also interesting to note that, even in 
the large scale clinical drug trials reviewed by Stegert, 80.4% were 
discontinued without reference to a pre-defined mechanism or evidence of 
planned interim analyses. Clearly this issue is not limited to research in 
emergency medicine.  
Where conventional stop criteria for futility are discussed, these generally 
relate to clinical trials that evaluate the effectiveness of drug therapies 
(Vickers, A. J., Kattan, M. W., & Daniel, S., 2007, Tyson et al., 2016; Stegert 
et al., 2016). They conclude that, even where no effect is seen, premature 
discontinuation should be avoided as this is likely to reduce the statistical 
power of later meta-analysis. Whilst this makes sense for therapeutic drug 
trials, this approach is unhelpful where the study intervention is a diagnostic 
test that is demonstrably not feasible in the study population. Indeed, in a 
vulnerable patient cohort, it could be argued that, continuation in these 
circumstances is not ethically justified.  
The decision to halt recruitment for the current study was taken in consultation 
with the supervising clinician and on expert ethics advice.  
 
9.2.6  How representative was the final study sample? 
By eliminating patients who lacked capacity to consent, the study protocol 
limited evaluation of RRI measurement to a small sub-set of the resuscitation 
room population. To gain a better understanding of how representative the 
study sample is, background data were analysed for all resuscitation room 
admissions over a sample period of four weeks (2 weeks in June, 2 weeks in 
January). 
No significant difference was noted in mean age of all attendees (62.0 years) 
and the study sample (62.3 years).  However the age range was slightly 
narrower for the study group (33 - 91 years) compared to overall resuscitation 
room admissions (22 – 96 years).  
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In the study sample, there was a slightly more even split between male and 
female (55% male, 45% female study sample. 60% male 40% female all 
admissions).  
In a relatively high proportion of patients in the study sample, respiratory 
problems were noted as the primary reason for admission (30%). By 
comparison, in the sample period for ‘all admissions’, the primary diagnosis 
on admission was classified as a respiratory related problem in 19.2 % of 
patients. The small final sample size makes it difficult to interpret the 
significance of this difference but, as SOB was a key factor in limiting the 
feasibility of RRI measurement, this may be an important feature of the 
sample group.  
However, the ‘all admissions’ data reviewed provides only the primary 
diagnosis on admission. This fails to capture the breadth of patient symptoms 
experienced on presentation. In practice, although difficult to quantify, SOB is 
likely to be a presenting symptom in a much higher proportion of patients 
admitted to the resuscitation room. This would be consistent with the finding 
that SOB was noted at the time of scan as a technical difficulty in 60% of 
patients in the sample group. 
 
9.2.7  Is RRI measurement likely to be feasible in the patients who were 
not recruited to the study? 
Patients were excluded from recruitment on the basis of one or more of three 
broad exclusion criteria.  
i. Lack of capacity to consent 
ii. History of renal disease 
iii. Cardiac arrest /  too ill to participate (high MEW score) 
 
Lack of capacity to consent does not necessarily mean that patients would 
lack capacity to cooperate with the scan. However, exclusions for reasons of 
capacity to consent included patients who were confused, agitated, in pain, 
under the influence of drugs (prescribed or recreational) or a combination of 
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the above. In patients requiring resuscitation room care, these characteristics 
are not uncommon. Although not tested by this study, it is reasonable to 
assume that cooperation with the scan would be compromised in these 
patients, perhaps more so than in patients demonstrating full capacity to 
consent.  
Patients admitted with cardiac arrest, with high MEW score or with reduced 
levels of consciousness were excluded from the study. The primary reason for 
exclusion was to minimise risk to the patient. Even where consent to scan 
may have been theoretically feasible, performance of a non- urgent, non-
contributory test was contraindicated due to the high risk of rapid deterioration 
or need for urgent medical intervention. From the study findings, it is 
reasonable to predict that RRI measurement would not be achievable in these 
patients with a standard point of care system.  
 
AKI is a significant risk factor for developing chronic kidney disease (CKD) 
and can present as an acute on chronic kidney injury (Wilson et al 2017). A 
prior history of CKD is a key predictor of AKI risk with the incidence of AKI risk 
increasing by up to six-fold in CKD patients (Porta et al 2016).  
The overarching aim of the study was to explore the performance of RRI as a 
predictor of AKI risk, primarily in patients where this might be missed. Patients 
presenting with a known history of renal disease were excluded from this 
initial feasibility study as baseline biochemistry and RRI values would be 
difficult to interpret. However, in patients with reduced functional reserve (due 
to known chronic renal disease), an episode of AKI is associated with high 
morbidity and mortality. If a revised measurement method is validated that 
eliminates the issue of motion blur, it would be worth exploring RRI as an 






9.3 Is the use of RRI measurement as a predictor of AKI in this 
patient group worth further investigation? 
AKI remains a serious health problem with associated spiralling costs and 
dismal patient outcomes where diagnosis and treatment are delayed. The 
impact of AKI on use of health resources is predicted to increase with an 
aging population. 
For an individual patient, an episode of AKI (even at Stage 1) is non-trivial and 
this potentially preventable condition is associated with a high risk of mortality. 
Innovations such as Trust wide data sharing initiatives improve outcome but, 
impact is still limited by delayed diagnosis due to the inherent lag in response 
time for existing tests based on sCr rise and fall in urine output. To improved 
outcomes, early diagnosis is key but, this remains challenging.  
 
9.3.1  Bio-markers 
In the last decade, there has been considerable attention focused on the 
development of bio-markers (such as urinary or serum neutrophil gelatinase-
associated lipocalin (NGAL) and cystatin-c) as alternative early indicators of 
renal damage (Soto et al., 2010; Bennett et al., 2011; Nickolas et al., 2012; 
Bagshaw et al., 2013; Vanmassenhove et al., 2013; Alge J. and Arthur J.M. 
2017).  
Schiffl & Lang (2012) present a review of the clinical impact of urinary 
biomarkers for the detection of AKI. They conclude that routine use of even 
the most promising of these markers in the ED is as yet unwarranted and that 
none of the markers studied have a clear advantage beyond established 
clinical decision making approaches. Despite considerable investment and 
initial enthusiasm, the role of biomarkers remains uncertain. Schiffl & Lang 
warn that indiscriminate use of biomarkers may in fact distract from adequate 
clinical evaluation and could worsen patient outcome.  
From review of more recent literature, biomarkers seem to be viewed as 
something of a magic bullet. However, there is a risk that a strong focus on 
biomarkers could inhibit evaluation of alternative approaches to early AKI 
diagnosis. This view is supported by Vanmassenhove et al (2013) who 
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highlighted the cumbersome nature of early diagnosis of AKI using these 
methods, and in particular the difficulties that arise where timing and aetiology 
of AKI are not well defined. However, their use in management of renal 
replacement therapy and the evaluation of disease progression from AKI to 
chronic renal failure looks more promising (McCullough et al., 2013; Alge J. 
and Arthur J.M. 2017).  
The extent to which bio-markers may eventually provide individualised patient 
management of AKI remains to be seen, despite promising early results in ED 
patients (Soto et al., 2010; Nickolas et ., 2012; Schinstock et ., 2012). 
However, identification of a sensitive and specific early marker for renal injury 
has proved elusive. These tests remain costly, widely unavailable and are yet 
to be validated in large prospective studies; particularly where their 
contribution to decision making is evaluated. Unlike the use of troponins for 
confirmation of myocardial infarction, identification of a single marker for AKI 
seems unlikely as the aetiology of AKI itself is so complex.    
 
9.3.2  Evidence that RRI can predict AKI 
Since the initial proposal for this study, a number of papers have been 
published that support the hypothesis that RRI can act as a predictor of AKI 
risk. The studies reviewed in Chapter 4 all conclude that RRI performs better 
than existing tests as an independent predictor of AKI risk in the patient 
groups in which this was evaluated (Marty et al., 2016; Hertzberg et al., 2016; 
Giustiniano et ., 2014; Marty et ., 2015; Wybraniec et al., 2016).  
In all of these studies, RRI > 0.70 (measured prior to surgery or contrast 
enhanced imaging) was closely associated with increased risk of AKI, length 
of in-hospital stay and overall patient outcome. Whilst there is variation in the 
patient populations studied and a sizable grey zone around the cut off of RRI> 
0.70, collectively these authors present compelling evidence that the 
hypothesis for the current study was correct.  
A distinctive feature of the patients studied by these authors is that they were 
all pre-morbidly well. Inability to comply with breath hold (respiratory distress) 
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was cited amongst the exclusion criteria but not quantified. However, 
measurement of RRI in ambulatory patients (presenting for pre-operative / 
pre-contrast assessment) appears to be a feasible and useful marker for 
increased risk of AKI.  
 
9.4 Measurement of resistive index in other vascular beds 
As outlined in previous chapters, there is compelling experimental and clinical 
evidence that the determinants of RRI are systemic and that aortic pulse 
pressure is a key factor. If this is the case, it is possible that measurement of 
resistive index in an alternative vascular bed could act as a surrogate 
measure of RRI. Further exploration of RRI measurement in the splenic hilar 
vessels as outlined in the previous chapter may be worth considering. 
However, measurement in these vessels is unlikely to offer a credible 
alternative to renal measurement if patient breath hold is problematic.  
 
9.5 Technology solutions   
The ultrasound systems employed in point of care settings are necessarily 
compact. Most will lack some of the new design features and signal 
processing techniques that are emerging in high end systems. However, as 
novel applications of ultrasound have emerged that are specific to an ED 
context (for example ultrasound diagnosis of pneumothorax), equipment 
adaptations and bespoke software packages are also gradually emerging that 
support point-of-care specific tasks.  
Development of the technologies discussed in Chapter 7 to resolve the issue 
of motion blur should be well within reach. Two-dimensional flow index 
mapping (2D-FIM) in particular could be combined with image formation 
techniques that improve temporal resolution to make auto-capture of RRI 
feasible in patients who have difficulty with breath hold.  
Availability of a system that facilitates rapid automatic capture of RRI (with 
minimal operator training) could have wide potential outside of the ED. This 
would certainly strengthen the commercial case for development of an 
138 
 
automated measurement package. An estimated 65% of AKI episodes start in 
the community (Selby, et al. 2012). In an aging population where use of 
known nephrotoxic drugs and other risk factors continue to increase, it may 
also be worth exploring community based use of RRI to monitor risk of renal 
injury, particularly in hypertensive patients.    
 
9.6 Conclusions 
In the context of this study, measurement of RRI was NOT feasible in patients 
requiring resuscitation room care using a current point of care ultrasound 
system. Image blur due to patient breathing movement prevented reliable 
measurement of RRI in a high proportion of patients and this could not be 
mitigated without adaptation of the available technology.  
Review of studies published since the current study commenced provides 
some compelling evidence that RRI performs better than existing tests in early 
diagnosis of AKI and in prediction of AKI risk prior to surgery and contrast 
enhanced imaging. These are significant findings that support further 
evaluation of RRI in high risk patient groups.  
 
As AKI remains a significant global health challenge, the imperative to identify 
a more effective method of early detection is still a research priority. As a 
standard test on admission to the ED, eGFR has significant known limitations 
and may give false reassurance in patients at high risk due to loss of renal 
functional reserve. The technology ‘fix’ required to allow automatic capture of 
RRI measurements in patients with breathlessness is, at least in theory, trivial. 
Although beyond the scope of this study, at the time of writing, early dialogue 








The primary aim of this study was to evaluate the feasibility and usefulness of 
RRI as an indicator of AKI risk in an ED point of care setting. Whilst it is not 
possible to generalise from the limited data captured, if further evaluation of 
RRI in this patient group is to be considered, development of an alternative 
measurement algorithm is recommended. This should be well within the 
scope of current ultrasound systems with adapted Power Doppler based 
estimation of RRI, using maximum and minimum power of the Doppler signal 
as surrogate measures of peak systolic and end diastolic parameters. (See 
Chapter 7) 
 
Exploration of RI measurement in the splenic hilar vessels may be worth 
further exploration, particularly where unilateral renal abnormality is 
suspected. However, measurement of RI in an alternative abdominal vascular 
bed is unlikely to offer a useful substitute in acutely unwell patients with 
limited capacity for cooperation.  
 
The current study speculated that RRI could be a useful indicator of AKI risk. 
At the time of the initial proposal, no other studies were identified that explore 
this predictive use of RRI. Subsequent studies (identified in Chapter 4) 
confirm a link between the causative mechanisms for rise in RRI and post 
procedural AKI risk. This is an important finding that may have significant 
implications for future use of RRI, particularly prior to planned surgery or 
contrast enhanced imaging of patients who are pre-morbidly well.  
 
An ongoing challenge associated with AKI in an aging population is lack of 
meaningful individual baseline data. A number of the studies reviewed identify 
a close link between long term use of antihypertensives (and other 
nephrotoxic drugs) and life time risk of renal failure. In these patients, a 
gradual reduction in renal functional reserve places them at increased risk of 
renal injury during an episode of acute illness. Although a stand-alone 
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measurement of RRI tells us relatively little about renal function, it is worth 
speculating that serial measurement of RRI, possibly within the community, 
may be useful in identifying patients at high risk. RRI may also perform better 
than current definitions of return to ‘normal’ (eGFR and sCr) as an indicator of 
future risk where renal functional reserve has been diminished following an 
episode of AKI.  
Use of RRI measurement on this scale would require a more cost effective 
and accessible approach than that offered by expert hospital based 
ultrasound services. Ultimately, if further research supports RRI as a clinically 
useful predictor of AKI, this could be the driver required for commercial 
development of an automated measurement system. However, further large 
scale prospective studies are needed to confirm the predictive value of RRI 
for AKI if this investment is to be justified.  
 
As a broad principle, research activity involving patients in an acute setting 
should only be undertaken if the research questions cannot be answered 
elsewhere (Sahan et al 2016). There should be evidence to support the 
likelihood of improvement in diagnosis or therapy in this group, and a 
reasonable assumption that the intervention will be feasible in this context.  
This study has confirmed that, using a state of the art point of care ultrasound 
system, RRI measurement is not feasible in patients requiring resuscitation 
room care. However, these patients remain a high priority group where rapid 
clinical decision making is required and there is opportunity for early 
implementation of a renal protective care bundle.  
It is recommended that validation of RRI for AKI prediction and risk 
stratification should be explored further in alternative patient groups before 
implementation in an ED patient population can be considered.  
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Detailed summary of Phase 2 literature Search strategy   (2014) 
 
Outlined below are details of the initial Phase 2 literature search. It is from this 




In emergency department patients requiring resuscitations room care, 
can Renal Resistive Index predict the development of acute kidney 
injury? 
Specific objectives of the search strategy were to identify current literature 
that: 
1. establish the evidence base for the role of RRI in the diagnosis 
           and prognostic stratification of AKI.  
2. relate directly to the diagnosis and management of AKI in emergency 
 department patients.  
3. relate directly to the use of RRI to identify patient risk of AKI in an  
           ED context. (ie Has this study already been done?) 
 
Terminology 
The term ‘acute kidney injury’ is recognised internationally. However, there 
are numerous inconsistencies in use of terminology within current literature. 
The search strategy was formulated using a range of key words and 
truncations that reflect these observed variations. 
English language papers reporting the use of Doppler renal resistive index 
use a variety of synonymous terms and abbreviations including renal RI, 
renal resistive index, renal Doppler, RI and RRI. 
In subsequent stages of the search these terms were used to identify studies 
of Doppler ultrasound investigation of renal blood flow parameters and the 
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terms “emergency” and  “ED” were used to identify emergency department 
context specific studies.  
Initial search  
An initial search was performed in each database using the Boolean 
operators “AND” and “OR” to identify papers with the words “acute kidney 
injury” OR “acute renal failure” OR “acute renal injury” OR “acute kidney 
failure” in the title / abstract.  
A repeat search for renal RI, renal resistive index, renal Doppler, RI and 
RRI was undertaken using the same limits.   
Limits were activated to include Humans, Clinical Trial, All Adult: 19+ 
years, published in the last 5 years. No language restrictions were used. 
 
In Pubmed, a combined search for these terms identified two papers by 
Schnell, D., L. Camous, et al. (2013) and Schnell, D., S. Deruddre, et al. 
(2012). Neither of the two papers fit the search criteria of an emergency 
department context. 
The search was then repeated with an extended time limitation of 10 years. 
No additional papers were identified. Repeat of the search with the clinical 
trial limit removed again identified no additional papers matching the 
remaining criteria.  
The initial search terms for AKI were then combined separately with 
emergency department OR ED in a title/abstract search. This identified 7 
papers. 
Of these, 3 papers (Nickolas et al. 2012, Ruedinger et al.2012 and Schinstock 
et al 2013) explore the diagnosis and prognostic stratification of AKI in an ED 
context. Manual review of these papers confirms no direct reference to renal 
resistive index.    
The above search strategy was repeated in EMBASE (restricted to humans 
and time limited from 2009). This identified 3 further papers meeting all 
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criteria, Barbani et al. (2010), Fremin et al. (2012) and Ngai et al. (2011) 
However none of these related directly to an ED context.   
Combined search for AKI and RRI (and alternative terms) returned 90 papers.  
Manual review of these identified 34 papers that relate to the use of RRI as a 
predictor of AKI.   
AKI diagnosis and management updated search 
To gain an overview of the current evidence base for AKI diagnosis and 
management, the strategy used in the Phase 2 (Unit 8) literature search was 
repeated to identify papers published in the intervening period.  
Search terms were revised to target papers with the term ‘acute kidney injury’ 
or the abbreviation ‘AKI’ in the title. When limited to Humans, Clinical Trial, 
All Adult: 19+ years, published in the last 5 years, this identified 177 
papers in total in pubmed.  
Manual review of these identified 73 papers relating to the initial diagnosis of 
AKI.  
Exclusion criteria included narrow focus on comparative renal replacement 
therapies, peri-operative risk of AKI associated with alternative surgical 
interventions and assessment of transplanted kidneys. 
Search of the 73 papers identified above combined with (emergency 
department [Title/Abstract]) identified no additional relevant studies.  
Author searches for the key papers identified in the initial stage of the search 
identified Bagshaw S.M, as a prolific author with 37 AKI related papers listed 
in PUBMED for this 5 year period. Manual review of these identified no 
additional relevant clinical trials.  
Repeat of the above search in EMBASE for AKI or acute kidney injury and 




EMBASE search for AKI or acute kidney injury in combination with 
“emergency department” identified 138 papers, manual review of which 
identified 5 additional studies of AKI diagnosis in an ED population.  
The Cochrane Central Register of Controlled Trials was used to search for 
AKI studies that had not been identified by combined searches within the 
other data bases. This identified 21 review articles all of which focus on drug 
treatments for the prevention and treatment of AKI and comparative methods 
of renal replacement therapy. None of the studies identified evaluated 
methods of AKI diagnosis or prognostic stratification. Further exploration of 
the Cochrane data base for relevant trials identified only one further study of 
renal resistive index (Naesens et al 2014).  
Review of Cochrane Renal Review Group activity (including protocols 
currently undergoing referee scrutiny) identified two protocols in progress that 
explore the use of biomarkers in the assessment of renal function. No 
protocols are identified that link directly to either the role of RRI or an ED 
context.  
Repeat search in Web of Science [Title=(acute kidney injury) AND 
Title=(“resistive index”)] identified 8 references including 2 previously 
unidentified conference abstracts (An et al 2013, Sinning et al 2013). Review 
of the conference proceedings in which these abstracts were published 
identified one further abstract (Youngsoo Kim et al 2013) that explores 
diagnosis and progression of AKI in ED trauma patients.  
Despite the obvious advantages of electronic data bases, it is recognised that 
they are not infallible. (Aveyard 2010). However, in this instance, manual 
review of the reference lists for each of the papers identified above produced 
no further records of new clinical trials relevant to the search.    
 
Conclusion 
Building on the search undertaken during Unit 5, combined searches in 
PUBMED, EMBASE, Web of Science and Cochrane Central Register of 
160 
 
Controlled Trials identified a small number of new studies that add additional 
support to the use of RRI as a predictor of AKI.  
However, no studies were identified that explore this measure in an ED 
population. The originality of the proposed study is therefore confirmed.  
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Combined search for AKI and RRI (and alternative terms) – manual review of 
90 papers identified 32 papers that relate to the use of RRI as a predictor of 
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Manual review of 171 papers identified 73 studies relating to the initial 
diagnosis of AKI. 
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Appendix A2a     PARTICIPANT INFORMATION SHEET   PISv1.1b 
(Short version) 
 
Study Title: Can measurement of renal resistive index identify risk of acute kidney 
injury in emergency department patients requiring resuscitation room care? 
We would like to invite you to take part in a research study.  Before you decide to take part 
we would like to provide you with some information about the research and what it will 
involve for you. Take as long as you need to read the information and please ask us to 
explain anything you do not understand or if you have any further questions. 
 
What is the purpose of this research study?   We want to know if an ultrasound scan 
can help us to identify patients who are at risk of a condition known as acute kidney 
injury. It is important that we treat this condition quickly to prevent permanent 
damage to the kidneys. However, in its early stage it can be difficult to detect.  
 
Why have I been invited to take part?   You are being asked to take part in the study 
as your current illness means that you may be at risk of acute kidney injury.  
 
Who is doing the research? A PhD student from the University of Bath, working 
under the supervision of one of the Consultant doctors in the Emergency 
Department.  
 
What will happen if I agree to take part?   You will be required to sign a consent 
form to say that you are happy to take part in the study.  
We will do an ultrasound scan of your kidneys. This will take around five to ten 
minutes. It will involve putting a small amount of gel onto your upper abdomen and 
you will be asked to hold your breath briefly while we take the measurements. 
 
How will this affect my treatment? 
Taking part in the study will not change your treatment in any way.  
 
Do I have to agree to take part?   No. Taking part in the study is entirely voluntary.  
 
Are there any risks involved?   No. Ultrasound is a very safe imaging technique that 
does not involve ionising radiation or any known risk used in this way. The research 
team are all qualified ultrasound users.  
 
Can I change my mind?   Yes. You are free to withdraw at any time up to the stage 
where we analyse the results of the study. You do not need to give a reason for your 
withdrawal. 
 
Further information   Before you leave the department you will be given a more 
detailed information sheet about the study. You will be able to ask more questions 
and consider if you want to take part.  
 
Heather Venables (Principle Researcher) 
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Appendix A2 b    PARTICIPANT INFORMATION SHEET   PISv1.1b 
(Long  version) 
Study Title: Can measurement of renal resistive index identify risk of acute kidney 
injury in emergency department patients requiring resuscitation room care? 
We would like to invite you to take part in a research study.  Before you decide to take 
part we would like to provide you with some information about the research and what it 
will involve for you. Take as long as you need to read the information and please ask us 
to explain anything you do not understand or if you have any further questions.  
 
What is the purpose of this research study?   We want to know if an ultrasound scan 
can help us to identify patients who are at risk of a condition known as acute kidney 
injury. It is important that we treat this condition quickly to prevent permanent 
damage to the kidneys. However, in its early stage it can be difficult to detect.  
In patients with this condition, there is a sudden change in how well their kidneys 
are working.  This study will explore if an ultrasound scan to measure blood flow in 
the kidney could be a better way of detecting these changes.  
 
Why have I been invited to take part?   You are being asked to take part in the study 
as your current illness means that you may be at risk of acute kidney injury.  
 
Who is doing the research?   The research is being undertaken by a postgraduate 
student from the University of Bath, working under the supervision of one of the 
Consultant doctors in the Emergency Department here at The Royal Derby Hospital. 
The study has been approved by both the University of Bath and by the local NHS 
ethics committee. 
 
What will happen if I agree to take part?   You will be required to sign a consent 
form to say that you are happy to take part in the study.  
 
As well as the routine blood and urine tests that we take to check how well your 
kidneys are working, we will do an ultrasound scan of your kidneys. This will take 
around five to ten minutes. It will involve putting a small amount of gel onto your 
upper abdomen and you will be asked to hold your breath briefly while we take the 
measurements. 
 
Who will do the scan?   If you agree to take part in the study, the doctor in charge of 
your care will ask another member of the study research team to complete the 
scan. This will be either the lead researcher who is a qualified sonographer or one of 
the Emergency Department doctors.  
 
How will this affect my treatment?   Taking part in the study will not change your 
treatment in any way. The doctor in charge of your care will not be told the scan 
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results and these will not be used to alter how we manage your current illness or 
future treatment.  
 
Are there any risks involved?   No. Ultrasound is a very safe imaging technique that 
does not involve ionising radiation or any known risk used in this way. The research 
team are all trained ultrasound users who hold a recognised ultrasound qualification.  
 
Are there any benefits if I decide to take part?   There are no known benefits for 
you in this study. Your care will not be altered in any way. However, we are hopeful 
that the results of the study will be of benefit to future patients.  
 
Do I have to agree to take part?   No. Taking part in the study is entirely voluntary. 
Whatever you decide, this will not change your treatment in any way.  
 
Can I change my mind?   Yes. There will be further opportunities to ask more 
questions and consider if you want to take part. You are free to withdraw at any time 
up to the stage where we analyse the results of the study. You have the right to ask 
that any data you have supplied to that point be withdrawn. You do not need to give 
a reason for your withdrawal. 
 
Confidentiality   The results of your scan and the data that we collect from your 
medical notes will be kept confidential. We will not collect any personal details 
about you except your age, gender, blood and urine test results and relevant history 
of kidney disease. All data will be anonymised, stored in accordance with Trust data 
protection regulations and will only be accessible to the research team.  
 
Any personal details, such as your hospital number or date of birth will be kept 
separately to the data collected as part of the study. These details will only be 
identifiable by a ‘research study number’ and will only be accessed by the principle 
investigator and the doctor supervising the study. . 
 
What will happen to the results of the study? 
The final report will be submitted to the University of Bath, for journal publication 
and for presentation nationally / internationally. 
 
Further information   If you, or a member of your family need any further information 
about the study, a member of the study research team will be glad to answer your 
questions.  
I can be contacted at any time by email at h.venables@derby.ac.uk or you can 
contact Dr Iain Lennon (the doctor who is supervising the study) on 01332 787859 
 
If you would like to find out about the final results of this study, you are welcome to 
email h.venables@derby.ac.uk     




Appendix 3 Data collection sheet  - Derby RRI Study 2016 
 
Please ensure the patient has received and read the patient information 




Adult patient requiring 




Unable to consent 
Confirmed or suspected cardiac arrest 




Age: Sex:         M   /    F            (Circle appropriate) 
















 RRI Measurement 
Scanned by: (N.B. this should not be the treating 
doctor) 
Your    Grade 
 
 Consultant    
 Middle Grade    
 FY1-ST2    
 Other     










In which kidney? 
(Right preferred) 
 




















Please return this form to the Collection Box in Cubicles Area 
 
Thank you for your involvement, 
Both kidneys imaged?                            Y   /    N 






Plan documented in clinical notes?                           
Y   /   N 
Any technical difficulties?                                                                                                                         
Y   /    N        
(Please specify) 
 
Study ref. number 
Official use only 
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Appendix 4   Diagnosis and staging criteria for AKI 
 
 
AKIN diagnostic criteria for AKI   (Mehta et al. 2007) 
1. Rapid time course (less than 48 hours) 
2. Reduction of kidney function  
o Rise in serum creatinine  
 Absolute increase in serum creatinine of ≥0.3 mg/dl 
(≥26.4 μmol/l) 
 Percentage increase in serum creatinine of ≥50% 




RIFLE criteria for staging of AKI   (Ricci et al. 2011) 
 Risk: serum creatinine increased 1.5 times or urine production of <0.5 
ml/kg for 6 hours 
 Injury: doubling of creatinine or urine production <0.5 ml/kg for 12 
hours 
 Failure: tripling of creatinine or creatinine >355 μmol/l (with a rise of 
>44) (>4 mg/dl) OR urine output below 0.3 ml/kg for 24 hours 
 Loss: persistent AKI or complete loss of kidney function for more than 4 
weeks 
 End-stage renal disease: complete loss of kidney function for more 















Patient Identification Number for this trial: 
CONSENT FORM 
Title of Project: In emergency department patients requiring resuscitation room care, can 
Renal Resistive Index measurements predict the development of acute kidney injury?                                                                                                 
Name of Researcher: Heather Venables 
Please initial 
all boxes  
1. I confirm that I have read and understand the information sheet [dated 11
th
 OCT 
2015] version [PISshortv1.1] for the above study.  I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily. 
   
2. I understand that my participation is voluntary and that I am free to withdraw (up 
to the point of data analysis) without giving any reason, without my medical care 
or legal rights being affected. 
 
3. I understand that relevant sections of my medical notes and data collected 
during the study may be looked at by the research team where it is relevant to 
my taking part in this research.  I give permission for these individuals to have 
access to my records. 
 
4. I agree to take part in the above study.    
 
            
Name of Participant   Date    Signature 
 
             
Name of recruiting   Date    Signature  
Doctor.  
     
            




Appendix 6    Phase 2 : Reflection on sample size estimate 
 
The importance of a priori calculation of study sample size and anticipated 
study power is well documented (Suresh 2012, Peeling 2010, Bacchetti 2010, 
Fozgate 2009). However, this key stage of study design is frequently missing 
from studies that evaluate the characteristics of diagnostic test (ibid). Study 
power of anything less than 80% appears to be a standard measure by which 
most review committees would consider a study to be unethical. However, this 
appears to be an almost arbitrary cut off and the assumptions on which power 
and sample size calculations are made may be inherently difficult to 
determine at the outset of a study (Bacchetti 2010).    
To extent to which estimates of diagnostic parameters such as test sensitivity, 
specificity, predictive value etc. can be viewed as precise is dependent on 
confidence intervals. In general, the larger the sample size, the narrower 
these intervals are likely to be. However, in an Emergency Department 
setting, where patients are un-well and disruption to care pathways needs to 
be minimised, a large sample size may be ethically unjustified.  
Prevalence of the condition in the total study population will also affect the 
precision of estimates. Where prevalence is low, sensitivity estimates may be 
misleading. Predictive values are also population specific with PPV increasing 
and NPV decreasing as prevalence of the condition in the population 
increases.  
Sensitivity and Specificity 
For the proposed study, one of the key challenges has been estimating how 
well RRI is likely to perform in the study population. Sensitivity and specificity 
are as yet unknown, as is prevalence of the condition in the study population. 
A priori power calculation must therefore be based on ‘best guesses’.    
RRI is a continuous variable and in the studies reviewed, cut off points for 
normal vary and are context specific. Standard deviation for these values in 
an ED population is unknown and small changes in estimated values have a 
marked impact on sample size calculation.  
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Reported test characteristics from previous studies of RRI are based almost 
exclusively in a critical care context where patients are very unwell and the 
prevalence of AKI is high (53% - 69%).  
Audit of available local data suggests that approximately 32% of patients will 
be identified as at risk of AKI at admission (eGFR < 60). However at follow-up 
(eGFR < 60 at 48 hours) this falls to approximately 7%.  (See table T1.10c) 
Poor specificity is a known limitation of sCr based calculation of eGFR (where 
a baseline value is not known).  The fall in confirmed AKI numbers at 48hrs 
would therefore be anticipated. However, these numbers will also be 
influenced by successful preventive treatment and reversal of renal 
dysfunction.   
Sensitivity of eGFR in this population is unknown. However, as change in sCr 
level is known to lag behind the initial renal insult, risk at presentation based 
on sCr level is likely to be underestimated. This would imply low sensitivity of 
the standard test.  
Follow-up data on patients with eGFR >60 (normal) at admission are not yet 
available. From the audit data analysed to date, it is not possible to establish 
an accurate prevalence of AKI in this population.  
Best guesses 
The College of Emergency Medicine recommend a fairly pragmatic approach 
to sample size calculation using a simple two way table, ‘best guess’ 
estimates of sensitivity / specificity and prevalence and required confidence 
intervals (CEM 2014).  
NICE (2013) report AKI in 13–18% of all UK hospital admissions.  
For the purpose of calculation of confidence intervals for this study, an 
estimated prevalence of 15% has been assumed. This is consistent with Trust 
data on all hospital admissions. (The actual prevalence is likely to be higher in 




A conservative target recruitment of 200 patients (based on discussion of 
feasibility with the department lead) and a reported range of values of 
sensitivity and specificity (Appendix  A1.3) have been used as the basis for 
estimation of predictive values. 
 
200 patients    Prevalence 15%  
Sensitivity 90%    Specificity  80% 
True +ve  27      True –ve  136 
False +ve  34      False –ve  3 
 
 
200 patients    Prevalence 15%   
Sensitivity  81%   Specificity 70% 
True +ve  24      True –ve  119 
False +ve  51     False –ve  6 
 
These estimates of predictive values were used to calculate confidence 
intervals using MedCalc Software, (On-line) Version 13.2.2 - Last modified: 
May 22, 2014  
http://www.medcalc.org/calc/diagnostic_test.php 
(See tables T1.10 a & T1.10 b) 
 
Conclusion 
The extent to which the confidence intervals calculated above are accurate or 
acceptable remains to be seen. Negative predictive values appear to be 
encouraging but are dependent on accurate prediction of prevalence. 
Increasing risk of AKI is closely associated with severity of illness. As patients 
lacking capacity to consent (sicker or unconscious patients) will be excluded, 
the prevalence of AKI is therefore likely to be lower in the study population 































than in a typical resuscitation room population. Predictive values in an 
unselected population are likely to be higher. 
For RRI to be clinically useful in this context, improved test characteristics will 
need to be  sufficiently better than the existing screening test to justify the 
associated resource implications. Where ultrasound is used in an ED context, 
it is generally used as a ‘rule in’ tool rather than to exclude patients from 
routine clinical follow up. Specificity (important for a rule in test) needs to be 
high enough to enable clinicians to make a meaningful risk benefit judgement 
re implementation of a renal care protective bundle in patients with a positive 
test result. This may for example include withdrawal or avoidance of drugs 
such as anti hypertensives, NSAIDs, gentamicin etc that would otherwise be 
used routinely. However, the specificity of eGFR (the current ‘gold standard’) 
is remarkably low. So low in fact that it is use simply to flag the need for 
further monitoring rather than to change management.  
Confidence intervals for RRI sensitivity appear to be fairly wide. However, 
they appear to be considerably smaller than the acknowledged confidence 
intervals for eGFR. Recent studies suggest that the sensitivity of RRI in this 
context is likely to be better than eGFR. 
Inaccuracies in sample size calculation appear to be an acknowledged feature 
of a high percentage of published studies (Ayeni et al 2011, Giraudeau 2009, 
Bacchetti 2010).  Yet this seems to be regarded as a ‘make or break’ stage of 
study design within the ethical review process. In considering the design of 
this particular study, numerous approaches to power and sample calculation 
have been explored and I feel I now have a far better appreciation of the 
interdependence of the variables used. However, the degree of estimation 
necessary in some of these parameters leaves me questioning the extent to 
which a meaningful conclusion can be reached.  If I was an accountant I 
would be asking “ ….what number did you have in mind?”.  
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Table T1.10 a 
200 patients    Prevalence 15%   Sensitivity 90%    Specificity  80% 
  Disease         
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= 90.00 % 95% CI: 73.44 % to 97.77 % 
Specificity 
d 
b + d 
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= 4.50 95% CI: 3.26 to 6.22 
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95% CI: 93.81 % to 99.53 % 
 
MedCalc Software, (On-line) Version 13.2.2 
 
Table T1.10 b 
200 patients    Prevalence 15%   Sensitivity  81%   Specificity 70% 
  Disease         


















  c + d = 125 





a + c 
 
= 80.00 % 95% CI: 61.42 % to 92.24 % 
Specificity 
d 
b + d 
 





100 - Specificity 
 






100 - Sensitivity 
Specificity 
 
= 0.29 95% CI: 0.14 to 0.59 
Disease 
prevalence 
a + c 
a + b + c + d 
 





a + b 
 





c + d 
 
= 95.20 % (*) 95% CI: 89.84 % to 98.21 % 
 
MedCalc Software, (On-line) Version 13.2.2 
 
